www.globalpharmainsights.com Open in urlscan Pro
143.204.237.71 Public Scan

Go To Rescan
Add Verdict Report

Submitted URL:
http://app.go02.informamarkets.com/e/er?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEA...
Effective URL:
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesiv...
Submission: On June 12 via manual (June 12th 2020, 5:43:17 pm UTC) from IN

Summary HTTP 152 Redirects Links 28 Behaviour Indicators

Summary

This website contacted 39 IPs in 9 countries across 30 domains to perform 152 HTTP transactions. The main IP is 143.204.237.71, located in Seattle, United States and belongs to AMAZON-02, US. The main domain is www.globalpharmainsights.com.
TLS certificate: Issued by Amazon on May 7th 2020. Valid for: a year.

This is the only time www.globalpharmainsights.com was scanned on urlscan.io!

urlscan.io Verdict: No classification

Domain & IP information

	IP Address	AS Autonomous System
1 1	141.145.8.14 141.145.8.14	43898 (ORCL-AM-OPC1) (ORCL-AM-OPC1)
1 1	141.145.8.13 141.145.8.13	43898 (ORCL-AM-OPC1) (ORCL-AM-OPC1)
57	143.204.237.71 143.204.237.71	16509 (AMAZON-02) (AMAZON-02)
4	2a00:1450:400... 2a00:1450:4001:81d::2002	15169 (GOOGLE) (GOOGLE)
3	2a02:26f0:10c... 2a02:26f0:10c:382::1e80	20940 (AKAMAI-ASN1) (AKAMAI-ASN1)
1 1	178.79.245.69 178.79.245.69	22822 (LLNW) (LLNW)
1	178.79.227.128 178.79.227.128	22822 (LLNW) (LLNW)
17	216.58.210.2 216.58.210.2	15169 (GOOGLE) (GOOGLE)
1	2a00:1450:400... 2a00:1450:4001:821::2002	15169 (GOOGLE) (GOOGLE)
1	2a00:1450:400... 2a00:1450:4001:809::2001	15169 (GOOGLE) (GOOGLE)
7	2a00:1450:400... 2a00:1450:4001:802::2001	15169 (GOOGLE) (GOOGLE)
2	34.241.125.133 34.241.125.133	16509 (AMAZON-02) (AMAZON-02)
1	54.229.146.68 54.229.146.68	16509 (AMAZON-02) (AMAZON-02)
1 1	66.117.28.86 66.117.28.86	15224 (OMNITURE) (OMNITURE)
1	143.204.89.116 143.204.89.116	16509 (AMAZON-02) (AMAZON-02)
1	2a00:1450:400... 2a00:1450:4001:825::2008	15169 (GOOGLE) (GOOGLE)
5	2606:4700::68... 2606:4700::6812:fb0	13335 (CLOUDFLAR...) (CLOUDFLARENET)
6	2a01:4a0:1338... 2a01:4a0:1338:28::c38a:ff0a	201011 (NETZBETRI...) (NETZBETRIEB-GMBH)
1	15.188.154.177 15.188.154.177	16509 (AMAZON-02) (AMAZON-02)
1	147.75.33.233 147.75.33.233	54825 (PACKET) (PACKET)
1	143.204.237.68 143.204.237.68	16509 (AMAZON-02) (AMAZON-02)
2	2a00:1450:400... 2a00:1450:4001:819::2004	15169 (GOOGLE) (GOOGLE)
14	72.247.226.64 72.247.226.64	16625 (AKAMAI-AS) (AKAMAI-AS)
2	2a03:2880:f01... 2a03:2880:f01c:8012:face:b00c:0:3	32934 (FACEBOOK) (FACEBOOK)
1	2a02:26f0:10c... 2a02:26f0:10c:287::19fd	20940 (AKAMAI-ASN1) (AKAMAI-ASN1)
1	172.217.22.98 172.217.22.98	15169 (GOOGLE) (GOOGLE)
1	147.75.101.5 147.75.101.5	54825 (PACKET) (PACKET)
2	34.253.133.202 34.253.133.202	16509 (AMAZON-02) (AMAZON-02)
1	35.177.118.109 35.177.118.109	16509 (AMAZON-02) (AMAZON-02)
1	147.75.33.229 147.75.33.229	54825 (PACKET) (PACKET)
1	2a00:1450:400... 2a00:1450:4001:808::2002	15169 (GOOGLE) (GOOGLE)
1	2a03:2880:f11... 2a03:2880:f11c:8183:face:b00c:0:25de	32934 (FACEBOOK) (FACEBOOK)
2 2	37.252.172.250 37.252.172.250	29990 (ASN-APPNEX) (ASN-APPNEX)
2	34.192.142.95 34.192.142.95	14618 (AMAZON-AES) (AMAZON-AES)
1	2a00:1450:400... 2a00:1450:4001:814::2003	15169 (GOOGLE) (GOOGLE)
1	2a00:1450:401... 2a00:1450:4017:802::2003	15169 (GOOGLE) (GOOGLE)
1 1	172.217.23.130 172.217.23.130	15169 (GOOGLE) (GOOGLE)
1	35.241.8.149 35.241.8.149	15169 (GOOGLE) (GOOGLE)
3	2a00:1450:400... 2a00:1450:4001:800::2002	15169 (GOOGLE) (GOOGLE)
1 2	99.80.128.92 99.80.128.92	16509 (AMAZON-02) (AMAZON-02)
1 4	72.247.224.172 72.247.224.172	16625 (AKAMAI-AS) (AKAMAI-AS)
1	151.101.12.84 151.101.12.84	54113 (FASTLY) (FASTLY)
1 1	3.248.3.168 3.248.3.168	16509 (AMAZON-02) (AMAZON-02)
1	54.171.23.184 54.171.23.184	16509 (AMAZON-02) (AMAZON-02)
1	54.84.119.213 54.84.119.213	14618 (AMAZON-AES) (AMAZON-AES)
152	39

1 141.145.8.14 (Amsterdam, Netherlands) 1 redirects

ASN43898 (ORCL-AM-OPC1, NL)

app.go02.informamarkets.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 141.145.8.13 (Amsterdam, Netherlands) 1 redirects

ASN43898 (ORCL-AM-OPC1, NL)

s734445500.t.eloqua.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

57 143.204.237.71 (Seattle, United States)

ASN16509 (AMAZON-02, US)
PTR: server-143-204-237-71.cph50.r.cloudfront.net

www.globalpharmainsights.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

4 2a00:1450:4001:81d::2002 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)

www.googletagservices.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

3 2a02:26f0:10c:382::1e80 (Ascension Island)

ASN20940 (AKAMAI-ASN1, EU)

assets.adobedtm.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 178.79.245.69 (Italy) 1 redirects

ASN22822 (LLNW, US)
PTR: vps-011.fra.llnw.net

video.limelight.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 178.79.227.128 (Italy)

ASN22822 (LLNW, US)
PTR: https-178-79-227-128.vie.llnw.net

s.delvenetworks.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

17 216.58.210.2 (Mountain View, United States)

ASN15169 (GOOGLE, US)
PTR: fra16s07-in-f2.1e100.net

securepubads.g.doubleclick.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2a00:1450:4001:821::2002 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)

adservice.google.de	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2a00:1450:4001:809::2001 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)

ed730ada98a1d488854a0d81e1ecf867.safeframe.googlesyndication.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

7 2a00:1450:4001:802::2001 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)

tpc.googlesyndication.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 34.241.125.133 (Dublin, Ireland)

ASN16509 (AMAZON-02, US)
PTR: ec2-34-241-125-133.eu-west-1.compute.amazonaws.com

dpm.demdex.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 54.229.146.68 (Dublin, Ireland)

ASN16509 (AMAZON-02, US)
PTR: ec2-54-229-146-68.eu-west-1.compute.amazonaws.com

informaglobalexhibitions.demdex.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 66.117.28.86 (United States) 1 redirects

ASN15224 (OMNITURE, US)

cm.everesttech.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 143.204.89.116 (Seattle, United States)

ASN16509 (AMAZON-02, US)
PTR: server-143-204-89-116.fra50.r.cloudfront.net

tags.crwdcntrl.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2a00:1450:4001:825::2008 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)

www.googletagmanager.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

5 2606:4700::6812:fb0 (United States)

ASN13335 (CLOUDFLARENET, US)

assets.pinterest.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

6 2a01:4a0:1338:28::c38a:ff0a (Germany)

ASN201011 (NETZBETRIEB-GMBH, DE)

use.typekit.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 15.188.154.177 (Paris, France)

ASN16509 (AMAZON-02, US)
PTR: ec2-15-188-154-177.eu-west-3.compute.amazonaws.com

informaglobalexhibitions.d3.sc.omtrdc.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 147.75.33.233 (Amsterdam, Netherlands)

ASN54825 (PACKET, US)
PTR: pkt-ams-k2-shared-ingress14

static.hotjar.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 143.204.237.68 (Seattle, United States)

ASN16509 (AMAZON-02, US)
PTR: server-143-204-237-68.cph50.r.cloudfront.net

s.dpmsrv.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 2a00:1450:4001:819::2004 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)

www.google.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

14 72.247.226.64 (United States)

ASN16625 (AKAMAI-AS, US)
PTR: a72-247-226-64.deploy.static.akamaitechnologies.com

z.moatads.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools
px.moatads.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 2a03:2880:f01c:8012:face:b00c:0:3 (Ireland)

ASN32934 (FACEBOOK, US)

connect.facebook.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2a02:26f0:10c:287::19fd (Ascension Island)

ASN20940 (AKAMAI-ASN1, EU)

p.typekit.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 172.217.22.98 (United States)

ASN15169 (GOOGLE, US)
PTR: fra15s18-in-f98.1e100.net

www.googleadservices.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 147.75.101.5 (Central, Hong Kong)

ASN54825 (PACKET, US)
PTR: pkt-ams-k2-shared-ingress16

script.hotjar.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 34.253.133.202 (Dublin, Ireland)

ASN16509 (AMAZON-02, US)
PTR: ec2-34-253-133-202.eu-west-1.compute.amazonaws.com

ml314.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 35.177.118.109 (London, United Kingdom)

ASN16509 (AMAZON-02, US)
PTR: ec2-35-177-118-109.eu-west-2.compute.amazonaws.com

geo.moatads.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 147.75.33.229 (Amsterdam, Netherlands)

ASN54825 (PACKET, US)
PTR: pkt-ams-k2-shared-ingress12

vars.hotjar.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2a00:1450:4001:808::2002 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)

googleads.g.doubleclick.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2a03:2880:f11c:8183:face:b00c:0:25de (Ireland)

ASN32934 (FACEBOOK, US)

www.facebook.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 37.252.172.250 (Ascension Island) 2 redirects

ASN29990 (ASN-APPNEX, US)
PTR: 538.bm-nginx-loadbalancer.mgmt.fra1.adnexus.net

ib.adnxs.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 34.192.142.95 (Ashburn, United States)

ASN14618 (AMAZON-AES, US)
PTR: ec2-34-192-142-95.compute-1.amazonaws.com

a.dpmsrv.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2a00:1450:4001:814::2003 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)

www.google.de	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 2a00:1450:4017:802::2003 (Ireland)

ASN15169 (GOOGLE, US)

csi.gstatic.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 172.217.23.130 (United States) 1 redirects

ASN15169 (GOOGLE, US)
PTR: fra16s18-in-f2.1e100.net

cm.g.doubleclick.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 35.241.8.149 (Ascension Island)

ASN15169 (GOOGLE, US)
PTR: 149.8.241.35.bc.googleusercontent.com

idsync.rlcdn.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

3 2a00:1450:4001:800::2002 (Frankfurt am Main, Germany)

ASN15169 (GOOGLE, US)

pagead2.googlesyndication.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

2 99.80.128.92 (Dublin, Ireland) 1 redirects

ASN16509 (AMAZON-02, US)
PTR: ec2-99-80-128-92.eu-west-1.compute.amazonaws.com

bcp.crwdcntrl.net	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

4 72.247.224.172 (United States) 1 redirects

ASN16625 (AKAMAI-AS, US)
PTR: a72-247-224-172.deploy.static.akamaitechnologies.com

s.adroll.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 151.101.12.84 (Frankfurt am Main, Germany)

ASN54113 (FASTLY, US)

log.pinterest.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 3.248.3.168 (Dublin, Ireland) 1 redirects

ASN16509 (AMAZON-02, US)
PTR: ec2-3-248-3-168.eu-west-1.compute.amazonaws.com

d.adroll.mgr.consensu.org	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 54.171.23.184 (Dublin, Ireland)

ASN16509 (AMAZON-02, US)
PTR: ec2-54-171-23-184.eu-west-1.compute.amazonaws.com

d.adroll.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

1 54.84.119.213 (Ashburn, United States)

ASN14618 (AMAZON-AES, US)
PTR: ec2-54-84-119-213.compute-1.amazonaws.com

in.ml314.com	Domain lookup VirusTotal SecurityTrails crt.sh Censys Domaintools

	Apex Domain Subdomains	Transfer
57	globalpharmainsights.com www.globalpharmainsights.com	897 KB
19	doubleclick.net 1 redirects securepubads.g.doubleclick.net googleads.g.doubleclick.net cm.g.doubleclick.net	127 KB
15	moatads.com z.moatads.com geo.moatads.com px.moatads.com	200 KB
11	googlesyndication.com ed730ada98a1d488854a0d81e1ecf867.safeframe.googlesyndication.com tpc.googlesyndication.com pagead2.googlesyndication.com	46 KB
7	typekit.net use.typekit.net p.typekit.net	157 KB
6	pinterest.com assets.pinterest.com log.pinterest.com	23 KB
5	adroll.com 1 redirects s.adroll.com d.adroll.com	14 KB
4	googletagservices.com www.googletagservices.com	97 KB
3	ml314.com ml314.com in.ml314.com	14 KB
3	dpmsrv.com s.dpmsrv.com a.dpmsrv.com	86 KB
3	hotjar.com static.hotjar.com script.hotjar.com vars.hotjar.com	72 KB
3	crwdcntrl.net 1 redirects tags.crwdcntrl.net bcp.crwdcntrl.net	15 KB
3	demdex.net dpm.demdex.net informaglobalexhibitions.demdex.net	2 KB
3	adobedtm.com assets.adobedtm.com	64 KB
2	adnxs.com 2 redirects ib.adnxs.com	3 KB
2	facebook.net connect.facebook.net	68 KB
2	google.com www.google.com	119 B
2	google.de adservice.google.de www.google.de	282 B
1	consensu.org 1 redirects d.adroll.mgr.consensu.org	137 B
1	rlcdn.com idsync.rlcdn.com	59 B
1	gstatic.com csi.gstatic.com	361 B
1	facebook.com www.facebook.com	260 B
1	googleadservices.com www.googleadservices.com	11 KB
1	omtrdc.net informaglobalexhibitions.d3.sc.omtrdc.net	449 B
1	googletagmanager.com www.googletagmanager.com	33 KB
1	everesttech.net 1 redirects cm.everesttech.net	554 B
1	delvenetworks.com s.delvenetworks.com	19 KB
1	limelight.com 1 redirects video.limelight.com	285 B
1	eloqua.com 1 redirects s734445500.t.eloqua.com	1 KB
1	informamarkets.com 1 redirects app.go02.informamarkets.com	906 B
152	30

	Domain	Requested by
57	www.globalpharmainsights.com	www.globalpharmainsights.com
17	securepubads.g.doubleclick.net	www.googletagservices.com securepubads.g.doubleclick.net www.globalpharmainsights.com
12	px.moatads.com	www.globalpharmainsights.com
7	tpc.googlesyndication.com	securepubads.g.doubleclick.net tpc.googlesyndication.com
6	use.typekit.net	www.globalpharmainsights.com use.typekit.net
5	assets.pinterest.com	www.globalpharmainsights.com assets.pinterest.com
4	s.adroll.com	1 redirects www.globalpharmainsights.com s.adroll.com
4	www.googletagservices.com	www.globalpharmainsights.com securepubads.g.doubleclick.net
3	pagead2.googlesyndication.com	securepubads.g.doubleclick.net
3	assets.adobedtm.com	www.globalpharmainsights.com assets.adobedtm.com
2	bcp.crwdcntrl.net	1 redirects tags.crwdcntrl.net
2	a.dpmsrv.com	www.globalpharmainsights.com
2	ib.adnxs.com	2 redirects
2	ml314.com	z.moatads.com ml314.com
2	connect.facebook.net	www.globalpharmainsights.com connect.facebook.net
2	z.moatads.com	securepubads.g.doubleclick.net
2	www.google.com	securepubads.g.doubleclick.net www.globalpharmainsights.com
2	dpm.demdex.net	assets.adobedtm.com www.globalpharmainsights.com
1	in.ml314.com	ml314.com
1	d.adroll.com
1	d.adroll.mgr.consensu.org	1 redirects
1	log.pinterest.com
1	idsync.rlcdn.com	www.globalpharmainsights.com
1	cm.g.doubleclick.net	1 redirects
1	csi.gstatic.com	securepubads.g.doubleclick.net
1	www.google.de	www.globalpharmainsights.com
1	www.facebook.com	www.globalpharmainsights.com
1	googleads.g.doubleclick.net	www.googleadservices.com
1	vars.hotjar.com	static.hotjar.com
1	geo.moatads.com	z.moatads.com
1	script.hotjar.com	static.hotjar.com
1	www.googleadservices.com	www.googletagmanager.com
1	p.typekit.net	www.globalpharmainsights.com
1	s.dpmsrv.com	www.globalpharmainsights.com
1	static.hotjar.com	www.globalpharmainsights.com
1	informaglobalexhibitions.d3.sc.omtrdc.net	assets.adobedtm.com
1	www.googletagmanager.com	assets.adobedtm.com
1	tags.crwdcntrl.net	assets.adobedtm.com
1	cm.everesttech.net	1 redirects
1	informaglobalexhibitions.demdex.net	assets.adobedtm.com
1	ed730ada98a1d488854a0d81e1ecf867.safeframe.googlesyndication.com	securepubads.g.doubleclick.net
1	adservice.google.de	www.googletagservices.com
1	s.delvenetworks.com	www.globalpharmainsights.com
1	video.limelight.com	1 redirects
1	s734445500.t.eloqua.com	1 redirects
1	app.go02.informamarkets.com	1 redirects
152	46

This site contains links to these domains. Also see Links.

Domain
engage.informa.com
twitter.com
www.facebook.com
www.linkedin.com
www.youtube.com
www.cphi.com
www.cphi-online.com
awards.cphi.com
www.informamarkets.com

Subject Issuer	Validity	Valid
digital.hospitalar.com Amazon	`2020-05-07` - `2021-06-07`	a year	crt.sh
*.g.doubleclick.net GTS CA 1O1	`2020-05-26` - `2020-08-18`	3 months	crt.sh
assets.adobedtm.com DigiCert SHA2 High Assurance Server CA	`2019-10-22` - `2021-10-01`	2 years	crt.sh
*.hs.llnwd.net Sectigo RSA Organization Validation Secure Server CA	`2020-05-12` - `2021-05-12`	a year	crt.sh
*.google.de GTS CA 1O1	`2020-05-26` - `2020-08-18`	3 months	crt.sh
tpc.googlesyndication.com GTS CA 1O1	`2020-05-26` - `2020-08-18`	3 months	crt.sh
*.demdex.net DigiCert SHA2 High Assurance Server CA	`2018-01-09` - `2021-02-12`	3 years	crt.sh
*.crwdcntrl.net Go Daddy Secure Certificate Authority - G2	`2019-06-13` - `2021-06-28`	2 years	crt.sh
*.google-analytics.com GTS CA 1O1	`2020-05-26` - `2020-08-18`	3 months	crt.sh
*.pinterest.com DigiCert SHA2 High Assurance Server CA	`2020-05-28` - `2021-06-10`	a year	crt.sh
use.typekit.net DigiCert SHA2 Secure Server CA	`2020-01-28` - `2022-02-01`	2 years	crt.sh
*.d3.sc.omtrdc.net DigiCert SHA2 High Assurance Server CA	`2020-02-28` - `2022-03-04`	2 years	crt.sh
static.hotjar.com Let's Encrypt Authority X3	`2020-04-04` - `2020-07-03`	3 months	crt.sh
*.dpmsrv.com Amazon	`2019-05-14` - `2020-06-14`	a year	crt.sh
www.google.com GTS CA 1O1	`2020-05-20` - `2020-08-12`	3 months	crt.sh
moatads.com DigiCert SHA2 Secure Server CA	`2020-01-17` - `2021-03-17`	a year	crt.sh
*.facebook.com DigiCert SHA2 High Assurance Server CA	`2020-05-14` - `2020-08-05`	3 months	crt.sh
*.typekit.net DigiCert SHA2 Secure Server CA	`2019-12-06` - `2021-12-10`	2 years	crt.sh
www.googleadservices.com GTS CA 1O1	`2020-05-26` - `2020-08-18`	3 months	crt.sh
script.hotjar.com Let's Encrypt Authority X3	`2020-04-04` - `2020-07-03`	3 months	crt.sh
*.ml314.com Amazon	`2020-02-17` - `2021-03-17`	a year	crt.sh
*.moatads.com DigiCert SHA2 Secure Server CA	`2019-03-12` - `2021-06-10`	2 years	crt.sh
vars.hotjar.com Let's Encrypt Authority X3	`2020-04-04` - `2020-07-03`	3 months	crt.sh
www.google.de GTS CA 1O1	`2020-05-26` - `2020-08-18`	3 months	crt.sh
*.gstatic.com GTS CA 1O1	`2020-05-26` - `2020-08-18`	3 months	crt.sh
*.rlcdn.com Sectigo RSA Domain Validation Secure Server CA	`2020-04-14` - `2021-04-23`	a year	crt.sh
*.adroll.com DigiCert SHA2 Secure Server CA	`2020-01-29` - `2021-04-29`	a year	crt.sh
adroll.mgr.consensu.org Amazon	`2019-11-06` - `2020-12-06`	a year	crt.sh

This page contains 8 frames:

Primary Page: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Frame ID: FC725839DB59BE777EC7EC7C5414AA48
Requests: 126 HTTP requests in this frame

Frame: https://informaglobalexhibitions.demdex.net/dest5.html?d_nsid=0
Frame ID: C88DC44309FF0A7B69414A5553A661C7
Requests: 1 HTTP requests in this frame

Frame: https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjst7KusWkoJxjrzqYha89BaCm7rcRE0CfIL9bTK_buSIGuPhCIcgvsWp1AH5M4Dw2Dv26N7sUL3D2Ufa-pIIs7JfDBrkdwIFova5mdkPsQM11KZbhdHOneMgw8KoL6nCJAabMoGUqFZdeEBjDTewCYgd-eiaUwQ7TibOzezlJQtJphlu694F5Z08881yUk5aUwu1p2NL0UwZE3v8hpXXn_ePv3_zfKE8km-UODwei50P2bjc7TuAd7ZSaY3HA0HbydQL7ASJ5QI8yTuMk0nGKN5PIeT7EH2Vp0vAf8wA5VNaSF2hEskILk8ZJjwKt8E15jckDTPiCib_VpLCQp7c9XekY-zl_i4&sig=Cg0ArKJSzIocuu5QyLG8EAE&adurl=
Frame ID: 479BE8E4C8339E091F27FC63AAE2B36D
Requests: 14 HTTP requests in this frame

Frame: https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjssbWL_xdBiqH6AcN-Jw5GMikq14H1F0nife-qhO9uckQWhNrDE0uygAoLOO7P5ByR8nzszYQDnq33lp2ezPwpwWqKxSPcseLzz2gOYog1otI3WJsoJK7ZQqSXTO5bZgfqZIiQv0wFovxH6mvc5hobzYgKJSLkr33Zy57XDd41rDeg5Ar5jNhIbJvX2yZ1mU1KsqvsPwouQzOg48N8ddWGiQDVPHhYZ3dxwdb4Jje-2Wst-6u2k5u83h2U3N0X55y98bpYr-Qig5sdlw33T19PuHHrfaIP6AzrWiXGfoztKA6ocGLDmO09k5VVjgZ-yFsboG0rbdOICVsmCvFZsYI-eh26meTuk&sig=Cg0ArKJSzN0lgJ-Ovf0_EAE&adurl=
Frame ID: 59ED32968F32CD5A67E3615A854D445F
Requests: 7 HTTP requests in this frame

Frame: https://vars.hotjar.com/box-469cf41adb11dc78be68c1ae7f9457a4.html
Frame ID: EF6FE8525F4807796F9CA47D678B45B9
Requests: 1 HTTP requests in this frame

Frame: https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/css/ckeditor.css?qbs4lh
Frame ID: A63D84993EAEBC556007428A2F1094E3
Requests: 4 HTTP requests in this frame

Frame: https://bcp.crwdcntrl.net/5/ct=y/c=7499/rand=349806432/pv=y/int=%23OpR%2366886%23globalpharmainsights%20%3A%20Site%20Section%20%3A%20manufacturing-outsourcing/int=%23OpR%2366887%23globalpharmainsights%20%3A%20Site%20Section%20%3A%20manufacturing-outsourcing%20%3A%20gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir/int=%23OpR%2366985%23globalpharmainsights%20%3A%20Total%20Site%20Traffic/rb=%7B%22article_category%22%3A%5B%22Home%22%2C%22Sectors%22%2C%22Manufacturing%20%26%20Outsourcing%22%5D%7D/rt=ifr
Frame ID: D275409ED1F46EAFAE69CA53FD1BA2CE
Requests: 1 HTTP requests in this frame

Frame: https://tpc.googlesyndication.com/sodar/sodar2/210/runner.html
Frame ID: 333A3739F0ADFF47088697A07030078E
Requests: 1 HTTP requests in this frame

Screenshot
Live screenshot

Full Image

Page URL History Show full URLs

http://app.go02.informamarkets.com/e/er?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-A... HTTP 302
https://s734445500.t.eloqua.com/e/er?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-A... HTTP 302
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture... Page URL

Detected technologies

Drupal (CMS) Expand

Overall confidence: 100%
Detected patterns

html /<(?:link|style)[^>]+"\/sites\/(?:default|all)\/(?:themes|modules)\//i
meta generator /^Drupal(?:\s([\d.]+))?/i
headers expires /19 Nov 1978/i

PHP (Programming Languages) Expand

Overall confidence: 100%
Detected patterns

headers server /php\/?([\d.]+)?/i
html /<(?:link|style)[^>]+"\/sites\/(?:default|all)\/(?:themes|modules)\//i
meta generator /^Drupal(?:\s([\d.]+))?/i
headers expires /19 Nov 1978/i

CentOS (Operating Systems) Expand

Overall confidence: 100%
Detected patterns

headers server /CentOS/i

OpenSSL (Web Server Extensions) Expand

Overall confidence: 100%
Detected patterns

headers server /OpenSSL(?:\/([\d.]+[a-z]?))?/i

Apache (Web Servers) Expand

Overall confidence: 100%
Detected patterns

headers server /(?:Apache(?:$|\/([\d.]+)|[^/-])|(?:^|\b)HTTPD)/i

Amazon Web Services (PaaS) Expand

Overall confidence: 100%
Detected patterns

headers via /$CloudFront$$/i

Amazon Cloudfront (CDN) Expand

Overall confidence: 100%
Detected patterns

headers via /$CloudFront$$/i

DoubleClick for Publishers (DFP) (Advertising Networks) Expand

Overall confidence: 100%
Detected patterns

script /googletagservices\.com\/tag\/js\/gpt(?:_mobile)?\.js/i

Facebook (Widgets) Expand

Overall confidence: 100%
Detected patterns

script /\/\/connect\.facebook\.net\/[^/]*\/[a-z]*\.js/i

Page Statistics

152
Requests

100 %
HTTPS

36 %
IPv6

30
Domains

46
Subdomains

39
IPs

9
Countries

1945 kB
Transfer

6138 kB
Size

24
Cookies

28 Outgoing links

These are links going to different origins than the main page.

URL: http://engage.informa.com/cp/cookie-policy
Title: Cookie Policy

Search URL Search Domain Scan URL

URL: https://twitter.com/cphiww

Search URL Search Domain Scan URL

URL: https://www.facebook.com/cphiww

Search URL Search Domain Scan URL

URL: https://www.linkedin.com/company/cphi/

Search URL Search Domain Scan URL

URL: https://www.youtube.com/channel/UCyF5QLMfQCiBHi4EW0zXdsA

Search URL Search Domain Scan URL

URL: https://www.cphi.com/
Title: CPhI Global Events

Search URL Search Domain Scan URL

URL: https://www.cphi-online.com/
Title: CPhI Online

Search URL Search Domain Scan URL

URL: https://awards.cphi.com/
Title: Awards

Search URL Search Domain Scan URL

URL: https://www.cphi-online.com/wuxi-biologics-signs-lease-for-a-clinical-news083557.html
Title: WuXi Biologics signs lease for a clinical manufacturing facility in the US

Search URL Search Domain Scan URL

URL: https://www.cphi-online.com/ai-to-deliver-next-evolution-of-drug-news083556.html
Title: AI to deliver next evolution of drug manufacturing and supply chain efficiency

Search URL Search Domain Scan URL

URL: https://www.cphi-online.com/achilles-therapeutics-to-set-up-manufacturing-news083536.html
Title: Achilles Therapeutics to set up manufacturing operations at the CGT Catapult manufacturing centre

Search URL Search Domain Scan URL

URL: https://www.cphi-online.com/vektor-pharma-finalizes-formula-for-novel-news083535.html
Title: Vektor Pharma finalizes formula for novel transdermal drug delivery system to treat Parkinson's

Search URL Search Domain Scan URL

URL: https://www.cphi-online.com/iron-drops-prod1254657.html
Title: Iron Drops

Search URL Search Domain Scan URL

URL: https://www.cphi-online.com/system-supplier-prod1080684.html
Title: System Supplier

Search URL Search Domain Scan URL

URL: https://www.cphi-online.com/vibratory-feeding-system-for-tablets-capsules-prod1252897.html
Title: Vibratory Feeding System for Tablets & Capsules

Search URL Search Domain Scan URL

URL: https://www.cphi-online.com/ph-lift-prod1254531.html
Title: PH LIFT

Search URL Search Domain Scan URL

URL: https://www.cphi-online.com/heron-shanghai-pharmaceutical-science-and-comp284195.html
Title: Heron (ShangHai) Pharmaceutical Science and Technology Co., Ltd.

Search URL Search Domain Scan URL

URL: https://www.cphi-online.com/salvus-d-o-o-comp276579.html
Title: Salvus d.o.o

Search URL Search Domain Scan URL

URL: https://www.cphi-online.com/ambe-phytoextracts-pvt-ltd-comp270366.html
Title: AMBE Phytoextracts Pvt.,Ltd.

Search URL Search Domain Scan URL

URL: https://www.cphi-online.com/capricorn-life-sciences-b-v-comp269118.html
Title: Capricorn Life Sciences B.V

Search URL Search Domain Scan URL

URL: http://www.facebook.com/sharer.php?u=https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir&t=Gilead%20signs%20agreements%20with%20generics%20firms%20to%20manufacture%20and%20market%20remdesivir
Title:

Search URL Search Domain Scan URL

URL: http://www.linkedin.com/shareArticle?mini=true&url=https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir&title=Gilead%20signs%20agreements%20with%20generics%20firms%20to%20manufacture%20and%20market%20remdesivir&summary=Gilead%20Sciences%20has%20signed%20agreements%20with%20five%20generic%20pharmaceutical%20manufacturers%20based%20in%20India%20and%20Pakistan%20allowing%20them%20to%20manufacture%20its%20antiviral%20drug%20remdesivir%20for%20distribution%20in%20127%20developing%20countries,%20the%20biotech%20company%20said%20on%20Tuesday.Earlier%20this%20month,%20the%20US%20Food%20and%20Drug%20Administration%20issued%20an%20emergency%20use%20authorization%20for%20remdesivir%20for%20the%20treatment%20of%20severe%20COVID-19%20in%20hospitalized%20patients,%20saying%20a%20clinical%20trial%20had%20shown%20the%20investigational%20drug%20to%20shorten%20recovery%20in%20some%20participants.&source=Global%20Pharma%20Insights
Title:

Search URL Search Domain Scan URL

URL: http://twitter.com/share?url=https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir&text=Gilead%20signs%20agreements%20with%20generics%20firms%20to%20manufacture%20and%20market%20remdesivir
Title:

Search URL Search Domain Scan URL

URL: https://www.informamarkets.com/accessibility
Title: Accessibility

Search URL Search Domain Scan URL

URL: https://www.informamarkets.com/privacy-policy
Title: Privacy Policy

Search URL Search Domain Scan URL

URL: https://www.informamarkets.com/cookie-policy
Title: Cookie Policy

Search URL Search Domain Scan URL

URL: https://www.informamarkets.com/terms-of-use
Title: Terms of Use

Search URL Search Domain Scan URL

URL: https://www.informamarkets.com/visitor-terms-and-conditions
Title: Visitor Terms and Conditions

Search URL Search Domain Scan URL

Page URL History

This captures the URL locations of the websites, including HTTP redirects and client-side redirects via JavaScript or Meta fields.

http://app.go02.informamarkets.com/e/er?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL&s=734445500&lid=1275&elqTrackId=CB71927AB18C6CF05752FFFA80CD5CFF&elq=0e925bb808be4c53ac9ae463b0b5929a&elqaid=1425&elqat=1 HTTP 302
https://s734445500.t.eloqua.com/e/er?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL&s=734445500&lid=1275&elqTrackId=CB71927AB18C6CF05752FFFA80CD5CFF&elq=0e925bb808be4c53ac9ae463b0b5929a&elqaid=1425&elqat=1 HTTP 302
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL Page URL

Redirected requests

There were HTTP redirect chains for the following requests:

Request Chain 21

https://video.limelight.com/player/embed.js HTTP 302
https://s.delvenetworks.com/deployments/embed-code/embed-code-1.8.0/embed.js

Request Chain 41

https://cm.everesttech.net/cm/dd?d_uuid=70003426728527337834171526736603995012 HTTP 302
https://dpm.demdex.net/ibs:dpid=411&dpuuid=XuO_pAAAAceZ3y3-

Request Chain 107

https://ib.adnxs.com/getuid?https://a.dpmsrv.com/dpmpxl/index.php?id=$UID&q%3DxImp%26v%3D1.x%26cl%3D55%26pixelIndex%3D0%26r%3D614811%26tzOffset%3D-120%26url%3Dhttps%253A%252F%252Fwww.globalpharmainsights.com%252Fmanufacturing-outsourcing%252Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%253Futm_campaign%253DHLN00GPI-ES-AWARENESS-GENERAL1%2526utm_emailname%253DHLN00GPI-ES-AWARENESS-EM1%25252F1-FEATURES%2526utm_medium%253Demail%2526utm_source%253DEloqua%2526utm_MDMContactID%253Df3bea1f6-c791-47dc-8d2d-b71160403f3f%2526utm_campaigntype%253DOthers%2526utm_sub%253DIntroducing%252520your%252520new%252520knowledge%252520platform%25253A%252520Global%252520Pharma%252520Insights%2526eM%253D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5&_=1591983780665 HTTP 307
https://ib.adnxs.com/bounce?%2Fgetuid%3Fhttps%3A%2F%2Fa.dpmsrv.com%2Fdpmpxl%2Findex.php%3Fid%3D%24UID%26q%253DxImp%2526v%253D1.x%2526cl%253D55%2526pixelIndex%253D0%2526r%253D614811%2526tzOffset%253D-120%2526url%253Dhttps%25253A%25252F%25252Fwww.globalpharmainsights.com%25252Fmanufacturing-outsourcing%25252Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%25253Futm_campaign%25253DHLN00GPI-ES-AWARENESS-GENERAL1%252526utm_emailname%25253DHLN00GPI-ES-AWARENESS-EM1%2525252F1-FEATURES%252526utm_medium%25253Demail%252526utm_source%25253DEloqua%252526utm_MDMContactID%25253Df3bea1f6-c791-47dc-8d2d-b71160403f3f%252526utm_campaigntype%25253DOthers%252526utm_sub%25253DIntroducing%25252520your%25252520new%25252520knowledge%25252520platform%2525253A%25252520Global%25252520Pharma%25252520Insights%252526eM%25253D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5%26_%3D1591983780665 HTTP 302
https://a.dpmsrv.com/dpmpxl/index.php?id=2301816357575935815&q=xImp&v=1.x&cl=55&pixelIndex=0&r=614811&tzOffset=-120&url=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5&_=1591983780665

Request Chain 131

https://cm.g.doubleclick.net/pixel?google_nid=datapoint_dmp&google_cm&ap_id=2301816357575935815&pixelIndex=0&_=1591983780666 HTTP 302
https://a.dpmsrv.com/dpmpxl/index.php?q=dfp&ap_id=2301816357575935815&pixelIndex=0&_=1591983780666&google_gid=CAESEDoi2KiuGyoCBm8JE-ozslc&google_cver=1

Request Chain 134

https://bcp.crwdcntrl.net/5/c=7499/rand=349806432/pv=y/int=%23OpR%2366886%23globalpharmainsights%20%3A%20Site%20Section%20%3A%20manufacturing-outsourcing/int=%23OpR%2366887%23globalpharmainsights%20%3A%20Site%20Section%20%3A%20manufacturing-outsourcing%20%3A%20gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir/int=%23OpR%2366985%23globalpharmainsights%20%3A%20Total%20Site%20Traffic/rb=%7B%22article_category%22%3A%5B%22Home%22%2C%22Sectors%22%2C%22Manufacturing%20%26%20Outsourcing%22%5D%7D/rt=ifr HTTP 302
https://bcp.crwdcntrl.net/5/ct=y/c=7499/rand=349806432/pv=y/int=%23OpR%2366886%23globalpharmainsights%20%3A%20Site%20Section%20%3A%20manufacturing-outsourcing/int=%23OpR%2366887%23globalpharmainsights%20%3A%20Site%20Section%20%3A%20manufacturing-outsourcing%20%3A%20gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir/int=%23OpR%2366985%23globalpharmainsights%20%3A%20Total%20Site%20Traffic/rb=%7B%22article_category%22%3A%5B%22Home%22%2C%22Sectors%22%2C%22Manufacturing%20%26%20Outsourcing%22%5D%7D/rt=ifr

Request Chain 141

https://s.adroll.com/j/exp/IXZC4QKE6BDSVNBBOX54JQ/index.js HTTP 302
https://s.adroll.com/j/exp/index.js

Request Chain 143

https://d.adroll.mgr.consensu.org/consent/iabcheck/IXZC4QKE6BDSVNBBOX54JQ?_s=8ee5f25dbb67299de2a6efc265a5b475&_b=2 HTTP 302
https://d.adroll.com/consent/check/IXZC4QKE6BDSVNBBOX54JQ/?_s=8ee5f25dbb67299de2a6efc265a5b475&_b=2

152 HTTP transactions
3 data transactions

Method
Protocol Status Resource
Path Size
x-fer Time
Latency Type
MIME-Type IP
Location

GET
H2

200

Primary Request gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir Show response
www.globalpharmainsights.com/manufacturing-outsourcing/
Redirect Chain

http://app.go02.informamarkets.com/e/er?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6...
https://s734445500.t.eloqua.com/e/er?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c7...
https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN...

113 KB
19 KB

344ms
235ms

Document
text/html

143.204.237.71
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL

https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

143.204.237.71 Seattle, United States, ASN16509 (AMAZON-02, US),

Reverse DNS

server-143-204-237-71.cph50.r.cloudfront.net

Software

Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 / PHP/7.2.31

Resource Hash

86de25d82ed6992e663dd9837c9fec1489ac001607539a9e5da581ce7e7397b9

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Frame-Options	SAMEORIGIN

Request headers

:method: GET
:authority: www.globalpharmainsights.com
:scheme: https
:path: /manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
pragma: no-cache
cache-control: no-cache
upgrade-insecure-requests: 1
user-agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept: text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site: none
sec-fetch-mode: navigate
sec-fetch-user: ?1
sec-fetch-dest: document
accept-encoding: gzip, deflate, br
accept-language: en-US
Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

status: 200
content-type: text/html; charset=utf-8
date: Fri, 12 Jun 2020 17:42:59 GMT
server: Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
x-content-type-options: nosniff
x-powered-by: PHP/7.2.31
x-drupal-cache: HIT
etag: "1591981740-1-https://www.globalpharmainsights.com"
x-ua-compatible: IE=edge,chrome=1
content-language: en
x-frame-options: SAMEORIGIN
x-generator: Drupal 7 (http://drupal.org)
link: <https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir>; rel="canonical",<https://www.globalpharmainsights.com/node/191>; rel="shortlink"
cache-control: public, max-age=300
last-modified: Fri, 12 Jun 2020 17:09:00 GMT
expires: Sun, 19 Nov 1978 05:00:00 GMT
content-encoding: gzip
vary: Cookie,Accept-Encoding
x-cache: Miss from cloudfront
via: 1.1 1624c79cd07e6098196697a6a7907e4b.cloudfront.net (CloudFront)
x-amz-cf-pop: CPH50-C1
x-amz-cf-id: xg3VwTEhnCc8zbVaDxYaf9sHcV0vjpbsTAzKG37MfDYQPfeO3PzgIA==

Redirect headers

Cache-Control: private,no-cache, no-store
Pragma: no-cache
Content-Type: text/html; charset=utf-8
Expires: -1
Location: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Set-Cookie: ELOQUA=GUID=7CBB73FC95864329BB115652ABF891D3; domain=.eloqua.com; expires=Mon, 12-Jul-2021 17:42:58 GMT; path=/;SameSite=None; secure ELQSTATUS=OK; domain=.eloqua.com; expires=Mon, 12-Jul-2021 17:42:58 GMT; path=/;SameSite=None; secure
P3P: CP="IDC DSP COR DEVa TAIa OUR BUS PHY ONL UNI COM NAV CNT STA",
X-Content-Type-Options: nosniff
Date: Fri, 12 Jun 2020 17:42:58 GMT
Content-Length: 731

GET
H2 200 css_PpiQEI-azlEmknynFVbTW6pWwXhVPT_fbABYbBL6JWQ.css
www.globalpharmainsights.com/sites/cphi.com/files/css/ 2 KB
1 KB 48ms
46ms Stylesheet
text/css 143.204.237.71
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL

https://www.globalpharmainsights.com/sites/cphi.com/files/css/css_PpiQEI-azlEmknynFVbTW6pWwXhVPT_fbABYbBL6JWQ.css

Requested by

Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

143.204.237.71 Seattle, United States, ASN16509 (AMAZON-02, US),

Reverse DNS

server-143-204-237-71.cph50.r.cloudfront.net

Software

Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.28 /

Resource Hash

3e9890108f9ace5126927ca71556d35baa56c178553d3fdf6c00586c12fa2564

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Fri, 29 May 2020 22:06:32 GMT
content-encoding: gzip
x-content-type-options: nosniff
age: 1193788
x-cache: Hit from cloudfront
status: 200
content-length: 922
last-modified: Thu, 07 May 2020 03:02:16 GMT
server: Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.28
etag: "39a-5a5061bb444b8"
vary: Accept-Encoding
content-type: text/css
via: 1.1 1624c79cd07e6098196697a6a7907e4b.cloudfront.net (CloudFront)
cache-control: max-age=1209600
x-amz-cf-pop: CPH50-C1
accept-ranges: bytes
x-amz-cf-id: 7jVo_yTAH3o3_sUFB-0H1a_Tv-ls4bNw4YIZRGEndOtY1Xw_Fggc0w==
expires: Fri, 12 Jun 2020 22:06:32 GMT

GET
H2 200 css_b2lxsoMjuDz1VEsoXFy0Cgo8pcav1Ny1N-EHn8knPc0.css
www.globalpharmainsights.com/sites/cphi.com/files/css/ 19 KB
4 KB 53ms
52ms Stylesheet
text/css 143.204.237.71
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL

https://www.globalpharmainsights.com/sites/cphi.com/files/css/css_b2lxsoMjuDz1VEsoXFy0Cgo8pcav1Ny1N-EHn8knPc0.css

Requested by

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

143.204.237.71 Seattle, United States, ASN16509 (AMAZON-02, US),

Reverse DNS

server-143-204-237-71.cph50.r.cloudfront.net

Software

Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30 /

Resource Hash

6f6971b28323b83cf5544b285c5cb40a0a3ca5c6afd4dcb537e1079fc9273dcd

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Thu, 04 Jun 2020 12:04:44 GMT
content-encoding: gzip
x-content-type-options: nosniff
age: 711496
x-cache: Hit from cloudfront
status: 200
content-length: 3400
last-modified: Thu, 04 Jun 2020 03:46:25 GMT
server: Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30
etag: "d48-5a739fd2ae2f0"
vary: Accept-Encoding
content-type: text/css
via: 1.1 1624c79cd07e6098196697a6a7907e4b.cloudfront.net (CloudFront)
cache-control: max-age=1209600
x-amz-cf-pop: CPH50-C1
accept-ranges: bytes
x-amz-cf-id: OdIZjM5gE899mhxlFdm4DN7Ht3VXobCj-K7fyPtGE1Wy5yVMAOIGvQ==
expires: Thu, 18 Jun 2020 12:04:44 GMT

GET
H2 200 css_EMysOwdNz4P_aEBvy91ee-H45803PIdurHGMjmMp-B4.css
www.globalpharmainsights.com/sites/cphi.com/files/css/ 17 KB
4 KB 49ms
48ms Stylesheet
text/css 143.204.237.71
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL

https://www.globalpharmainsights.com/sites/cphi.com/files/css/css_EMysOwdNz4P_aEBvy91ee-H45803PIdurHGMjmMp-B4.css

Requested by

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

143.204.237.71 Seattle, United States, ASN16509 (AMAZON-02, US),

Reverse DNS

server-143-204-237-71.cph50.r.cloudfront.net

Software

Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30 /

Resource Hash

10ccac3b074dcf83ff68406fcbdd5e7be1f8e7cd373c876eac718c8e6329f81e

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Tue, 02 Jun 2020 00:37:59 GMT
content-encoding: gzip
x-content-type-options: nosniff
age: 925501
x-cache: Hit from cloudfront
status: 200
content-length: 3876
last-modified: Tue, 28 Apr 2020 23:04:16 GMT
server: Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30
etag: "f24-5a461d9cdee40"
vary: Accept-Encoding
content-type: text/css
via: 1.1 1624c79cd07e6098196697a6a7907e4b.cloudfront.net (CloudFront)
cache-control: max-age=1209600
x-amz-cf-pop: CPH50-C1
accept-ranges: bytes
x-amz-cf-id: OoAE_qVmHUvLO72CJWIBULk7QCLdz0QnnlkDBL9zKWIGbFFfRWQ4DA==
expires: Tue, 16 Jun 2020 00:37:59 GMT

GET
H2 200 css_fIVgxWnE83pCcIB_bpOeDbuIS61SfKIUkuXnxkQZul4.css
www.globalpharmainsights.com/sites/cphi.com/files/css/ 36 KB
6 KB 124ms
122ms Stylesheet
text/css 143.204.237.71
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL

https://www.globalpharmainsights.com/sites/cphi.com/files/css/css_fIVgxWnE83pCcIB_bpOeDbuIS61SfKIUkuXnxkQZul4.css

Requested by

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

143.204.237.71 Seattle, United States, ASN16509 (AMAZON-02, US),

Reverse DNS

server-143-204-237-71.cph50.r.cloudfront.net

Software

Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /

Resource Hash

7c8560c569c4f37a4270807f6e939e0dbb884bad527ca21492e5e7c64419ba5e

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Thu, 11 Jun 2020 12:40:11 GMT
content-encoding: gzip
x-content-type-options: nosniff
age: 104568
x-cache: Hit from cloudfront
status: 200
content-length: 5883
last-modified: Thu, 04 Jun 2020 03:47:14 GMT
server: Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
etag: "16fb-5a73a0013d5f8"
vary: Accept-Encoding
content-type: text/css
via: 1.1 1624c79cd07e6098196697a6a7907e4b.cloudfront.net (CloudFront)
cache-control: max-age=1209600
x-amz-cf-pop: CPH50-C1
accept-ranges: bytes
x-amz-cf-id: ze5e-sNoWwbRdlrT4OPPsYf86O4aJbvwdhPmqZZNIlRiz_C-ASGXPA==
expires: Thu, 25 Jun 2020 12:40:11 GMT

GET
H2 200 css_D7P9VJVOeSYziGwjDq2JYJvJeZunkrocOLn6kFWVyq4.css
www.globalpharmainsights.com/sites/cphi.com/files/css/ 771 KB
103 KB 70ms
69ms Stylesheet
text/css 143.204.237.71
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL

https://www.globalpharmainsights.com/sites/cphi.com/files/css/css_D7P9VJVOeSYziGwjDq2JYJvJeZunkrocOLn6kFWVyq4.css

Requested by

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

143.204.237.71 Seattle, United States, ASN16509 (AMAZON-02, US),

Reverse DNS

server-143-204-237-71.cph50.r.cloudfront.net

Software

Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /

Resource Hash

0fb3fd54954e792633886c230ead89609bc9799ba792ba1c38b9fa905595caae

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Thu, 11 Jun 2020 09:59:54 GMT
content-encoding: gzip
x-content-type-options: nosniff
age: 114186
x-cache: Hit from cloudfront
status: 200
content-length: 105279
last-modified: Wed, 10 Jun 2020 03:24:35 GMT
server: Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
etag: "19b3f-5a7b262142168"
vary: Accept-Encoding
content-type: text/css
via: 1.1 1624c79cd07e6098196697a6a7907e4b.cloudfront.net (CloudFront)
cache-control: max-age=1209600
x-amz-cf-pop: CPH50-C1
accept-ranges: bytes
x-amz-cf-id: PIKeKP_zjKRPtK3Vf1zlvvzW5FUOSHcgX9vWaD9GjhHUg6odehWh4Q==
expires: Thu, 25 Jun 2020 09:59:54 GMT

GET
H2 200 gpt.js Show response
www.googletagservices.com/tag/js/ 44 KB
14 KB 44ms
39ms Script
text/javascript 2a00:1450:4001:81d::2002
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.googletagservices.com/tag/js/gpt.js

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:81d::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

8a65be80c906eb0aaad3615fbe5e445502fd0d17fe9aa761b8746d7e072f7ee0

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Fri, 12 Jun 2020 17:42:59 GMT
content-encoding: gzip
x-content-type-options: nosniff
server: sffe
etag: "540 / 614 of 1000 / last-modified: 1591967766"
vary: Accept-Encoding
content-type: text/javascript
status: 200
cache-control: private, max-age=900, stale-while-revalidate=3600
timing-allow-origin: *
alt-svc: h3-27="googleads.g.doubleclick.net:443"; ma=2592000,h3-27=":443"; ma=2592000,h3-25="googleads.g.doubleclick.net:443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050="googleads.g.doubleclick.net:443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length: 14701
x-xss-protection: 0
expires: Fri, 12 Jun 2020 17:42:59 GMT

GET
H2 200 header.png
www.globalpharmainsights.com/sites/all/themes/penton_subtheme_cphi/images/logos/ 12 KB
13 KB 132ms
127ms Image
image/png 143.204.237.71
AMAZON-02

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.globalpharmainsights.com/sites/all/themes/penton_subtheme_cphi/images/logos/header.png

Requested by

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

143.204.237.71 Seattle, United States, ASN16509 (AMAZON-02, US),

Reverse DNS

server-143-204-237-71.cph50.r.cloudfront.net

Software

Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30 /

Resource Hash

f3398fb55770fb83d26d8537073b425b2b9c64f8652a74a0a17a17d35c8cd834

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Thu, 04 Jun 2020 03:37:26 GMT
via: 1.1 1624c79cd07e6098196697a6a7907e4b.cloudfront.net (CloudFront)
x-content-type-options: nosniff
age: 741933
x-cache: Hit from cloudfront
status: 200
content-length: 12472
last-modified: Thu, 04 Jun 2020 02:32:06 GMT
server: Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30
etag: "30b8-5a738f35f8c84"
content-type: image/png
cache-control: max-age=1209600
x-amz-cf-pop: CPH50-C1
accept-ranges: bytes
x-amz-cf-id: AYNS0vFXh4b5HmS6Hv0QI1LAiwjVv14w9J7CB8Af4QEftoFow7JG8Q==
expires: Thu, 18 Jun 2020 03:37:26 GMT

GET
H2 200 CPHI%20Online%20TEAL%20LOGO%20no%20border.png
www.globalpharmainsights.com/sites/cphi.com/files/styles/hp_widget_program_standard/public/ 14 KB
14 KB 75ms
70ms Image
image/png 143.204.237.71
AMAZON-02

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.globalpharmainsights.com/sites/cphi.com/files/styles/hp_widget_program_standard/public/CPHI%20Online%20TEAL%20LOGO%20no%20border.png?itok=WDbHTO0d

Requested by

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

143.204.237.71 Seattle, United States, ASN16509 (AMAZON-02, US),

Reverse DNS

server-143-204-237-71.cph50.r.cloudfront.net

Software

Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30 /

Resource Hash

6228e9180404b87bdd1d53f6d32ceecd1e73407ae40c6d5851a12fa0caba889d

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Fri, 05 Jun 2020 12:34:31 GMT
via: 1.1 1624c79cd07e6098196697a6a7907e4b.cloudfront.net (CloudFront)
x-content-type-options: nosniff
age: 623309
x-cache: Hit from cloudfront
status: 200
content-length: 14117
last-modified: Fri, 17 Apr 2020 14:46:33 GMT
server: Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30
etag: "3725-5a37d9d975f40"
content-type: image/png
cache-control: max-age=1209600
x-amz-cf-pop: CPH50-C1
accept-ranges: bytes
x-amz-cf-id: pfphsdxbTsz_u4LwAtbpVzlFWIYbMw6aGEuCMYzbh75IaaFgZYJdYw==
expires: Fri, 19 Jun 2020 12:34:31 GMT

GET
H2 200 HLN00CPO-Gilead-distribution.jpg
www.globalpharmainsights.com/sites/cphi.com/files/styles/article_featured_standard/public/ 57 KB
57 KB 127ms
122ms Image
image/jpeg 143.204.237.71
AMAZON-02

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.globalpharmainsights.com/sites/cphi.com/files/styles/article_featured_standard/public/HLN00CPO-Gilead-distribution.jpg?itok=uJBDDbK5

Requested by

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

143.204.237.71 Seattle, United States, ASN16509 (AMAZON-02, US),

Reverse DNS

server-143-204-237-71.cph50.r.cloudfront.net

Software

Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /

Resource Hash

32565490c2301442c897cf7c812b98f4543036571824c424e123735ccbd19137

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Fri, 12 Jun 2020 08:34:21 GMT
via: 1.1 1624c79cd07e6098196697a6a7907e4b.cloudfront.net (CloudFront)
x-content-type-options: nosniff
age: 32918
x-cache: Hit from cloudfront
status: 200
content-length: 58070
last-modified: Wed, 13 May 2020 08:45:23 GMT
server: Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
etag: "e2d6-5a58399d31e50"
content-type: image/jpeg
cache-control: max-age=1209600
x-amz-cf-pop: CPH50-C1
accept-ranges: bytes
x-amz-cf-id: Z5zpOPRQvdSTQncjCk7fSQRl1OBj8_C2OY2OB3quwEYpRm31zkMH_g==
expires: Fri, 26 Jun 2020 08:34:21 GMT

GET
H2 200 account-default-image.png
www.globalpharmainsights.com/sites/all/themes/penton_core_theme/images/ 5 KB
5 KB 126ms
122ms Image
image/png 143.204.237.71
AMAZON-02

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.globalpharmainsights.com/sites/all/themes/penton_core_theme/images/account-default-image.png

Requested by

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

143.204.237.71 Seattle, United States, ASN16509 (AMAZON-02, US),

Reverse DNS

server-143-204-237-71.cph50.r.cloudfront.net

Software

Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /

Resource Hash

12260d8e3e5f7c60dfda5731f3b77e1748c45fe480bec2d0cee49616dd48ae04

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Fri, 12 Jun 2020 16:01:23 GMT
via: 1.1 1624c79cd07e6098196697a6a7907e4b.cloudfront.net (CloudFront)
x-content-type-options: nosniff
age: 6096
x-cache: Hit from cloudfront
status: 200
content-length: 5140
last-modified: Fri, 12 Jun 2020 11:06:47 GMT
server: Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
etag: "1414-5a7e112b78fcc"
content-type: image/png
cache-control: max-age=1209600
x-amz-cf-pop: CPH50-C1
accept-ranges: bytes
x-amz-cf-id: nJJ-B21zvBuuonRgSWO9TTJkYQ7nWeMZTUZvR1QQlygOjZs79ajcbA==
expires: Fri, 26 Jun 2020 16:01:23 GMT

GET
H2 200 CPhI%20India_CoT.png
www.globalpharmainsights.com/sites/cphi.com/files/styles/article_related_thumb_standard/public/ 2 KB
2 KB 125ms
121ms Image
image/png 143.204.237.71
AMAZON-02

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.globalpharmainsights.com/sites/cphi.com/files/styles/article_related_thumb_standard/public/CPhI%20India_CoT.png?itok=FLPd7SgR

Requested by

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

143.204.237.71 Seattle, United States, ASN16509 (AMAZON-02, US),

Reverse DNS

server-143-204-237-71.cph50.r.cloudfront.net

Software

Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.28 /

Resource Hash

0444c8c10665ee4ae69b68f021bf722af7e87b5bb2e52ba9bcb9d8b741e98ae1

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Fri, 12 Jun 2020 04:54:16 GMT
via: 1.1 1624c79cd07e6098196697a6a7907e4b.cloudfront.net (CloudFront)
x-content-type-options: nosniff
age: 46123
x-cache: Hit from cloudfront
status: 200
content-length: 1691
last-modified: Thu, 16 Apr 2020 08:52:03 GMT
server: Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.28
etag: "69b-5a3648bf85c80"
content-type: image/png
cache-control: max-age=1209600
x-amz-cf-pop: CPH50-C1
accept-ranges: bytes
x-amz-cf-id: NIa9FDyofDtSZvv7JmrQqo8mD-6z7iQIjqC6mBLaQvuM9sQimksyKg==
expires: Fri, 26 Jun 2020 04:54:16 GMT

GET
H2 200 HLN00CPO-Remdesivir-Gilead.jpg
www.globalpharmainsights.com/sites/cphi.com/files/styles/article_related_thumb_standard/public/ 2 KB
2 KB 146ms
142ms Image
image/jpeg 143.204.237.71
AMAZON-02

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.globalpharmainsights.com/sites/cphi.com/files/styles/article_related_thumb_standard/public/HLN00CPO-Remdesivir-Gilead.jpg?itok=2ZaOW6BX

Requested by

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

143.204.237.71 Seattle, United States, ASN16509 (AMAZON-02, US),

Reverse DNS

server-143-204-237-71.cph50.r.cloudfront.net

Software

Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /

Resource Hash

1a57e0006d9f342948a1fe2394bc31e62f529a5394c037ce0efcd92d0bd1da55

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Tue, 09 Jun 2020 09:11:28 GMT
via: 1.1 1624c79cd07e6098196697a6a7907e4b.cloudfront.net (CloudFront)
x-content-type-options: nosniff
age: 289891
x-cache: Hit from cloudfront
status: 200
content-length: 1842
last-modified: Wed, 06 May 2020 10:00:41 GMT
server: Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
etag: "732-5a4f7d636cbd0"
content-type: image/jpeg
cache-control: max-age=1209600
x-amz-cf-pop: CPH50-C1
accept-ranges: bytes
x-amz-cf-id: -2rRlaE42fV6gI10avKMR-j-jG1t_s5w4O4XhrOP7LY0BR7XfGMF_w==
expires: Tue, 23 Jun 2020 09:11:28 GMT

GET
H2 200 HLN00CPO-Continuous-manufacturing-cogs.jpg
www.globalpharmainsights.com/sites/cphi.com/files/styles/article_related_thumb_standard/public/ 2 KB
3 KB 131ms
128ms Image
image/jpeg 143.204.237.71
AMAZON-02

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.globalpharmainsights.com/sites/cphi.com/files/styles/article_related_thumb_standard/public/HLN00CPO-Continuous-manufacturing-cogs.jpg?itok=YD6TVkcM

Requested by

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

143.204.237.71 Seattle, United States, ASN16509 (AMAZON-02, US),

Reverse DNS

server-143-204-237-71.cph50.r.cloudfront.net

Software

Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /

Resource Hash

240d40d23dcebd0e448df4c2b45863b27c86f706f8a53a79c3b4b98ce193b67b

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Fri, 12 Jun 2020 08:36:45 GMT
via: 1.1 1624c79cd07e6098196697a6a7907e4b.cloudfront.net (CloudFront)
x-content-type-options: nosniff
age: 32774
x-cache: Hit from cloudfront
status: 200
content-length: 2307
last-modified: Fri, 12 Jun 2020 08:34:21 GMT
server: Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
etag: "903-5a7def19fb820"
content-type: image/jpeg
cache-control: max-age=1209600
x-amz-cf-pop: CPH50-C1
accept-ranges: bytes
x-amz-cf-id: 4z_KFLx4tV8nZTgAj7JuW5CtZ_UlvLz2PyBExwIvn4Xk20glN7qy7w==
expires: Fri, 26 Jun 2020 08:36:45 GMT

GET
H2 200 HLN00COP-COVID-19-weekly-tracker.jpg
www.globalpharmainsights.com/sites/cphi.com/files/styles/article_related_thumb_standard/public/ 2 KB
2 KB 130ms
126ms Image
image/jpeg 143.204.237.71
AMAZON-02

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.globalpharmainsights.com/sites/cphi.com/files/styles/article_related_thumb_standard/public/HLN00COP-COVID-19-weekly-tracker.jpg?itok=o-1CYn9m

Requested by

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

143.204.237.71 Seattle, United States, ASN16509 (AMAZON-02, US),

Reverse DNS

server-143-204-237-71.cph50.r.cloudfront.net

Software

Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.28 /

Resource Hash

e4dff53a6d9d1b0557739d82c88285e80935eb9fa580043136af323748cab6ee

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Sat, 30 May 2020 10:33:15 GMT
via: 1.1 1624c79cd07e6098196697a6a7907e4b.cloudfront.net (CloudFront)
x-content-type-options: nosniff
age: 1148984
x-cache: Hit from cloudfront
status: 200
content-length: 1683
last-modified: Thu, 16 Apr 2020 08:16:22 GMT
server: Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.28
etag: "693-5a3640c57d488"
content-type: image/jpeg
cache-control: max-age=1209600
x-amz-cf-pop: CPH50-C1
accept-ranges: bytes
x-amz-cf-id: GZrDNL4IIsNEY0P0ybYREWIfRirGKF9rUGzEKDbnLYG0yLKTx7tHQQ==
expires: Sat, 13 Jun 2020 10:33:15 GMT

GET
H2 200 footer.png
www.globalpharmainsights.com/sites/all/themes/penton_subtheme_cphi/images/logos/ 11 KB
12 KB 131ms
128ms Image
image/png 143.204.237.71
AMAZON-02

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.globalpharmainsights.com/sites/all/themes/penton_subtheme_cphi/images/logos/footer.png

Requested by

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

143.204.237.71 Seattle, United States, ASN16509 (AMAZON-02, US),

Reverse DNS

server-143-204-237-71.cph50.r.cloudfront.net

Software

Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30 /

Resource Hash

e46041e34d5f1093b7b2c0858814e0e6468b9b6a80426a23d54230239ed92026

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Thu, 04 Jun 2020 03:37:27 GMT
via: 1.1 1624c79cd07e6098196697a6a7907e4b.cloudfront.net (CloudFront)
x-content-type-options: nosniff
age: 741932
x-cache: Hit from cloudfront
status: 200
content-length: 11655
last-modified: Thu, 04 Jun 2020 02:22:15 GMT
server: Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30
etag: "2d87-5a738d02a09ca"
content-type: image/png
cache-control: max-age=1209600
x-amz-cf-pop: CPH50-C1
accept-ranges: bytes
x-amz-cf-id: 1CqMa84Cf0_71gNDItUHztJWVfPjjBMZaWshjwWSlr1jvq2VSo7hKA==
expires: Thu, 18 Jun 2020 03:37:27 GMT

GET
H2 200 js__PiZuK2o4XAnDCWOhogiGF01gyHzeu7QxvOyfTe-YyM.js Show response
www.globalpharmainsights.com/sites/cphi.com/files/js/ 97 KB
35 KB 84ms
84ms Script
text/javascript 143.204.237.71
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL

https://www.globalpharmainsights.com/sites/cphi.com/files/js/js__PiZuK2o4XAnDCWOhogiGF01gyHzeu7QxvOyfTe-YyM.js

Requested by

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

143.204.237.71 Seattle, United States, ASN16509 (AMAZON-02, US),

Reverse DNS

server-143-204-237-71.cph50.r.cloudfront.net

Software

Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.28 /

Resource Hash

fcf899b8ada8e170270c258e868822185d358321f37aeed0c6f3b27d37be6323

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Fri, 29 May 2020 22:06:32 GMT
content-encoding: gzip
x-content-type-options: nosniff
age: 1193787
x-cache: Hit from cloudfront
status: 200
content-length: 34910
last-modified: Thu, 07 May 2020 03:06:03 GMT
server: Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.28
etag: "885e-5a50629326688"
vary: Accept-Encoding
content-type: text/javascript
via: 1.1 1624c79cd07e6098196697a6a7907e4b.cloudfront.net (CloudFront)
cache-control: max-age=1209600
x-amz-cf-pop: CPH50-C1
accept-ranges: bytes
x-amz-cf-id: yi3TyoY7YtKEE2vxOh50unPN5IS1Y6WyPnWOQvS65yGSWHTaMRxBzQ==
expires: Fri, 12 Jun 2020 22:06:32 GMT

GET
H2 200 js_s3L_uC35AiN5EGYY533su-jccnLRp2aKpOnjgPLbo34.js Show response
www.globalpharmainsights.com/sites/cphi.com/files/js/ 20 KB
7 KB 70ms
70ms Script
text/javascript 143.204.237.71
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL

https://www.globalpharmainsights.com/sites/cphi.com/files/js/js_s3L_uC35AiN5EGYY533su-jccnLRp2aKpOnjgPLbo34.js

Requested by

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

143.204.237.71 Seattle, United States, ASN16509 (AMAZON-02, US),

Reverse DNS

server-143-204-237-71.cph50.r.cloudfront.net

Software

Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /

Resource Hash

b372ffb82df9022379106618e77decbbe8dc7272d1a7668aa4e9e380f2dba37e

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Thu, 11 Jun 2020 09:59:55 GMT
content-encoding: gzip
x-content-type-options: nosniff
age: 114184
x-cache: Hit from cloudfront
status: 200
content-length: 6931
last-modified: Wed, 10 Jun 2020 03:26:19 GMT
server: Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
etag: "1b13-5a7b26851d908"
vary: Accept-Encoding
content-type: text/javascript
via: 1.1 1624c79cd07e6098196697a6a7907e4b.cloudfront.net (CloudFront)
cache-control: max-age=1209600
x-amz-cf-pop: CPH50-C1
accept-ranges: bytes
x-amz-cf-id: 9_lTqkhrSOtb8LERhu2EMQjVvQlXqEILzVRbA1YMSWx1gKtPyNIycQ==
expires: Thu, 25 Jun 2020 09:59:55 GMT

GET
H2 200 launch-560312491757.min.js Show response
assets.adobedtm.com/100e8b570010/c89496dc0f21/ 178 KB
50 KB 32ms
9ms Script
application/x-javascript 2a02:26f0:10c:382::1e80
AKAMAI-ASN1

General

Check archive.org

Show headers Download Go to

Full URL: https://assets.adobedtm.com/100e8b570010/c89496dc0f21/launch-560312491757.min.js
Requested by: Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 2a02:26f0:10c:382::1e80 , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software: AkamaiNetStorage /
Resource Hash: 6ab81fba1ff6dbfb3aac51f5a2a8b1a5a4bc58cbeeac086de3f6e838cb3c93cf

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Fri, 12 Jun 2020 17:42:59 GMT
content-encoding: gzip
last-modified: Wed, 27 May 2020 12:11:50 GMT
server: AkamaiNetStorage
etag: "1dd9abe35bae1a8805e8349a0bd9dfcb:1590581510.227931"
vary: Accept-Encoding
content-type: application/x-javascript
status: 200
cache-control: max-age=3600
accept-ranges: bytes
timing-allow-origin: *
content-length: 51138
expires: Fri, 12 Jun 2020 18:42:59 GMT

GET
H2 200 js_I-uzEZ6lB_oNELbin5YHol-LXruj-gjGpig7o5Yiy3g.js Show response
www.globalpharmainsights.com/sites/cphi.com/files/js/ 166 KB
48 KB 70ms
62ms Script
text/javascript 143.204.237.71
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL

https://www.globalpharmainsights.com/sites/cphi.com/files/js/js_I-uzEZ6lB_oNELbin5YHol-LXruj-gjGpig7o5Yiy3g.js

Requested by

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

143.204.237.71 Seattle, United States, ASN16509 (AMAZON-02, US),

Reverse DNS

server-143-204-237-71.cph50.r.cloudfront.net

Software

Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /

Resource Hash

23ebb3119ea507fa0d10b6e29f9607a25f8b5ebba3fa08c6a6283ba39622cb78

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Thu, 11 Jun 2020 12:40:11 GMT
content-encoding: gzip
x-content-type-options: nosniff
age: 104568
x-cache: Hit from cloudfront
status: 200
content-length: 48418
last-modified: Thu, 04 Jun 2020 03:47:14 GMT
server: Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
etag: "bd22-5a73a001558b0"
vary: Accept-Encoding
content-type: text/javascript
via: 1.1 1624c79cd07e6098196697a6a7907e4b.cloudfront.net (CloudFront)
cache-control: max-age=1209600
x-amz-cf-pop: CPH50-C1
accept-ranges: bytes
x-amz-cf-id: dUr9seB1Pe4O9vD3HbDum86ESVidk2c-kIZnDtbJC3g-c7BpgdrDGQ==
expires: Thu, 25 Jun 2020 12:40:11 GMT

GET
H2 200 js_13l6iCSWqEmXf4TMDp51TAkvk6FN2jCQAjkAuVSOeqo.js Show response
www.globalpharmainsights.com/sites/cphi.com/files/js/ 15 KB
4 KB 149ms
142ms Script
text/javascript 143.204.237.71
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL

https://www.globalpharmainsights.com/sites/cphi.com/files/js/js_13l6iCSWqEmXf4TMDp51TAkvk6FN2jCQAjkAuVSOeqo.js

Requested by

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

143.204.237.71 Seattle, United States, ASN16509 (AMAZON-02, US),

Reverse DNS

server-143-204-237-71.cph50.r.cloudfront.net

Software

Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30 /

Resource Hash

d7797a882496a849977f84cc0e9e754c092f93a14dda3090023900b9548e7aaa

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Thu, 04 Jun 2020 12:04:44 GMT
content-encoding: gzip
x-content-type-options: nosniff
age: 711495
x-cache: Hit from cloudfront
status: 200
content-length: 3712
last-modified: Thu, 04 Jun 2020 03:46:26 GMT
server: Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30
etag: "e80-5a739fd32dde8"
vary: Accept-Encoding
content-type: text/javascript
via: 1.1 1624c79cd07e6098196697a6a7907e4b.cloudfront.net (CloudFront)
cache-control: max-age=1209600
x-amz-cf-pop: CPH50-C1
accept-ranges: bytes
x-amz-cf-id: RUifbDLeNiTz3TzLqeuIYuQO3-YBI-lL4niCpDnAr83oMtnQfrf8sA==
expires: Thu, 18 Jun 2020 12:04:44 GMT

GET
H2 200 js_FoO86KRzi68_J27zYA1BNIfKpwyO0UJ-deA5Irn5IQ8.js Show response
www.globalpharmainsights.com/sites/cphi.com/files/js/ 5 KB
2 KB 150ms
143ms Script
text/javascript 143.204.237.71
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL

https://www.globalpharmainsights.com/sites/cphi.com/files/js/js_FoO86KRzi68_J27zYA1BNIfKpwyO0UJ-deA5Irn5IQ8.js

Requested by

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

143.204.237.71 Seattle, United States, ASN16509 (AMAZON-02, US),

Reverse DNS

server-143-204-237-71.cph50.r.cloudfront.net

Software

Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30 /

Resource Hash

1683bce8a4738baf3f276ef3600d413487caa70c8ed1427e75e03922b9f9210f

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Thu, 04 Jun 2020 12:04:43 GMT
content-encoding: gzip
x-content-type-options: nosniff
age: 711496
x-cache: Hit from cloudfront
status: 200
content-length: 1311
last-modified: Thu, 04 Jun 2020 03:47:14 GMT
server: Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30
etag: "51f-5a73a00163758"
vary: Accept-Encoding
content-type: text/javascript
via: 1.1 1624c79cd07e6098196697a6a7907e4b.cloudfront.net (CloudFront)
cache-control: max-age=1209600
x-amz-cf-pop: CPH50-C1
accept-ranges: bytes
x-amz-cf-id: -jNLk_EIPqbePzdYyB7aczal7Mr7mQDKfQCKJv1lZ3e4Ei2iu6dxQw==
expires: Thu, 18 Jun 2020 12:04:43 GMT

GET
H/1.1

200
OK

embed.js Show response
s.delvenetworks.com/deployments/embed-code/embed-code-1.8.0/
Redirect Chain

https://video.limelight.com/player/embed.js
https://s.delvenetworks.com/deployments/embed-code/embed-code-1.8.0/embed.js

18 KB
19 KB

176ms
46ms

Script
application/javascript

178.79.227.128
LLNW

General

Check archive.org

Show headers Download Go to

Full URL: https://s.delvenetworks.com/deployments/embed-code/embed-code-1.8.0/embed.js
Requested by: Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_256_GCM
Server: 178.79.227.128 , Italy, ASN22822 (LLNW, US),
Reverse DNS: https-178-79-227-128.vie.llnw.net
Software: AmazonS3 /
Resource Hash: 29ca0635f3a13ba2340907510cd06b2d26e9fd4abf88295914626c2096ac8924

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date: Fri, 12 Jun 2020 17:43:00 GMT
Last-Modified: Tue, 28 May 2019 17:21:09 GMT
Server: AmazonS3
Age: 12861816
x-amz-id-2: torXJvnStoGsPk/UOytLPBBuyM1j6Y34WHrxoq56Us3exNyNKdL7OVpZks2UDGYX+hjfTW6k5gw=
Content-Type: application/javascript
Access-Control-Allow-Origin: *
Cache-Control: max-age=31536000
Content-Length: 18768
Connection: keep-alive
Accept-Ranges: bytes
x-amz-request-id: D0AFD37E9857C7F6
X-LLID: b0cf72cb7f4bfe06968a91a8c6f2c6ec
Expires: Thu, 14 Jan 2021 20:59:24 GMT

Redirect headers

Location: https://s.delvenetworks.com/deployments/embed-code/embed-code-1.8.0/embed.js
Date: Fri, 12 Jun 2020 17:42:59 GMT
Server: Apache
Connection: Keep-Alive
Keep-Alive: timeout=2, max=100
Content-Length: 330
Content-Type: text/html; charset=iso-8859-1

GET
H2 200 js_jm3tTtzLZz9ztr1QmbjNUQg7CXVPQ0KIq1izyBk1azg.js Show response
www.globalpharmainsights.com/sites/cphi.com/files/js/ 278 KB
67 KB 83ms
77ms Script
text/javascript 143.204.237.71
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL

https://www.globalpharmainsights.com/sites/cphi.com/files/js/js_jm3tTtzLZz9ztr1QmbjNUQg7CXVPQ0KIq1izyBk1azg.js

Requested by

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

143.204.237.71 Seattle, United States, ASN16509 (AMAZON-02, US),

Reverse DNS

server-143-204-237-71.cph50.r.cloudfront.net

Software

Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30 /

Resource Hash

8e6ded4edccb673f73b6bd5099b8cd51083b09754f434288ab58b3c819356b38

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Thu, 04 Jun 2020 12:04:44 GMT
content-encoding: gzip
x-content-type-options: nosniff
age: 711495
x-cache: Hit from cloudfront
status: 200
content-length: 67949
last-modified: Thu, 04 Jun 2020 03:47:15 GMT
server: Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30
etag: "1096d-5a73a0017d950"
vary: Accept-Encoding
content-type: text/javascript
via: 1.1 1624c79cd07e6098196697a6a7907e4b.cloudfront.net (CloudFront)
cache-control: max-age=1209600
x-amz-cf-pop: CPH50-C1
accept-ranges: bytes
x-amz-cf-id: 5QtX3kAlHlgkI7gNOUhDCaMQDZstjLeKLrJJED6fwSjKENApfnAk5g==
expires: Thu, 18 Jun 2020 12:04:44 GMT

GET
H2 200 js_L6OZG5KXpK9TmHNSbl24vOE0yJf48VytacfkHRBNEVc.js Show response
www.globalpharmainsights.com/sites/cphi.com/files/js/ 10 KB
3 KB 94ms
87ms Script
text/javascript 143.204.237.71
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL

https://www.globalpharmainsights.com/sites/cphi.com/files/js/js_L6OZG5KXpK9TmHNSbl24vOE0yJf48VytacfkHRBNEVc.js

Requested by

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

143.204.237.71 Seattle, United States, ASN16509 (AMAZON-02, US),

Reverse DNS

server-143-204-237-71.cph50.r.cloudfront.net

Software

Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /

Resource Hash

2fa3991b9297a4af539873526e5db8bce134c897f8f15cad69c7e41d104d1157

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Thu, 11 Jun 2020 09:59:55 GMT
content-encoding: gzip
x-content-type-options: nosniff
age: 114184
x-cache: Hit from cloudfront
status: 200
content-length: 2833
last-modified: Wed, 10 Jun 2020 03:24:35 GMT
server: Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
etag: "b11-5a7b262197c80"
vary: Accept-Encoding
content-type: text/javascript
via: 1.1 1624c79cd07e6098196697a6a7907e4b.cloudfront.net (CloudFront)
cache-control: max-age=1209600
x-amz-cf-pop: CPH50-C1
accept-ranges: bytes
x-amz-cf-id: IPPn7hHfW9jvdRRA_2wOFkgfwj3XCV3QzVtMIP5hdi6g2nN5mcqE5g==
expires: Thu, 25 Jun 2020 09:59:55 GMT

GET
H2 200 js_bPh3Q6AKPB-AdasJkcfWUQYxe6rsN1QNiUqwOfElCSA.js Show response
www.globalpharmainsights.com/sites/cphi.com/files/js/ 48 KB
13 KB 80ms
73ms Script
text/javascript 143.204.237.71
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL

https://www.globalpharmainsights.com/sites/cphi.com/files/js/js_bPh3Q6AKPB-AdasJkcfWUQYxe6rsN1QNiUqwOfElCSA.js

Requested by

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

143.204.237.71 Seattle, United States, ASN16509 (AMAZON-02, US),

Reverse DNS

server-143-204-237-71.cph50.r.cloudfront.net

Software

Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /

Resource Hash

6cf87743a00a3c1f8075ab0991c7d65106317baaec37540d894ab039f1250920

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Thu, 11 Jun 2020 12:40:11 GMT
content-encoding: gzip
x-content-type-options: nosniff
age: 104568
x-cache: Hit from cloudfront
status: 200
content-length: 12544
last-modified: Thu, 04 Jun 2020 03:47:15 GMT
server: Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
etag: "3100-5a73a0018fa60"
vary: Accept-Encoding
content-type: text/javascript
via: 1.1 1624c79cd07e6098196697a6a7907e4b.cloudfront.net (CloudFront)
cache-control: max-age=1209600
x-amz-cf-pop: CPH50-C1
accept-ranges: bytes
x-amz-cf-id: t8V_6gM-hmFlg-Qp3q083hOaYpN1XPzgXFT7SpccuOygDlWoPxGxLQ==
expires: Thu, 25 Jun 2020 12:40:11 GMT

GET
H2 200 js_yIkX_vb0Dxng7O5aNwkJ-nqApJpaPl61cDQzkBEByaA.js Show response
www.globalpharmainsights.com/sites/cphi.com/files/js/ 94 KB
28 KB 96ms
90ms Script
text/javascript 143.204.237.71
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL

https://www.globalpharmainsights.com/sites/cphi.com/files/js/js_yIkX_vb0Dxng7O5aNwkJ-nqApJpaPl61cDQzkBEByaA.js

Requested by

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

143.204.237.71 Seattle, United States, ASN16509 (AMAZON-02, US),

Reverse DNS

server-143-204-237-71.cph50.r.cloudfront.net

Software

Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /

Resource Hash

c88917fef6f40f19e0ecee5a370909fa7a80a49a5a3e5eb5703433901101c9a0

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Thu, 11 Jun 2020 09:59:55 GMT
content-encoding: gzip
x-content-type-options: nosniff
age: 114184
x-cache: Hit from cloudfront
status: 200
content-length: 28579
last-modified: Thu, 04 Jun 2020 03:46:26 GMT
server: Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
etag: "6fa3-5a739fd360e50"
vary: Accept-Encoding
content-type: text/javascript
via: 1.1 1624c79cd07e6098196697a6a7907e4b.cloudfront.net (CloudFront)
cache-control: max-age=1209600
x-amz-cf-pop: CPH50-C1
accept-ranges: bytes
x-amz-cf-id: EcWfCyKS3clQ4en8c6DHAFCuHDpst1l88uQUTU3ScWJmVhSTQSR4wA==
expires: Thu, 25 Jun 2020 09:59:55 GMT

GET
H2 200 js_5mkVQduSavhPSKtIg-VBkjsgMwuU68PrQhH9Ye0ODvs.js Show response
www.globalpharmainsights.com/sites/cphi.com/files/js/ 11 KB
3 KB 99ms
93ms Script
text/javascript 143.204.237.71
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL

https://www.globalpharmainsights.com/sites/cphi.com/files/js/js_5mkVQduSavhPSKtIg-VBkjsgMwuU68PrQhH9Ye0ODvs.js

Requested by

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

143.204.237.71 Seattle, United States, ASN16509 (AMAZON-02, US),

Reverse DNS

server-143-204-237-71.cph50.r.cloudfront.net

Software

Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /

Resource Hash

e6691541db926af84f48ab4883e541923b20330b94ebc3eb4211fd61ed0e0efb

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Thu, 11 Jun 2020 09:59:55 GMT
content-encoding: gzip
x-content-type-options: nosniff
age: 114184
x-cache: Hit from cloudfront
status: 200
content-length: 2186
last-modified: Wed, 10 Jun 2020 03:26:19 GMT
server: Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
etag: "88a-5a7b2685353f0"
vary: Accept-Encoding
content-type: text/javascript
via: 1.1 1624c79cd07e6098196697a6a7907e4b.cloudfront.net (CloudFront)
cache-control: max-age=1209600
x-amz-cf-pop: CPH50-C1
accept-ranges: bytes
x-amz-cf-id: MOMhVAUkTZPjvwCqHRUsWP4FhK4CMlqM7uHVkxRCilME-dpqZN0w3g==
expires: Thu, 25 Jun 2020 09:59:55 GMT

GET
H2 200 js_39wR4vuLCUZcIK_NsEhVLhl6834Dd3heLLFQ5DLVNsc.js Show response
www.globalpharmainsights.com/sites/cphi.com/files/js/ 14 KB
4 KB 125ms
119ms Script
text/javascript 143.204.237.71
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL

https://www.globalpharmainsights.com/sites/cphi.com/files/js/js_39wR4vuLCUZcIK_NsEhVLhl6834Dd3heLLFQ5DLVNsc.js

Requested by

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

143.204.237.71 Seattle, United States, ASN16509 (AMAZON-02, US),

Reverse DNS

server-143-204-237-71.cph50.r.cloudfront.net

Software

Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /

Resource Hash

dfdc11e2fb8b09465c20afcdb048552e197af37e0377785e2cb150e432d536c7

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Thu, 11 Jun 2020 12:40:11 GMT
content-encoding: gzip
x-content-type-options: nosniff
age: 104568
x-cache: Hit from cloudfront
status: 200
content-length: 3655
last-modified: Tue, 12 May 2020 03:03:22 GMT
server: Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
etag: "e47-5a56ab4d71440"
vary: Accept-Encoding
content-type: text/javascript
via: 1.1 1624c79cd07e6098196697a6a7907e4b.cloudfront.net (CloudFront)
cache-control: max-age=1209600
x-amz-cf-pop: CPH50-C1
accept-ranges: bytes
x-amz-cf-id: Ti1ZQ7vVd6EcT4EgApm5zoLsrTAefk4pwuiClVeXCBXpghJqAxZAbQ==
expires: Thu, 25 Jun 2020 12:40:11 GMT

GET
H2 200 ckeditor.js Show response
www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/ 674 KB
203 KB 101ms
96ms Script
application/javascript 143.204.237.71
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL

https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/ckeditor.js?qbs4lh

Requested by

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

143.204.237.71 Seattle, United States, ASN16509 (AMAZON-02, US),

Reverse DNS

server-143-204-237-71.cph50.r.cloudfront.net

Software

Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /

Resource Hash

945fe441f86cf714fbe8313e5a79d879d27f3c3fd542246715655c0e93dc0c5c

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Fri, 12 Jun 2020 15:35:06 GMT
content-encoding: gzip
x-content-type-options: nosniff
last-modified: Fri, 12 Jun 2020 14:48:55 GMT
server: Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
age: 7673
vary: Accept-Encoding
x-cache: Hit from cloudfront
content-type: application/javascript
status: 200
cache-control: max-age=10800
x-amz-cf-pop: CPH50-C1
x-amz-cf-id: 4J8OvDry06aEEnmB91jlwwIwoo4HgWIV-hao4iu2Yj5lX08lspnYQQ==
via: 1.1 1624c79cd07e6098196697a6a7907e4b.cloudfront.net (CloudFront)
expires: Fri, 12 Jun 2020 18:35:06 GMT

GET
H2 200 js_ZrciCJCAxDyewaqeqgUiHehSzeEalZRdqNrEoAN5Q5c.js Show response
www.globalpharmainsights.com/sites/cphi.com/files/js/ 4 KB
2 KB 126ms
120ms Script
text/javascript 143.204.237.71
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL

https://www.globalpharmainsights.com/sites/cphi.com/files/js/js_ZrciCJCAxDyewaqeqgUiHehSzeEalZRdqNrEoAN5Q5c.js

Requested by

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

143.204.237.71 Seattle, United States, ASN16509 (AMAZON-02, US),

Reverse DNS

server-143-204-237-71.cph50.r.cloudfront.net

Software

Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /

Resource Hash

66b722089080c43c9ec1aa9eaa05221de852cde11a95945da8dac4a003794397

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Thu, 11 Jun 2020 09:59:55 GMT
content-encoding: gzip
x-content-type-options: nosniff
age: 114184
x-cache: Hit from cloudfront
status: 200
content-length: 1209
last-modified: Wed, 10 Jun 2020 03:26:19 GMT
server: Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
etag: "4b9-5a7b2684d58b0"
vary: Accept-Encoding
content-type: text/javascript
via: 1.1 1624c79cd07e6098196697a6a7907e4b.cloudfront.net (CloudFront)
cache-control: max-age=1209600
x-amz-cf-pop: CPH50-C1
accept-ranges: bytes
x-amz-cf-id: UtL30Scbzzb1Enw5aDlx_5Jxe4S8T_iBJuSHCtGQX1LjbEp5lXoc1g==
expires: Thu, 25 Jun 2020 09:59:55 GMT

GET
H2 200 fa-brands-400.woff2
www.globalpharmainsights.com/sites/all/themes/shared_fonts/ 75 KB
75 KB 114ms
113ms Font
text/plain 143.204.237.71
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL

https://www.globalpharmainsights.com/sites/all/themes/shared_fonts/fa-brands-400.woff2

Requested by

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

143.204.237.71 Seattle, United States, ASN16509 (AMAZON-02, US),

Reverse DNS

server-143-204-237-71.cph50.r.cloudfront.net

Software

Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30 /

Resource Hash

089630244600f33230010f5e04c67419ec642c5228540adb42e3fe92c631e6bf

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer: https://www.globalpharmainsights.com/sites/cphi.com/files/css/css_D7P9VJVOeSYziGwjDq2JYJvJeZunkrocOLn6kFWVyq4.css
Origin: https://www.globalpharmainsights.com

Response headers

date: Thu, 04 Jun 2020 03:37:26 GMT
via: 1.1 1624c79cd07e6098196697a6a7907e4b.cloudfront.net (CloudFront)
x-content-type-options: nosniff
last-modified: Thu, 04 Jun 2020 02:32:03 GMT
server: Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30
age: 741933
etag: "12b04-5a738f33322a2"
x-cache: Hit from cloudfront
status: 200
cache-control: max-age=1209600
x-amz-cf-pop: CPH50-C1
accept-ranges: bytes
content-length: 76548
x-amz-cf-id: 5CCr5gXFiwPLW0D7KupjvWJrxGafoD_y5f9BAcKofTZQi-IwFUd79A==
expires: Thu, 18 Jun 2020 03:37:26 GMT

GET
H2 200 fa-solid-900.woff2
www.globalpharmainsights.com/sites/all/themes/shared_fonts/ 74 KB
75 KB 121ms
120ms Font
text/plain 143.204.237.71
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL

https://www.globalpharmainsights.com/sites/all/themes/shared_fonts/fa-solid-900.woff2

Requested by

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

143.204.237.71 Seattle, United States, ASN16509 (AMAZON-02, US),

Reverse DNS

server-143-204-237-71.cph50.r.cloudfront.net

Software

Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30 /

Resource Hash

2c3097237d60f42e800ebe4009c9af144bb19e5581e1c0501c7b259eee7e210c

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer: https://www.globalpharmainsights.com/sites/cphi.com/files/css/css_D7P9VJVOeSYziGwjDq2JYJvJeZunkrocOLn6kFWVyq4.css
Origin: https://www.globalpharmainsights.com

Response headers

date: Thu, 04 Jun 2020 03:37:26 GMT
via: 1.1 1624c79cd07e6098196697a6a7907e4b.cloudfront.net (CloudFront)
x-content-type-options: nosniff
last-modified: Thu, 04 Jun 2020 02:32:03 GMT
server: Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30
age: 741933
etag: "12958-5a738f32a1dfe"
x-cache: Hit from cloudfront
status: 200
cache-control: max-age=1209600
x-amz-cf-pop: CPH50-C1
accept-ranges: bytes
content-length: 76120
x-amz-cf-id: 5spbGBNvGPbF4xxI7Y_lOszJ_6eDBbc19i8-hwhfGq_HHTJnO33y2w==
expires: Thu, 18 Jun 2020 03:37:26 GMT

GET
H2 200 fa-regular-400.woff2
www.globalpharmainsights.com/sites/all/themes/shared_fonts/ 13 KB
14 KB 128ms
127ms Font
text/plain 143.204.237.71
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL

https://www.globalpharmainsights.com/sites/all/themes/shared_fonts/fa-regular-400.woff2

Requested by

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

143.204.237.71 Seattle, United States, ASN16509 (AMAZON-02, US),

Reverse DNS

server-143-204-237-71.cph50.r.cloudfront.net

Software

Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30 /

Resource Hash

093f782260d70f914e7e591eba1502d3e992e9f7a69a17d1df6c32bcddd6f06a

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer: https://www.globalpharmainsights.com/sites/cphi.com/files/css/css_D7P9VJVOeSYziGwjDq2JYJvJeZunkrocOLn6kFWVyq4.css
Origin: https://www.globalpharmainsights.com

Response headers

date: Mon, 08 Jun 2020 10:54:19 GMT
via: 1.1 1624c79cd07e6098196697a6a7907e4b.cloudfront.net (CloudFront)
x-content-type-options: nosniff
last-modified: Mon, 08 Jun 2020 10:42:22 GMT
server: Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30
age: 370120
etag: "3520-5a79044072182"
x-cache: Hit from cloudfront
status: 200
cache-control: max-age=1209600
x-amz-cf-pop: CPH50-C1
accept-ranges: bytes
content-length: 13600
x-amz-cf-id: bhZshjzqrMoJOToFVJccoi63f5NkHCgTBi7a-2dpWEKxSpwNz-r0Tw==
expires: Mon, 22 Jun 2020 10:54:19 GMT

GET
H2 200 pubads_impl_2020060803.js Show response
securepubads.g.doubleclick.net/gpt/ 246 KB
88 KB 28ms
28ms Script
text/javascript 216.58.210.2
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060803.js?21066388

Requested by

Host: www.googletagservices.com
URL: https://www.googletagservices.com/tag/js/gpt.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

216.58.210.2 Mountain View, United States, ASN15169 (GOOGLE, US),

Reverse DNS

fra16s07-in-f2.1e100.net

Software

sffe /

Resource Hash

b67d56e8da32fd316174c18e3056154cfdbe6029fcc2e15b4318981f075172c1

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Intervention: <https://www.chromestatus.com/feature/5718547946799104>; level="warning"

Response headers

date: Fri, 12 Jun 2020 17:42:59 GMT
content-encoding: gzip
x-content-type-options: nosniff
last-modified: Tue, 09 Jun 2020 00:14:21 GMT
server: sffe
vary: Accept-Encoding
content-type: text/javascript
status: 200
cache-control: private, immutable, max-age=31536000
accept-ranges: bytes
timing-allow-origin: *
alt-svc: h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length: 90021
x-xss-protection: 0
expires: Fri, 12 Jun 2020 17:42:59 GMT

GET
H2 200 integrator.sync.js Show response
adservice.google.de/adsid/ 113 B
175 B 20ms
20ms Script
application/javascript 2a00:1450:4001:821::2002
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://adservice.google.de/adsid/integrator.sync.js?domain=www.globalpharmainsights.com

Requested by

Host: www.googletagservices.com
URL: https://www.googletagservices.com/tag/js/gpt.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:821::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

cafe /

Resource Hash

ea03bfd7fdda1eac185ebc3e8e74b33065b04c8e0adc48cbbd4136748dbd2742

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin: *
date: Fri, 12 Jun 2020 17:42:59 GMT
content-encoding: gzip
x-content-type-options: nosniff
server: cafe
p3p: CP="This is not a P3P policy! See http://support.google.com/accounts/answer/151657 for more info."
status: 200
cache-control: private, no-cache, no-store
content-disposition: attachment; filename="f.txt"
content-type: application/javascript; charset=UTF-8
alt-svc: h3-27="googleads.g.doubleclick.net:443"; ma=2592000,h3-27=":443"; ma=2592000,h3-25="googleads.g.doubleclick.net:443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050="googleads.g.doubleclick.net:443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length: 108
x-xss-protection: 0

GET
H2 200 ads Show response
securepubads.g.doubleclick.net/gampad/ 483 B
458 B 52ms
52ms XHR
text/plain 216.58.210.2
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=452895018370859&correlator=4333297944938301&output=ldjh&impl=fif&eid=21066388%2C21066031%2C21065516%2C21066300&vrg=2020060803&npa=1&guci=1.2.0.0.2.1.0.0&sc=1&sfv=1-0-37&ecs=20200612&iu_parts=2441%2Cglobalpharmainsights.home%2Carticle%2Csectors%2Cmanufacturing_outsourcing&enc_prev_ius=%2F0%2F1%2F2%2F3%2F4&prev_iu_szs=1x1&prev_scp=pos%3Dinterstitial_a%26gdpr_banner%3Don%26ptype%3DArticle%26nid%3D191%26pterm%3Dmanufacturing_outsourcing%26sterm%3Dasia%2Cmiddle_east_africa%2Cfinished_dosage%2Cnews%26author%3Dgareth_carpenter%26reg%3Danonymous&cookie_enabled=1&bc=31&abxe=1&lmt=1591981740&dt=1591983779875&dlt=1591983779394&idt=444&frm=20&biw=1600&bih=1200&oid=3&adxs=0&adys=0&adks=1971742020&ucis=1&ifi=1&u_tz=120&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&dssz=11&icsg=186&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=1600x3114&msz=1600x0&ga_vid=698259743.1591983780&ga_sid=1591983780&ga_hid=1403020049&fws=0&ohw=0

Requested by

Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060803.js?21066388

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

216.58.210.2 Mountain View, United States, ASN15169 (GOOGLE, US),

Reverse DNS

fra16s07-in-f2.1e100.net

Software

cafe /

Resource Hash

6f8c42c830db02aa199c0acfdc782838d591dc563aeae575db843296c9bb5c1e

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Fri, 12 Jun 2020 17:42:59 GMT
content-encoding: br
x-content-type-options: nosniff
google-mediationgroup-id: -2
p3p: policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status: 200
alt-svc: h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length: 254
x-xss-protection: 0
google-lineitem-id: -2
pragma: no-cache
server: cafe
google-mediationtag-id: -2
google-creative-id: -2
content-type: text/plain; charset=UTF-8
access-control-allow-origin: https://www.globalpharmainsights.com
cache-control: no-cache, must-revalidate
access-control-allow-credentials: true
timing-allow-origin: *
expires: Fri, 01 Jan 1990 00:00:00 GMT

GET
H2 200 container.html
ed730ada98a1d488854a0d81e1ecf867.safeframe.googlesyndication.com/safeframe/1-0-37/html/ 0
0 54ms
38ms Other
text/html 2a00:1450:4001:809::2001
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL: https://ed730ada98a1d488854a0d81e1ecf867.safeframe.googlesyndication.com/safeframe/1-0-37/html/container.html
Requested by: Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060803.js?21066388
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2a00:1450:4001:809::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software: /
Resource Hash

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

GET
H2 200 container.html
tpc.googlesyndication.com/safeframe/1-0-37/html/ 0
0 6ms
6ms Other
text/html 2a00:1450:4001:802::2001
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL: https://tpc.googlesyndication.com/safeframe/1-0-37/html/container.html
Requested by: Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060803.js?21066388
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2a00:1450:4001:802::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software: /
Resource Hash

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

GET
H/1.1 200
OK id Show response
dpm.demdex.net/ 383 B
1 KB 40ms
39ms XHR
application/json 34.241.125.133
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL

https://dpm.demdex.net/id?d_visid_ver=4.5.2&d_fieldgroup=MC&d_rtbd=json&d_ver=2&d_orgid=DD4C6A00570E3C0F7F000101%40AdobeOrg&d_nsid=0&ts=1591983779938

Requested by

Host: assets.adobedtm.com
URL: https://assets.adobedtm.com/100e8b570010/c89496dc0f21/launch-560312491757.min.js

Protocol

HTTP/1.1

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

34.241.125.133 Dublin, Ireland, ASN16509 (AMAZON-02, US),

Reverse DNS

ec2-34-241-125-133.eu-west-1.compute.amazonaws.com

Software

Resource Hash

d6809cf326c6ddd30c16363f38ed4bde218411db80cdab5169198e3dd9e29011

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type: application/x-www-form-urlencoded

Response headers

DCS: dcs-prod-irl1-v072-06c003e32.edge-irl1.demdex.com 5.73.2.20200611122118 8ms (+0ms)
Pragma: no-cache
Strict-Transport-Security: max-age=31536000; includeSubDomains
Content-Encoding: gzip
X-TID: k5aBGyHbTdc=
Vary: Origin, Accept-Encoding, User-Agent
P3P: policyref="/w3c/p3p.xml", CP="NOI NID CURa ADMa DEVa PSAa PSDa OUR SAMa BUS PUR COM NAV INT"
Access-Control-Allow-Origin: https://www.globalpharmainsights.com
Cache-Control: no-cache,no-store,must-revalidate,max-age=0,proxy-revalidate,no-transform,private
Access-Control-Allow-Credentials: true
Connection: keep-alive
Content-Type: application/json;charset=utf-8
Content-Length: 316
Expires: Thu, 01 Jan 1970 00:00:00 GMT

GET
H2 200 AppMeasurement.min.js Show response
assets.adobedtm.com/extensions/EP308220a2a4c4403f97fc1960100db40f/ 36 KB
13 KB 9ms
9ms Script
application/x-javascript 2a02:26f0:10c:382::1e80
AKAMAI-ASN1

General

Check archive.org

Show headers Download Go to

Full URL: https://assets.adobedtm.com/extensions/EP308220a2a4c4403f97fc1960100db40f/AppMeasurement.min.js
Requested by: Host: assets.adobedtm.com
URL: https://assets.adobedtm.com/100e8b570010/c89496dc0f21/launch-560312491757.min.js
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 2a02:26f0:10c:382::1e80 , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software: AkamaiNetStorage /
Resource Hash: adfcb165c69213b0aba3c64bc549f7ff156ec82110fb8ef144b1d16ebc13b04a

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Fri, 12 Jun 2020 17:42:59 GMT
content-encoding: gzip
last-modified: Tue, 10 Mar 2020 22:29:22 GMT
server: AkamaiNetStorage
etag: "42fa244f36955eedb3cd8ade6f492bf6:1583879362.816163"
vary: Accept-Encoding
content-type: application/x-javascript
status: 200
cache-control: no-cache
accept-ranges: bytes
timing-allow-origin: *
content-length: 13342
expires: Fri, 12 Jun 2020 18:42:59 GMT

GET
H/1.1 200
OK Cookie set dest5.html
informaglobalexhibitions.demdex.net/ Frame C88D 0
0 154ms
32ms Document
text/html 54.229.146.68
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL

https://informaglobalexhibitions.demdex.net/dest5.html?d_nsid=0

Requested by

Host: assets.adobedtm.com
URL: https://assets.adobedtm.com/100e8b570010/c89496dc0f21/launch-560312491757.min.js

Protocol

HTTP/1.1

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

54.229.146.68 Dublin, Ireland, ASN16509 (AMAZON-02, US),

Reverse DNS

ec2-54-229-146-68.eu-west-1.compute.amazonaws.com

Software

Resource Hash

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains

Request headers

Host: informaglobalexhibitions.demdex.net
Connection: keep-alive
Pragma: no-cache
Cache-Control: no-cache
Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Accept: text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
Sec-Fetch-Site: cross-site
Sec-Fetch-Mode: navigate
Sec-Fetch-Dest: iframe
Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Accept-Encoding: gzip, deflate, br
Accept-Language: en-US
Cookie: demdex=70003426728527337834171526736603995012
Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL

Response headers

Accept-Ranges: bytes
Cache-Control: max-age=21600
Content-Encoding: gzip
Content-Type: text/html
Expires: Thu, 01 Jan 1970 00:00:00 GMT
Last-Modified: Thu, 11 Jun 2020 13:37:38 GMT
P3P: policyref="/w3c/p3p.xml", CP="NOI NID CURa ADMa DEVa PSAa PSDa OUR SAMa BUS PUR COM NAV INT"
Pragma: no-cache
Set-Cookie: demdex=70003426728527337834171526736603995012;Path=/;Domain=.demdex.net;Expires=Wed, 09-Dec-2020 17:43:00 GMT;Max-Age=15552000;Secure;SameSite=None
Strict-Transport-Security: max-age=31536000; includeSubDomains
Vary: Accept-Encoding, User-Agent
X-TID: daY7x0v/Rn0=
Content-Length: 2785
Connection: keep-alive

GET
H/1.1

200
OK

ibs:dpid=411&dpuuid=XuO_pAAAAceZ3y3-
dpm.demdex.net/
Redirect Chain

https://cm.everesttech.net/cm/dd?d_uuid=70003426728527337834171526736603995012
https://dpm.demdex.net/ibs:dpid=411&dpuuid=XuO_pAAAAceZ3y3-

42 B
915 B

31ms
30ms

Image
image/gif

34.241.125.133
AMAZON-02

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://dpm.demdex.net/ibs:dpid=411&dpuuid=XuO_pAAAAceZ3y3-

Requested by

Protocol

HTTP/1.1

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

34.241.125.133 Dublin, Ireland, ASN16509 (AMAZON-02, US),

Reverse DNS

ec2-34-241-125-133.eu-west-1.compute.amazonaws.com

Software

Resource Hash

ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains
X-Content-Type-Options	nosniff

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

DCS: dcs-prod-irl1-v072-0b15588a7.edge-irl1.demdex.com 5.73.2.20200611122118 0ms (+1ms)
Pragma: no-cache
Strict-Transport-Security: max-age=31536000; includeSubDomains
X-Content-Type-Options: nosniff
X-TID: K5fshoY2ThY=
P3P: policyref="/w3c/p3p.xml", CP="NOI NID CURa ADMa DEVa PSAa PSDa OUR SAMa BUS PUR COM NAV INT"
Cache-Control: no-cache,no-store,must-revalidate,max-age=0,proxy-revalidate,no-transform,private
Connection: keep-alive
Content-Type: image/gif
Content-Length: 42
Expires: Thu, 01 Jan 1970 00:00:00 GMT

Redirect headers

Date: Fri, 12 Jun 2020 17:42:59 GMT
Server: AMO-cookiemap/1.1
P3P: CP="NOI NID DEVa PSAa PSDa OUR IND PUR COM NAV INT DEM"
Location: https://dpm.demdex.net/ibs:dpid=411&dpuuid=XuO_pAAAAceZ3y3-
Cache-Control: no-cache
Connection: Keep-Alive
Keep-Alive: timeout=15,max=100
Content-Length: 0

GET
H2 200 cc_af.js Show response
tags.crwdcntrl.net/c/7499/ 64 KB
15 KB 67ms
24ms Script
application/json 143.204.89.116
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://tags.crwdcntrl.net/c/7499/cc_af.js
Requested by: Host: assets.adobedtm.com
URL: https://assets.adobedtm.com/100e8b570010/c89496dc0f21/launch-560312491757.min.js
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 143.204.89.116 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS: server-143-204-89-116.fra50.r.cloudfront.net
Software: AmazonS3 /
Resource Hash: 3517e49035216248756bd8d6babd7e024b944f85eed8bc430ffdd509e593ba52

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Fri, 12 Jun 2020 12:40:31 GMT
content-encoding: gzip
last-modified: Wed, 27 May 2020 14:23:57 GMT
server: AmazonS3
age: 18149
x-amz-server-side-encryption: AES256
vary: Accept-Encoding
x-cache: Hit from cloudfront
content-type: application/json
status: 200
cache-control: max-age: 86400
x-amz-cf-pop: FRA50-C1
x-amz-cf-id: uucwSymCz06CQk8uS7HkbgIxJ-uhNpLdlbr3TUZhGZAJiCeLK1uBDw==
via: 1.1 6b8ac2d6d64dc42007741d312e2d73ab.cloudfront.net (CloudFront)

GET
H2 200 js Show response
www.googletagmanager.com/gtag/ 83 KB
33 KB 20ms
20ms Script
application/javascript 2a00:1450:4001:825::2008
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.googletagmanager.com/gtag/js?id=AW-998237655&l=dataLayer

Requested by

Host: assets.adobedtm.com
URL: https://assets.adobedtm.com/100e8b570010/c89496dc0f21/launch-560312491757.min.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:825::2008 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

Google Tag Manager /

Resource Hash

828f14b986ea2aa026084ad5372d6df5d65025a19cb3e3c4a0a8c4c399fc0473

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains
X-Xss-Protection	0

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Fri, 12 Jun 2020 17:43:00 GMT
content-encoding: br
vary: Accept-Encoding
status: 200
alt-svc: h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length: 33228
x-xss-protection: 0
last-modified: Fri, 12 Jun 2020 15:00:00 GMT
server: Google Tag Manager
strict-transport-security: max-age=31536000; includeSubDomains
content-type: application/javascript; charset=UTF-8
access-control-allow-origin: *
cache-control: private, max-age=900
access-control-allow-credentials: true
access-control-allow-headers: Cache-Control
expires: Fri, 12 Jun 2020 17:43:00 GMT

POST
H2 200 News Show response
www.globalpharmainsights.com/no_cache/feeds/ajax/rss/ 9 KB
10 KB 1053ms
1053ms XHR
application/json 143.204.237.71
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL

https://www.globalpharmainsights.com/no_cache/feeds/ajax/rss/News?fromPath=

Requested by

Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/cphi.com/files/js/js__PiZuK2o4XAnDCWOhogiGF01gyHzeu7QxvOyfTe-YyM.js

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

143.204.237.71 Seattle, United States, ASN16509 (AMAZON-02, US),

Reverse DNS

server-143-204-237-71.cph50.r.cloudfront.net

Software

Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 / PHP/7.2.31

Resource Hash

5a64c35b8a0dde36c53d51b561cda744650b8ffe8ec2048902f49ef788d8b264

Security Headers

Name	Value
X-Content-Type-Options	nosniff, nosniff

Request headers

Accept: application/json, text/javascript, */*; q=0.01
Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
X-Requested-With: XMLHttpRequest
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type: application/x-www-form-urlencoded; charset=UTF-8

Response headers

date: Fri, 12 Jun 2020 17:43:01 GMT
via: 1.1 1624c79cd07e6098196697a6a7907e4b.cloudfront.net (CloudFront)
x-content-type-options: nosniff, nosniff
server: Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
x-amz-cf-pop: CPH50-C1
x-powered-by: PHP/7.2.31
x-drupal-ajax-token: 1
x-cache: Miss from cloudfront
content-type: application/json; charset=utf-8
status: 200
expires: Sun, 19 Nov 1978 05:00:00 GMT
cache-control: no-cache, must-revalidate
x-amz-cf-id: 6uK9IMsD87oNbpJNZTwjPzgfrlVJKwkzu-wRl0yjMfBhX2_rf80-eA==
x-ua-compatible: IE=edge,chrome=1

POST
H2 200 Products Show response
www.globalpharmainsights.com/no_cache/feeds/ajax/rss/ 9 KB
10 KB 566ms
566ms XHR
application/json 143.204.237.71
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL

https://www.globalpharmainsights.com/no_cache/feeds/ajax/rss/Products?fromPath=

Requested by

Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/cphi.com/files/js/js__PiZuK2o4XAnDCWOhogiGF01gyHzeu7QxvOyfTe-YyM.js

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

143.204.237.71 Seattle, United States, ASN16509 (AMAZON-02, US),

Reverse DNS

server-143-204-237-71.cph50.r.cloudfront.net

Software

Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 / PHP/7.2.31

Resource Hash

827b0bcb94743cd5b8bea463206247215e5c19330e0607da39e5cbf4542836de

Security Headers

Name	Value
X-Content-Type-Options	nosniff, nosniff

Request headers

Accept: application/json, text/javascript, */*; q=0.01
Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
X-Requested-With: XMLHttpRequest
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type: application/x-www-form-urlencoded; charset=UTF-8

Response headers

date: Fri, 12 Jun 2020 17:43:00 GMT
via: 1.1 1624c79cd07e6098196697a6a7907e4b.cloudfront.net (CloudFront)
x-content-type-options: nosniff, nosniff
server: Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
x-amz-cf-pop: CPH50-C1
x-powered-by: PHP/7.2.31
x-drupal-ajax-token: 1
x-cache: Miss from cloudfront
content-type: application/json; charset=utf-8
status: 200
expires: Sun, 19 Nov 1978 05:00:00 GMT
cache-control: no-cache, must-revalidate
x-amz-cf-id: dxnQSkKib1g9x4MdCy33D7nTxnPDrlp_pdmaJ3bzydf62NQNJFnGBg==
x-ua-compatible: IE=edge,chrome=1

POST
H2 200 Suppliers Show response
www.globalpharmainsights.com/no_cache/feeds/ajax/rss/ 9 KB
10 KB 748ms
748ms XHR
application/json 143.204.237.71
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL

https://www.globalpharmainsights.com/no_cache/feeds/ajax/rss/Suppliers?fromPath=

Requested by

Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/cphi.com/files/js/js__PiZuK2o4XAnDCWOhogiGF01gyHzeu7QxvOyfTe-YyM.js

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

143.204.237.71 Seattle, United States, ASN16509 (AMAZON-02, US),

Reverse DNS

server-143-204-237-71.cph50.r.cloudfront.net

Software

Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 / PHP/7.2.31

Resource Hash

978f860860fc21279d27ef2fdc87b01a48f6d653d5c028066eb29c9436bf83a9

Security Headers

Name	Value
X-Content-Type-Options	nosniff, nosniff

Request headers

Accept: application/json, text/javascript, */*; q=0.01
Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
X-Requested-With: XMLHttpRequest
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type: application/x-www-form-urlencoded; charset=UTF-8

Response headers

date: Fri, 12 Jun 2020 17:43:00 GMT
via: 1.1 1624c79cd07e6098196697a6a7907e4b.cloudfront.net (CloudFront)
x-content-type-options: nosniff, nosniff
server: Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
x-amz-cf-pop: CPH50-C1
x-powered-by: PHP/7.2.31
x-drupal-ajax-token: 1
x-cache: Miss from cloudfront
content-type: application/json; charset=utf-8
status: 200
expires: Sun, 19 Nov 1978 05:00:00 GMT
cache-control: no-cache, must-revalidate
x-amz-cf-id: qbdgUumG0Z2yhZOZvAYCwChym7y2C2Ky1reyfD9Y1dHa4QDbg8AtoA==
x-ua-compatible: IE=edge,chrome=1

GET
H2 200 ui-bg_flat_75_ffffff_40x100.png
www.globalpharmainsights.com/sites/all/modules/contrib/jquery_update/replace/ui/themes/base/minified/images/ 178 B
605 B 96ms
95ms Image
image/png 143.204.237.71
AMAZON-02

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.globalpharmainsights.com/sites/all/modules/contrib/jquery_update/replace/ui/themes/base/minified/images/ui-bg_flat_75_ffffff_40x100.png

Requested by

Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/cphi.com/files/js/js__PiZuK2o4XAnDCWOhogiGF01gyHzeu7QxvOyfTe-YyM.js

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

143.204.237.71 Seattle, United States, ASN16509 (AMAZON-02, US),

Reverse DNS

server-143-204-237-71.cph50.r.cloudfront.net

Software

Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30 /

Resource Hash

39ab7ccd9f4e82579da78a9241265df288d8eb65dbbd7cf48aed2d0129887df5

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

Referer: https://www.globalpharmainsights.com/sites/cphi.com/files/css/css_b2lxsoMjuDz1VEsoXFy0Cgo8pcav1Ny1N-EHn8knPc0.css
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Thu, 04 Jun 2020 03:37:31 GMT
via: 1.1 1624c79cd07e6098196697a6a7907e4b.cloudfront.net (CloudFront)
x-content-type-options: nosniff
age: 741929
x-cache: Hit from cloudfront
status: 200
content-length: 178
last-modified: Thu, 04 Jun 2020 02:32:15 GMT
server: Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30
etag: "b2-5a738f3e757d5"
content-type: image/png
cache-control: max-age=1209600
x-amz-cf-pop: CPH50-C1
accept-ranges: bytes
x-amz-cf-id: PyqlnW6YM9erFztg56nACygPscrVGVEtuhnGDkoNdwTGmwNoYmjw7A==
expires: Thu, 18 Jun 2020 03:37:31 GMT

GET
H2 200 backtotop.png
www.globalpharmainsights.com/sites/all/modules/contrib/back_to_top/ 1 KB
2 KB 100ms
99ms Image
image/png 143.204.237.71
AMAZON-02

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.globalpharmainsights.com/sites/all/modules/contrib/back_to_top/backtotop.png

Requested by

Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/cphi.com/files/js/js__PiZuK2o4XAnDCWOhogiGF01gyHzeu7QxvOyfTe-YyM.js

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

143.204.237.71 Seattle, United States, ASN16509 (AMAZON-02, US),

Reverse DNS

server-143-204-237-71.cph50.r.cloudfront.net

Software

Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30 /

Resource Hash

b40e0334f469c4b2508b88c82d19923ecc01ac6be08b81550b1d6da930480e4f

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

Referer: https://www.globalpharmainsights.com/sites/cphi.com/files/css/css_EMysOwdNz4P_aEBvy91ee-H45803PIdurHGMjmMp-B4.css
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Thu, 04 Jun 2020 03:37:31 GMT
via: 1.1 1624c79cd07e6098196697a6a7907e4b.cloudfront.net (CloudFront)
x-content-type-options: nosniff
age: 741929
x-cache: Hit from cloudfront
status: 200
content-length: 1219
last-modified: Thu, 04 Jun 2020 02:32:16 GMT
server: Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.30
etag: "4c3-5a738f3f1d412"
content-type: image/png
cache-control: max-age=1209600
x-amz-cf-pop: CPH50-C1
accept-ranges: bytes
x-amz-cf-id: C1Ewx_bZKzFyRRpQR-UJelw3O1cQaGasObW4RBclixhDeyv5a4Y6qw==
expires: Thu, 18 Jun 2020 03:37:31 GMT

GET
H2 200 pinit.js Show response
assets.pinterest.com/js/ 361 B
674 B 54ms
38ms Script
application/javascript 2606:4700::6812:fb0
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL: https://assets.pinterest.com/js/pinit.js?_=1591983779771
Requested by: Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/cphi.com/files/js/js__PiZuK2o4XAnDCWOhogiGF01gyHzeu7QxvOyfTe-YyM.js
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700::6812:fb0 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software: cloudflare /
Resource Hash: 3faadebc89cdb21d11634a032816f152462d1cb8903eb21d0642501fcad065de

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Fri, 12 Jun 2020 17:43:00 GMT
content-encoding: br
x-cdn: cloudflare
status: 200
etag: W/"82bfd941d2c9b3b9e0650a27c9d11737"
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary: Accept-Encoding
access-control-allow-methods: GET
content-type: application/javascript; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: x-cdn
cache-control: max-age=300
cf-ray: 5a255f221fe5175a-FRA
cf-request-id: 034b39c94e0000175a3a9b6200000001
server: cloudflare

GET
H2 200 get_poll Show response
www.globalpharmainsights.com/ 4 KB
1 KB 817ms
817ms XHR
application/json 143.204.237.71
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL

https://www.globalpharmainsights.com/get_poll

Requested by

Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/cphi.com/files/js/js__PiZuK2o4XAnDCWOhogiGF01gyHzeu7QxvOyfTe-YyM.js

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

143.204.237.71 Seattle, United States, ASN16509 (AMAZON-02, US),

Reverse DNS

server-143-204-237-71.cph50.r.cloudfront.net

Software

Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 / PHP/7.2.31

Resource Hash

91396e50729417bf84b44875dd041e1a66bfd6c82ab31fbab85c3b29ce336ef5

Security Headers

Name	Value
X-Content-Type-Options	nosniff, nosniff
X-Frame-Options	SAMEORIGIN

Request headers

Accept: */*
Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
X-Requested-With: XMLHttpRequest
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Fri, 12 Jun 2020 17:43:00 GMT
content-encoding: gzip
x-content-type-options: nosniff, nosniff
x-amz-cf-pop: CPH50-C1
x-powered-by: PHP/7.2.31
x-cache: Miss from cloudfront
status: 200
x-ua-compatible: IE=edge,chrome=1
server: Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
x-frame-options: SAMEORIGIN
vary: Accept-Encoding,Cookie
content-language: en
via: 1.1 1624c79cd07e6098196697a6a7907e4b.cloudfront.net (CloudFront)
cache-control: no-cache, must-revalidate
x-drupal-cache: MISS
content-type: application/json
x-amz-cf-id: LFO04Zzh4KBBixBFfRijOlKS04Nb7vEYCgqpToR3bpIL3GhAq5rP2A==
expires: Sun, 19 Nov 1978 05:00:00 GMT

POST
H2 200 emit.php Show response
www.globalpharmainsights.com/sites/all/modules/contrib/radioactivity/ 0
424 B 751ms
750ms XHR
text/html 143.204.237.71
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL

https://www.globalpharmainsights.com/sites/all/modules/contrib/radioactivity/emit.php

Requested by

Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/cphi.com/files/js/js__PiZuK2o4XAnDCWOhogiGF01gyHzeu7QxvOyfTe-YyM.js

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

143.204.237.71 Seattle, United States, ASN16509 (AMAZON-02, US),

Reverse DNS

server-143-204-237-71.cph50.r.cloudfront.net

Software

Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 / PHP/7.2.31

Resource Hash

e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Security Headers

Name	Value
X-Content-Type-Options	nosniff, nosniff

Request headers

Accept: text/html, */*; q=0.01
Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
X-Requested-With: XMLHttpRequest
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type: application/x-www-form-urlencoded; charset=UTF-8

Response headers

date: Fri, 12 Jun 2020 17:43:00 GMT
via: 1.1 1624c79cd07e6098196697a6a7907e4b.cloudfront.net (CloudFront)
x-content-type-options: nosniff, nosniff
server: Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
x-amz-cf-pop: CPH50-C1
x-powered-by: PHP/7.2.31
x-cache: Miss from cloudfront
content-type: text/html; charset=UTF-8
status: 200
expires: Sun, 19 Nov 1978 05:00:00 GMT
cache-control: no-cache, must-revalidate
content-length: 0
x-amz-cf-id: osFrvBOkH360h0p7N5JfxD2fdA-UmIGeMdBgHEOGV88yufDo_CbTHA==
x-ua-compatible: IE=edge,chrome=1

GET
H2 200 191 Show response
www.globalpharmainsights.com/ajax/get-comments-count/ 3 B
496 B 475ms
474ms XHR
application/json 143.204.237.71
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL

https://www.globalpharmainsights.com/ajax/get-comments-count/191

Requested by

Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/cphi.com/files/js/js__PiZuK2o4XAnDCWOhogiGF01gyHzeu7QxvOyfTe-YyM.js

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

143.204.237.71 Seattle, United States, ASN16509 (AMAZON-02, US),

Reverse DNS

server-143-204-237-71.cph50.r.cloudfront.net

Software

Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 / PHP/7.2.31

Resource Hash

98089e6d36f78e9766c9ea34d5acb3611f3a92cd81c5eb102095d924ffc7d08b

Security Headers

Name	Value
X-Content-Type-Options	nosniff, nosniff
X-Frame-Options	SAMEORIGIN

Request headers

Accept: */*
Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
X-Requested-With: XMLHttpRequest
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Fri, 12 Jun 2020 17:43:00 GMT
via: 1.1 1624c79cd07e6098196697a6a7907e4b.cloudfront.net (CloudFront)
x-content-type-options: nosniff, nosniff
x-amz-cf-pop: CPH50-C1
x-powered-by: PHP/7.2.31
x-cache: Miss from cloudfront
status: 200
content-length: 3
x-ua-compatible: IE=edge,chrome=1
server: Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
x-frame-options: SAMEORIGIN
vary: Cookie
content-language: en
cache-control: no-cache, must-revalidate
x-drupal-cache: MISS
content-type: application/json
x-amz-cf-id: qml_gX1Nog89_Av7Dta7hShQvdaeVgAzXyWNvs2XI0ygFa96h1etLw==
expires: Sun, 19 Nov 1978 05:00:00 GMT

GET
H2 200 ntl8rdl.js Show response
use.typekit.net/ 20 KB
8 KB 37ms
19ms Script
text/javascript 2a01:4a0:1338:28::c38a:ff0a
NETZBETRIEB-GMBH

General

Check archive.org

Show headers Download Go to

Full URL

https://use.typekit.net/ntl8rdl.js

Requested by

Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/cphi.com/files/js/js_yIkX_vb0Dxng7O5aNwkJ-nqApJpaPl61cDQzkBEByaA.js

Protocol

Security

TLS 1.3, , AES_256_GCM

Server

2a01:4a0:1338:28::c38a:ff0a , Germany, ASN201011 (NETZBETRIEB-GMBH, DE),

Reverse DNS

Software

nginx /

Resource Hash

a3766442ecfc3a0e93a8e7c864fee2700c9220422bcc14016181c986b2f6744d

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains;

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

strict-transport-security: max-age=31536000; includeSubDomains;
content-encoding: gzip
server: nginx
status: 200
date: Fri, 12 Jun 2020 17:43:00 GMT
vary: Accept-Encoding
content-type: text/javascript;charset=utf-8
access-control-allow-origin: *
cache-control: public, max-age=600, stale-while-revalidate=604800
timing-allow-origin: *
content-length: 7560

GET
H2 200 ads Show response
securepubads.g.doubleclick.net/gampad/ 466 B
536 B 53ms
52ms XHR
text/plain 216.58.210.2
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=452895018370859&correlator=4333297944938301&output=ldjh&impl=fif&adsid=NT&eid=21066388%2C21066031%2C21065516%2C21066300&vrg=2020060803&npa=1&guci=1.2.0.0.2.1.0.0&sc=1&sfv=1-0-37&ecs=20200612&iu_parts=2441%2Cglobalpharmainsights.home%2Carticle%2Csectors%2Cmanufacturing_outsourcing&enc_prev_ius=%2F0%2F1%2F2%2F3%2F4&prev_iu_szs=1x1&prev_scp=pos%3Dadhesion%26ptype%3DArticle%26nid%3D191%26pterm%3Dmanufacturing_outsourcing%26sterm%3Dasia%2Cmiddle_east_africa%2Cfinished_dosage%2Cnews%26author%3Dgareth_carpenter%26reg%3Danonymous&cookie=ID%3D69099b46254b0af4-226794e176b6000d%3AT%3D1591983779%3AS%3DALNI_Mb0wtlnVdW1-iItdjHOdfzn0Hoa_g&bc=31&abxe=1&lmt=1591981740&dt=1591983780205&dlt=1591983779394&idt=444&frm=20&biw=1600&bih=1200&oid=3&adxs=0&adys=3064&adks=182313222&ucis=2&ifi=2&u_tz=120&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&dssz=39&icsg=9048220237820&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=0x0&msz=0x1&psts=AGkb-H9awlplzm3R5rYar7qljqzk&ga_vid=698259743.1591983780&ga_sid=1591983780&ga_hid=1403020049&fws=4&ohw=0&btvi=1

Requested by

Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060803.js?21066388

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

216.58.210.2 Mountain View, United States, ASN15169 (GOOGLE, US),

Reverse DNS

fra16s07-in-f2.1e100.net

Software

cafe /

Resource Hash

aa9cb054401d8fba9f696c2d3bc2bd1a4053f62d62025c54f3f9a44a9e015113

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Fri, 12 Jun 2020 17:43:00 GMT
content-encoding: br
x-content-type-options: nosniff
google-mediationgroup-id: -2
p3p: policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status: 200
alt-svc: h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length: 244
x-xss-protection: 0
google-lineitem-id: -2
pragma: no-cache
server: cafe
google-mediationtag-id: -2
google-creative-id: -2
content-type: text/plain; charset=UTF-8
access-control-allow-origin: https://www.globalpharmainsights.com
cache-control: no-cache, must-revalidate
access-control-allow-credentials: true
timing-allow-origin: *
expires: Fri, 01 Jan 1990 00:00:00 GMT

GET
H2 200 ads Show response
securepubads.g.doubleclick.net/gampad/ 472 B
542 B 56ms
55ms XHR
text/plain 216.58.210.2
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=452895018370859&correlator=4333297944938301&output=ldjh&impl=fif&adsid=NT&eid=21066388%2C21066031%2C21065516%2C21066300&vrg=2020060803&npa=1&guci=1.2.0.0.2.1.0.0&sc=1&sfv=1-0-37&ecs=20200612&iu_parts=2441%2Cglobalpharmainsights.home%2Carticle%2Csectors%2Cmanufacturing_outsourcing&enc_prev_ius=%2F0%2F1%2F2%2F3%2F4&prev_iu_szs=1x1&prev_scp=pos%3Dfootnote%26ptype%3DArticle%26nid%3D191%26pterm%3Dmanufacturing_outsourcing%26sterm%3Dasia%2Cmiddle_east_africa%2Cfinished_dosage%2Cnews%26author%3Dgareth_carpenter%26reg%3Danonymous%26gdpr_banner%3Don&cookie=ID%3D69099b46254b0af4-226794e176b6000d%3AT%3D1591983779%3AS%3DALNI_Mb0wtlnVdW1-iItdjHOdfzn0Hoa_g&bc=31&abxe=1&lmt=1591981740&dt=1591983780210&dlt=1591983779394&idt=444&frm=20&biw=1600&bih=1200&oid=3&adxs=0&adys=3065&adks=4125871842&ucis=3&ifi=3&u_tz=120&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&dssz=39&icsg=9048220237820&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=0x0&msz=0x1&psts=AGkb-H9awlplzm3R5rYar7qljqzk&ga_vid=698259743.1591983780&ga_sid=1591983780&ga_hid=1403020049&fws=4&ohw=0&btvi=2

Requested by

Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060803.js?21066388

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

216.58.210.2 Mountain View, United States, ASN15169 (GOOGLE, US),

Reverse DNS

fra16s07-in-f2.1e100.net

Software

cafe /

Resource Hash

53ad4b90162b4effc02fc4477fb02a886f4278c69cb4ac1e35ae0f8e8866e47c

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Fri, 12 Jun 2020 17:43:00 GMT
content-encoding: br
x-content-type-options: nosniff
google-mediationgroup-id: -2
p3p: policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status: 200
alt-svc: h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length: 249
x-xss-protection: 0
google-lineitem-id: -2
pragma: no-cache
server: cafe
google-mediationtag-id: -2
google-creative-id: -2
content-type: text/plain; charset=UTF-8
access-control-allow-origin: https://www.globalpharmainsights.com
cache-control: no-cache, must-revalidate
access-control-allow-credentials: true
timing-allow-origin: *
expires: Fri, 01 Jan 1990 00:00:00 GMT

GET
H2 200 ads Show response
securepubads.g.doubleclick.net/gampad/ 466 B
536 B 50ms
49ms XHR
text/plain 216.58.210.2
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=452895018370859&correlator=4333297944938301&output=ldjh&impl=fif&adsid=NT&eid=21066388%2C21066031%2C21065516%2C21066300&vrg=2020060803&npa=1&guci=1.2.0.0.2.1.0.0&sc=1&sfv=1-0-37&ecs=20200612&iu_parts=2441%2Cglobalpharmainsights.home%2Carticle%2Csectors%2Cmanufacturing_outsourcing&enc_prev_ius=%2F0%2F1%2F2%2F3%2F4&prev_iu_szs=1x1&ists=1&prev_scp=pos%3Doop_a%26ptype%3DArticle%26nid%3D191%26pterm%3Dmanufacturing_outsourcing%26sterm%3Dasia%2Cmiddle_east_africa%2Cfinished_dosage%2Cnews%26author%3Dgareth_carpenter%26reg%3Danonymous%26gdpr_banner%3Don&cookie=ID%3D69099b46254b0af4-226794e176b6000d%3AT%3D1591983779%3AS%3DALNI_Mb0wtlnVdW1-iItdjHOdfzn0Hoa_g&bc=31&abxe=1&lmt=1591981740&dt=1591983780213&dlt=1591983779394&idt=444&frm=20&biw=1600&bih=1200&oid=3&adxs=0&adys=3066&adks=3191156477&ucis=4&ifi=4&u_tz=120&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&dssz=39&icsg=9048220237820&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=0x0&msz=0x1&psts=AGkb-H9awlplzm3R5rYar7qljqzk&ga_vid=698259743.1591983780&ga_sid=1591983780&ga_hid=1403020049&fws=4&ohw=0&btvi=3

Requested by

Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060803.js?21066388

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

216.58.210.2 Mountain View, United States, ASN15169 (GOOGLE, US),

Reverse DNS

fra16s07-in-f2.1e100.net

Software

cafe /

Resource Hash

e5c09a3c6f42a17f9fc7c720f804e246b5231948b4e36e1e89e114f9b40af38a

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Fri, 12 Jun 2020 17:43:00 GMT
content-encoding: br
x-content-type-options: nosniff
google-mediationgroup-id: -2
p3p: policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status: 200
alt-svc: h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length: 243
x-xss-protection: 0
google-lineitem-id: -2
pragma: no-cache
server: cafe
google-mediationtag-id: -2
google-creative-id: -2
content-type: text/plain; charset=UTF-8
access-control-allow-origin: https://www.globalpharmainsights.com
cache-control: no-cache, must-revalidate
access-control-allow-credentials: true
timing-allow-origin: *
expires: Fri, 01 Jan 1990 00:00:00 GMT

GET
H2 200 ads Show response
securepubads.g.doubleclick.net/gampad/ 16 KB
7 KB 61ms
61ms XHR
text/plain 216.58.210.2
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=452895018370859&correlator=4333297944938301&output=ldjh&impl=fif&adsid=NT&eid=21066388%2C21066031%2C21065516%2C21066300&vrg=2020060803&npa=1&guci=1.2.0.0.2.1.0.0&sc=1&sfv=1-0-37&ecs=20200612&iu_parts=2441%2Cglobalpharmainsights.home%2Carticle%2Csectors%2Cmanufacturing_outsourcing&enc_prev_ius=%2F0%2F1%2F2%2F3%2F4&prev_iu_szs=300x250&prev_scp=pos%3D300_1_lft%26ptype%3DArticle%26nid%3D191%26pterm%3Dmanufacturing_outsourcing%26sterm%3Dasia%2Cmiddle_east_africa%2Cfinished_dosage%2Cnews%26author%3Dgareth_carpenter%26reg%3Danonymous&cookie=ID%3D69099b46254b0af4-226794e176b6000d%3AT%3D1591983779%3AS%3DALNI_Mb0wtlnVdW1-iItdjHOdfzn0Hoa_g&bc=31&abxe=1&lmt=1591981740&dt=1591983780218&dlt=1591983779394&idt=444&frm=20&biw=1600&bih=1200&oid=3&adxs=219&adys=548&adks=913738584&ucis=5&ifi=5&u_tz=120&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&dssz=39&icsg=9048220237820&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=0x250&msz=0x250&psts=AGkb-H9awlplzm3R5rYar7qljqzk&ga_vid=698259743.1591983780&ga_sid=1591983780&ga_hid=1403020049&fws=4&ohw=0&btvi=0

Requested by

Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060803.js?21066388

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

216.58.210.2 Mountain View, United States, ASN15169 (GOOGLE, US),

Reverse DNS

fra16s07-in-f2.1e100.net

Software

cafe /

Resource Hash

77cce556cc4f34f92a54d190c36fa87f5764dcc04addc2a948d3948d6a9274aa

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Fri, 12 Jun 2020 17:43:00 GMT
content-encoding: br
x-content-type-options: nosniff
google-mediationgroup-id: -2
p3p: policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status: 200
alt-svc: h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length: 6867
x-xss-protection: 0
google-lineitem-id: 5374575282
pragma: no-cache
server: cafe
google-mediationtag-id: -2
google-creative-id: 138311932788
content-type: text/plain; charset=UTF-8
access-control-allow-origin: https://www.globalpharmainsights.com
cache-control: no-cache, must-revalidate
access-control-allow-credentials: true
timing-allow-origin: *
expires: Fri, 01 Jan 1990 00:00:00 GMT

GET
H2 200 ads Show response
securepubads.g.doubleclick.net/gampad/ 466 B
534 B 55ms
54ms XHR
text/plain 216.58.210.2
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=452895018370859&correlator=4333297944938301&output=ldjh&impl=fif&adsid=NT&eid=21066388%2C21066031%2C21065516%2C21066300&vrg=2020060803&npa=1&guci=1.2.0.0.2.1.0.0&sc=1&sfv=1-0-37&ecs=20200612&iu_parts=2441%2Cglobalpharmainsights.home%2Carticle%2Csectors%2Cmanufacturing_outsourcing&enc_prev_ius=%2F0%2F1%2F2%2F3%2F4&prev_iu_szs=1x1&ists=1&prev_scp=pos%3Dwrap%26combo%3Dwrap%26ptype%3DArticle%26nid%3D191%26pterm%3Dmanufacturing_outsourcing%26sterm%3Dasia%2Cmiddle_east_africa%2Cfinished_dosage%2Cnews%26author%3Dgareth_carpenter%26reg%3Danonymous&cookie=ID%3D69099b46254b0af4-226794e176b6000d%3AT%3D1591983779%3AS%3DALNI_Mb0wtlnVdW1-iItdjHOdfzn0Hoa_g&bc=31&abxe=1&lmt=1591981740&dt=1591983780222&dlt=1591983779394&idt=444&frm=20&biw=1600&bih=1200&oid=3&adxs=0&adys=3067&adks=2395764730&ucis=6&ifi=6&u_tz=120&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&dssz=39&icsg=9048220237820&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=0x0&msz=0x1&psts=AGkb-H9awlplzm3R5rYar7qljqzk&ga_vid=698259743.1591983780&ga_sid=1591983780&ga_hid=1403020049&fws=4&ohw=0&btvi=4

Requested by

Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060803.js?21066388

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

216.58.210.2 Mountain View, United States, ASN15169 (GOOGLE, US),

Reverse DNS

fra16s07-in-f2.1e100.net

Software

cafe /

Resource Hash

5673739086e46a311ae6f7e15a31d247a1b6926348725842c173d7793baab076

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Fri, 12 Jun 2020 17:43:00 GMT
content-encoding: br
x-content-type-options: nosniff
google-mediationgroup-id: -2
p3p: policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status: 200
alt-svc: h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length: 244
x-xss-protection: 0
google-lineitem-id: -2
pragma: no-cache
server: cafe
google-mediationtag-id: -2
google-creative-id: -2
content-type: text/plain; charset=UTF-8
access-control-allow-origin: https://www.globalpharmainsights.com
cache-control: no-cache, must-revalidate
access-control-allow-credentials: true
timing-allow-origin: *
expires: Fri, 01 Jan 1990 00:00:00 GMT

POST
H2 200 penton-legal-comm-get-message Show response
www.globalpharmainsights.com/ajax/ 821 B
2 KB 970ms
969ms XHR
text/html 143.204.237.71
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL

https://www.globalpharmainsights.com/ajax/penton-legal-comm-get-message

Requested by

Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/cphi.com/files/js/js__PiZuK2o4XAnDCWOhogiGF01gyHzeu7QxvOyfTe-YyM.js

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

143.204.237.71 Seattle, United States, ASN16509 (AMAZON-02, US),

Reverse DNS

server-143-204-237-71.cph50.r.cloudfront.net

Software

Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 / PHP/7.2.31

Resource Hash

8b9aec49be5d5cc900eec1c08755f843459d9995a7bae3f6375037da6c01c487

Security Headers

Name	Value
X-Content-Type-Options	nosniff, nosniff
X-Frame-Options	SAMEORIGIN

Request headers

Accept: */*
Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
X-Requested-With: XMLHttpRequest
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Fri, 12 Jun 2020 17:43:01 GMT
via: 1.1 1624c79cd07e6098196697a6a7907e4b.cloudfront.net (CloudFront)
x-content-type-options: nosniff, nosniff
x-amz-cf-pop: CPH50-C1
x-powered-by: PHP/7.2.31
x-cache: Miss from cloudfront
status: 200
content-length: 821
x-ua-compatible: IE=edge,chrome=1
server: Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
x-frame-options: SAMEORIGIN
content-language: en
cache-control: no-cache, must-revalidate
content-type: text/html; charset=UTF-8
x-amz-cf-id: wvhBVclsRGZyAdOInaOIJfNdot8mbRCRuS6rI8DCeNGVAn58t6yvyA==
expires: Sun, 19 Nov 1978 05:00:00 GMT

GET
H2 200 RC4488730ca17f46b783d3193a682c14ba-source.min.js Show response
assets.adobedtm.com/100e8b570010/c89496dc0f21/0eadc58b531c/ 994 B
838 B 9ms
9ms Script
application/x-javascript 2a02:26f0:10c:382::1e80
AKAMAI-ASN1

General

Check archive.org

Show headers Download Go to

Full URL: https://assets.adobedtm.com/100e8b570010/c89496dc0f21/0eadc58b531c/RC4488730ca17f46b783d3193a682c14ba-source.min.js
Requested by: Host: assets.adobedtm.com
URL: https://assets.adobedtm.com/100e8b570010/c89496dc0f21/launch-560312491757.min.js
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 2a02:26f0:10c:382::1e80 , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software: AkamaiNetStorage /
Resource Hash: 4b2699af5cddfe0118e20f883a6f4993c3482a7160e35bd1b8f609f45b89589d

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Fri, 12 Jun 2020 17:43:00 GMT
content-encoding: gzip
last-modified: Wed, 27 May 2020 12:11:51 GMT
server: AkamaiNetStorage
etag: "e296c46fda28eead0a6917455448db77:1590581511.027982"
vary: Accept-Encoding
content-type: application/x-javascript
status: 200
cache-control: max-age=3600
accept-ranges: bytes
timing-allow-origin: *
content-length: 593
expires: Fri, 12 Jun 2020 18:43:00 GMT

GET
H2 200 ckeditor.config.js Show response
www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ 4 KB
2 KB 59ms
59ms Script
application/javascript 143.204.237.71
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL

https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor.config.js?&t=I3I8

Requested by

Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/ckeditor.js?qbs4lh

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

143.204.237.71 Seattle, United States, ASN16509 (AMAZON-02, US),

Reverse DNS

server-143-204-237-71.cph50.r.cloudfront.net

Software

Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /

Resource Hash

fd21533b25982658fb3d45f7e662bfa071b0e58204e5b44587b955d46f4fe203

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Fri, 12 Jun 2020 15:35:19 GMT
content-encoding: gzip
x-content-type-options: nosniff
last-modified: Fri, 12 Jun 2020 09:29:07 GMT
server: Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
age: 7661
vary: Accept-Encoding
x-cache: Hit from cloudfront
content-type: application/javascript
status: 200
cache-control: max-age=10800
x-amz-cf-pop: CPH50-C1
x-amz-cf-id: cQbZ_pgy_uSZ_DOWSG1A4Nx0XcrhCLA162MGHNZ38sTa8faQD2Hi6g==
via: 1.1 1624c79cd07e6098196697a6a7907e4b.cloudfront.net (CloudFront)
expires: Fri, 12 Jun 2020 18:35:19 GMT

POST
H2 200 s54584186056262 Show response
informaglobalexhibitions.d3.sc.omtrdc.net/b/ss/,informaglobalprod/1/JS-2.20.0-LATI/ 43 B
449 B 109ms
27ms XHR
image/gif 15.188.154.177
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL

https://informaglobalexhibitions.d3.sc.omtrdc.net/b/ss/,informaglobalprod/1/JS-2.20.0-LATI/s54584186056262

Requested by

Host: assets.adobedtm.com
URL: https://assets.adobedtm.com/extensions/EP308220a2a4c4403f97fc1960100db40f/AppMeasurement.min.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

15.188.154.177 Paris, France, ASN16509 (AMAZON-02, US),

Reverse DNS

ec2-15-188-154-177.eu-west-3.compute.amazonaws.com

Software

jag /

Resource Hash

55c9d2f019f9d7ddfd69b2ad0351c5617338a222362aebb02b3b98a4dbc18486

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	1; mode=block

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type: text/plain;charset=UTF-8

Response headers

date: Fri, 12 Jun 2020 17:43:00 GMT
x-content-type-options: nosniff
x-c: master-1308.I3d0a82.M0-421
p3p: CP="This is not a P3P policy"
status: 200
content-length: 43
x-xss-protection: 1; mode=block
pragma: no-cache
last-modified: Sat, 13 Jun 2020 17:43:00 GMT
server: jag
xserver: anedge-6f7565dc8b-pnlmc
etag: 3418759135516524544-4614369651138827149
vary: *
content-type: image/gif;charset=utf-8
access-control-allow-origin: https://www.globalpharmainsights.com
cache-control: no-cache, no-store, max-age=0, no-transform, private
access-control-allow-credentials: true
expires: Thu, 11 Jun 2020 17:43:00 GMT

GET
H2 200 l
use.typekit.net/af/f80f1d/00000000000000003b9aefb8/27/ 32 KB
32 KB 20ms
5ms Font
application/font-woff2 2a01:4a0:1338:28::c38a:ff0a
NETZBETRIEB-GMBH

General

Check archive.org

Show headers Download Go to

Full URL: https://use.typekit.net/af/f80f1d/00000000000000003b9aefb8/27/l?primer=7cdcb44be4a7db8877ffa5c0007b8dd865b3bbc383831fe2ea177f62257a9191&fvd=n7&v=3
Requested by: Host: use.typekit.net
URL: https://use.typekit.net/ntl8rdl.js
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 2a01:4a0:1338:28::c38a:ff0a , Germany, ASN201011 (NETZBETRIEB-GMBH, DE),
Reverse DNS
Software: nginx /
Resource Hash: 4a85a057330bbc6272c3dd4c02a15317b08a92b4de7514d9fda7d8cbf82a3cac

Request headers

User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Origin: https://www.globalpharmainsights.com

Response headers

date: Fri, 12 Jun 2020 17:43:00 GMT
server: nginx
etag: "5b1424bf708a1baf048831772af7891cda52e1e0"
status: 200
content-type: application/font-woff2
access-control-allow-origin: *
cache-control: public, max-age=31536000
timing-allow-origin: *
content-length: 32980

GET
H2 200 l
use.typekit.net/af/29352b/00000000000000003b9aefb9/27/ 33 KB
33 KB 25ms
9ms Font
application/font-woff2 2a01:4a0:1338:28::c38a:ff0a
NETZBETRIEB-GMBH

General

Check archive.org

Show headers Download Go to

Full URL: https://use.typekit.net/af/29352b/00000000000000003b9aefb9/27/l?primer=7cdcb44be4a7db8877ffa5c0007b8dd865b3bbc383831fe2ea177f62257a9191&fvd=i7&v=3
Requested by: Host: use.typekit.net
URL: https://use.typekit.net/ntl8rdl.js
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 2a01:4a0:1338:28::c38a:ff0a , Germany, ASN201011 (NETZBETRIEB-GMBH, DE),
Reverse DNS
Software: nginx /
Resource Hash: 39492f3c9f87d34d4d53b7fa1fc66d5003f986552288bb55ac10e7507d4c69dd

Request headers

User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Origin: https://www.globalpharmainsights.com

Response headers

date: Fri, 12 Jun 2020 17:43:00 GMT
server: nginx
etag: "41bd63e072fcddb931e4f5c670a122a6ae75b1a8"
status: 200
content-type: application/font-woff2
access-control-allow-origin: *
cache-control: public, max-age=31536000
timing-allow-origin: *
content-length: 34024

GET
H2 200 l
use.typekit.net/af/af96c8/00000000000000003b9aefc0/27/ 31 KB
31 KB 23ms
9ms Font
application/font-woff2 2a01:4a0:1338:28::c38a:ff0a
NETZBETRIEB-GMBH

General

Check archive.org

Show headers Download Go to

Full URL: https://use.typekit.net/af/af96c8/00000000000000003b9aefc0/27/l?primer=7cdcb44be4a7db8877ffa5c0007b8dd865b3bbc383831fe2ea177f62257a9191&fvd=n4&v=3
Requested by: Host: use.typekit.net
URL: https://use.typekit.net/ntl8rdl.js
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 2a01:4a0:1338:28::c38a:ff0a , Germany, ASN201011 (NETZBETRIEB-GMBH, DE),
Reverse DNS
Software: nginx /
Resource Hash: 1e71dfd2075bdd8ab13805b0c9bc396c00c1a3d982d3e9ddde63ccfaf4f2eaaf

Request headers

User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Origin: https://www.globalpharmainsights.com

Response headers

date: Fri, 12 Jun 2020 17:43:00 GMT
server: nginx
etag: "625d31c6ff36363142e14c9d9cf9f2747ce3803a"
status: 200
content-type: application/font-woff2
access-control-allow-origin: *
cache-control: public, max-age=31536000
timing-allow-origin: *
content-length: 31984

GET
H2 200 l
use.typekit.net/af/20aa1e/00000000000000003b9aefc1/27/ 33 KB
33 KB 27ms
13ms Font
application/font-woff2 2a01:4a0:1338:28::c38a:ff0a
NETZBETRIEB-GMBH

General

Check archive.org

Show headers Download Go to

Full URL: https://use.typekit.net/af/20aa1e/00000000000000003b9aefc1/27/l?primer=7cdcb44be4a7db8877ffa5c0007b8dd865b3bbc383831fe2ea177f62257a9191&fvd=i4&v=3
Requested by: Host: use.typekit.net
URL: https://use.typekit.net/ntl8rdl.js
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 2a01:4a0:1338:28::c38a:ff0a , Germany, ASN201011 (NETZBETRIEB-GMBH, DE),
Reverse DNS
Software: nginx /
Resource Hash: 1ccdbe5fba95906eb04fed55b6d5fe05d4130f09d1ef62a2a195b07bfcd20d98

Request headers

User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Origin: https://www.globalpharmainsights.com

Response headers

date: Fri, 12 Jun 2020 17:43:00 GMT
server: nginx
etag: "0a37e0f13f84c73347be23130bb6d2063bc1d8a8"
status: 200
content-type: application/font-woff2
access-control-allow-origin: *
cache-control: public, max-age=31536000
timing-allow-origin: *
content-length: 33796

GET
H2 200 l
use.typekit.net/af/13a799/00000000000000003b9adee3/27/ 18 KB
18 KB 20ms
7ms Font
application/font-woff2 2a01:4a0:1338:28::c38a:ff0a
NETZBETRIEB-GMBH

General

Check archive.org

Show headers Download Go to

Full URL: https://use.typekit.net/af/13a799/00000000000000003b9adee3/27/l?primer=7cdcb44be4a7db8877ffa5c0007b8dd865b3bbc383831fe2ea177f62257a9191&fvd=n6&v=3
Requested by: Host: use.typekit.net
URL: https://use.typekit.net/ntl8rdl.js
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 2a01:4a0:1338:28::c38a:ff0a , Germany, ASN201011 (NETZBETRIEB-GMBH, DE),
Reverse DNS
Software: nginx /
Resource Hash: f7d3a5e83ab0db74bd9ce3800f7e2b57083a45d72048eb0a1ec59ea71d5d1c7d

Request headers

User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Origin: https://www.globalpharmainsights.com

Response headers

date: Fri, 12 Jun 2020 17:43:00 GMT
server: nginx
etag: "92db5ca13edfead8cacb9b7663621adc030e2d76"
status: 200
content-type: application/font-woff2
access-control-allow-origin: *
cache-control: public, max-age=31536000
timing-allow-origin: *
content-length: 18560

GET
H2 200 hotjar-1097635.js Show response
static.hotjar.com/c/ 3 KB
2 KB 44ms
14ms Script
application/javascript 147.75.33.233
PACKET

General

Check archive.org

Show headers Download Go to

Full URL

https://static.hotjar.com/c/hotjar-1097635.js?sv=6

Requested by

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

147.75.33.233 Amsterdam, Netherlands, ASN54825 (PACKET, US),

Reverse DNS

pkt-ams-k2-shared-ingress14

Software

Resource Hash

ca096b8d4d8e5ce3fc1f6f5c030e594c6d78ffc78d96ba89644896ce07e05fdb

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Fri, 12 Jun 2020 17:43:00 GMT
content-encoding: br
x-content-type-options: nosniff
section-io-tag: hotjarjs
age: 312
status: 200
section-io-cache: Hit
vary: Accept-Encoding
content-length: 1540
cache-control: max-age=60
etag: W/60206a9df33b701c95c13c8c5b67d433
access-control-max-age: 600
section-io-origin-status: 200
access-control-allow-origin: *
x-cache-hit: 1
section-io-origin-time-seconds: 0.076
section-io-id: 7946185c7de1b7c6aba5e435def1bbc9
accept-ranges: bytes
content-type: application/javascript
section-origin-responded: true

GET
H/1.1 200
OK dpm_8effee409c625e1a2d8f5033631840e6ce1dcb64.min.js Show response
s.dpmsrv.com/ 744 KB
85 KB 210ms
47ms Script
application/x-javascript 143.204.237.68
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://s.dpmsrv.com/dpm_8effee409c625e1a2d8f5033631840e6ce1dcb64.min.js
Requested by: Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 143.204.237.68 Seattle, United States, ASN16509 (AMAZON-02, US),
Reverse DNS: server-143-204-237-68.cph50.r.cloudfront.net
Software: AmazonS3 /
Resource Hash: 0ab78fc81d215277fd8c18fe638064daaffbefb5f4bcef74514dc6f976da95c9

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date: Fri, 12 Jun 2020 17:40:36 GMT
Content-Encoding: gzip
Last-Modified: Fri, 12 Jun 2020 17:40:15 GMT
Server: AmazonS3
Age: 146
ETag: "bd8e05cf6593b9e5118c099bda2f1bdc"
X-Cache: Hit from cloudfront
Content-Type: application/x-javascript
Via: 1.1 4bade328d3b2aa91384925c67cd91548.cloudfront.net (CloudFront)
Connection: keep-alive
X-Amz-Cf-Pop: CPH50-C1
Accept-Ranges: bytes
Content-Length: 86037
X-Amz-Cf-Id: V-tOB_FBqMeF4iEvkgWEUDmH1kOpGn8ZAnVmwKNz0RulWl7j9wtrhA==

GET
H2 200 view
securepubads.g.doubleclick.net/pcs/ Frame 479B 0
0 34ms
32ms Fetch
image/gif 216.58.210.2
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjst7KusWkoJxjrzqYha89BaCm7rcRE0CfIL9bTK_buSIGuPhCIcgvsWp1AH5M4Dw2Dv26N7sUL3D2Ufa-pIIs7JfDBrkdwIFova5mdkPsQM11KZbhdHOneMgw8KoL6nCJAabMoGUqFZdeEBjDTewCYgd-eiaUwQ7TibOzezlJQtJphlu694F5Z08881yUk5aUwu1p2NL0UwZE3v8hpXXn_ePv3_zfKE8km-UODwei50P2bjc7TuAd7ZSaY3HA0HbydQL7ASJ5QI8yTuMk0nGKN5PIeT7EH2Vp0vAf8wA5VNaSF2hEskILk8ZJjwKt8E15jckDTPiCib_VpLCQp7c9XekY-zl_i4&sig=Cg0ArKJSzIocuu5QyLG8EAE&adurl=

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

216.58.210.2 Mountain View, United States, ASN15169 (GOOGLE, US),

Reverse DNS

fra16s07-in-f2.1e100.net

Software

cafe /

Resource Hash

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin: *
date: Fri, 12 Jun 2020 17:43:00 GMT
x-content-type-options: nosniff
server: cafe
status: 200
p3p: policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin: *
cache-control: private
content-type: image/gif
alt-svc: h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length: 0
x-xss-protection: 0

GET
H2 200 window_focus_fy2019.js Show response
tpc.googlesyndication.com/pagead/js/r20200609/r20110914/client/ Frame 479B 3 KB
2 KB 8ms
5ms Script
text/javascript 2a00:1450:4001:802::2001
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://tpc.googlesyndication.com/pagead/js/r20200609/r20110914/client/window_focus_fy2019.js

Requested by

Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060803.js?21066388

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:802::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

cafe /

Resource Hash

7d2d1f9c78d8c0755bb8830fd20121d6d05c949c89b20536a89b6643f748c600

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Wed, 10 Jun 2020 00:53:40 GMT
content-encoding: gzip
x-content-type-options: nosniff
age: 233360
p3p: policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status: 200
content-disposition: attachment; filename="f.txt"
alt-svc: h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length: 1479
x-xss-protection: 0
server: cafe
etag: 9751230926324105381
vary: Accept-Encoding, Origin
content-type: text/javascript; charset=UTF-8
cache-control: public, max-age=1209600
timing-allow-origin: *
expires: Wed, 24 Jun 2020 00:53:40 GMT

GET
H2 200 osd_listener.js Show response
www.googletagservices.com/activeview/js/current/ Frame 479B 73 KB
28 KB 44ms
42ms Script
text/javascript 2a00:1450:4001:81d::2002
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.googletagservices.com/activeview/js/current/osd_listener.js?cache=r20110914

Requested by

Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060803.js?21066388

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:81d::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

84058f4935f4a903f78426d22151ce5ca07e601bcf127fdc75f316b725be4c40

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Fri, 12 Jun 2020 17:43:00 GMT
content-encoding: gzip
x-content-type-options: nosniff
server: sffe
etag: "1591788966119694"
vary: Accept-Encoding
content-type: text/javascript
status: 200
cache-control: private, max-age=3000
accept-ranges: bytes
alt-svc: h3-27="googleads.g.doubleclick.net:443"; ma=2592000,h3-27=":443"; ma=2592000,h3-25="googleads.g.doubleclick.net:443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050="googleads.g.doubleclick.net:443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length: 28177
x-xss-protection: 0
expires: Fri, 12 Jun 2020 17:43:00 GMT

GET
H2 204 l
www.google.com/ads/measurement/ Frame 479B 0
0 20ms
18ms Image
text/html 2a00:1450:4001:819::2004
GOOGLE

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://www.google.com/ads/measurement/l?ebcid=ALh7CaTckhF9rb9ATeWUuP-WkhSkpbC_-l81GN1Rhv3NVb5Mth7LhUTP8jTTAhKrgdD3eRmnXZPL
Requested by: Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060803.js?21066388
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2a00:1450:4001:819::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),
Reverse DNS
Software: /
Resource Hash: e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

GET
H2 200 moatad.js Show response
z.moatads.com/pentonmedia53440730609/ Frame 479B 290 KB
98 KB 71ms
25ms Script
application/x-javascript 72.247.226.64
AKAMAI-AS

General

Check archive.org

Show headers Download Go to

Full URL: https://z.moatads.com/pentonmedia53440730609/moatad.js
Requested by: Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060803.js?21066388
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 72.247.226.64 , United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS: a72-247-226-64.deploy.static.akamaitechnologies.com
Software: AmazonS3 /
Resource Hash: 7c86268aee3ee868908336bbb2a43d11dd200942de23762f1851e54c25233441

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Fri, 12 Jun 2020 17:43:00 GMT
content-encoding: gzip
last-modified: Tue, 09 Jun 2020 16:53:21 GMT
server: AmazonS3
x-amz-request-id: BF5F8DCB03251522
etag: "635e31427ca583c8b5d9961b3e554e44"
vary: Accept-Encoding
content-type: application/x-javascript
status: 200
cache-control: max-age=60137
accept-ranges: bytes
content-length: 100310
x-amz-id-2: bRWYBsFPZ8nI8j7IHWNM/QLpH12DxWiDHaaAUaBHiAp9vom3LyD3cMw5CJrgg9fuP9Yh6bGDsiE=

GET
H2 200 8783790369963399186
tpc.googlesyndication.com/simgad/ Frame 479B 16 KB
16 KB 8ms
6ms Image
image/gif 2a00:1450:4001:802::2001
GOOGLE

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://tpc.googlesyndication.com/simgad/8783790369963399186

Requested by

Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060803.js?21066388

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:802::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

348ca2d79ab4ee80d72d725484651deb121af2c6ea349e6c18eef7ca833fae74

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Fri, 12 Jun 2020 09:13:15 GMT
x-content-type-options: nosniff
age: 30585
x-dns-prefetch-control: off
status: 200
alt-svc: h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length: 16265
x-xss-protection: 0
last-modified: Tue, 19 May 2020 07:50:29 GMT
server: sffe
content-type: image/gif
access-control-allow-origin: *
cache-control: public, max-age=31536000
accept-ranges: bytes
timing-allow-origin: *
expires: Sat, 12 Jun 2021 09:13:15 GMT

GET
H2 200 osd.js Show response
www.googletagservices.com/activeview/js/current/ 73 KB
27 KB 39ms
39ms Script
text/javascript 2a00:1450:4001:81d::2002
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.googletagservices.com/activeview/js/current/osd.js?cb=%2Fr20100101

Requested by

Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060803.js?21066388

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:81d::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

2d233c1838084b7e804e0e7a887190eeeb356132b1f625c7fa96ed3efd61e8b2

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Fri, 12 Jun 2020 17:43:00 GMT
content-encoding: gzip
x-content-type-options: nosniff
server: sffe
etag: "1591788966119694"
vary: Accept-Encoding
content-type: text/javascript
status: 200
cache-control: private, max-age=3000
accept-ranges: bytes
alt-svc: h3-27="googleads.g.doubleclick.net:443"; ma=2592000,h3-27=":443"; ma=2592000,h3-25="googleads.g.doubleclick.net:443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050="googleads.g.doubleclick.net:443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length: 27882
x-xss-protection: 0
expires: Fri, 12 Jun 2020 17:43:00 GMT

GET
H2 200 fbevents.js Show response
connect.facebook.net/en_US/ 131 KB
31 KB 6ms
6ms Script
application/x-javascript 2a03:2880:f01c:8012:face:b00c:0:3
FACEBOOK

General

Check archive.org

Show headers Download Go to

Full URL

https://connect.facebook.net/en_US/fbevents.js

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a03:2880:f01c:8012:face:b00c:0:3 , Ireland, ASN32934 (FACEBOOK, US),

Reverse DNS

Software

Resource Hash

4cb61e44bf63a9e090e666898cd04d382e4c33b55b62cc5e9ff7dab055fbf787

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; preload; includeSubDomains
X-Content-Type-Options	nosniff
X-Frame-Options	DENY
X-Xss-Protection	0

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

strict-transport-security: max-age=31536000; preload; includeSubDomains
content-encoding: gzip
x-content-type-options: nosniff
status: 200
alt-svc: h3-27=":443"; ma=3600
content-length: 31766
x-xss-protection: 0
pragma: public
x-fb-debug: QWrSrdelhk40g0fXZX29reirQzhkiOTUbdvCL3Oe+I+kwmFrhaCcDQHyK2//SnYquKdctV7PdQolf9wUllL8nw==
x-fb-trip-id: 664085054
x-frame-options: DENY
date: Fri, 12 Jun 2020 17:43:00 GMT, Fri, 12 Jun 2020 17:43:00 GMT
vary: Accept-Encoding
content-type: application/x-javascript; charset=utf-8
cache-control: public, max-age=1200
expires: Sat, 01 Jan 2000 00:00:00 GMT

GET
H2 200 pinit_main.js Show response
assets.pinterest.com/js/ 69 KB
21 KB 25ms
25ms Script
application/javascript 2606:4700::6812:fb0
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL: https://assets.pinterest.com/js/pinit_main.js?0.7881628563734719
Requested by: Host: assets.pinterest.com
URL: https://assets.pinterest.com/js/pinit.js?_=1591983779771
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700::6812:fb0 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software: cloudflare /
Resource Hash: fb3c1eca6871a3f5a4504450ce3723ebca58e2d62dc113011e31eb4be36c94a6

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Fri, 12 Jun 2020 17:43:00 GMT
content-encoding: br
x-cdn: cloudflare
status: 200
etag: W/"e8887b4f8f70f289103ee0c74e6b81d6"
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary: Accept-Encoding
access-control-allow-methods: GET
content-type: application/javascript; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: x-cdn
cache-control: max-age=300
cf-ray: 5a255f232a26175a-FRA
cf-request-id: 034b39c9f60000175a3a9cb200000001
server: cloudflare

GET
H2 200 ads Show response
securepubads.g.doubleclick.net/gampad/ 356 B
236 B 51ms
50ms XHR
text/plain 216.58.210.2
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=452895018370859&correlator=4333297944938301&output=ldjh&impl=fif&adsid=NT&eid=21066388%2C21066031%2C21065516%2C21066300&vrg=2020060803&npa=1&guci=1.2.0.0.2.1.0.0&sc=1&sfv=1-0-37&ecs=20200612&iu_parts=2441%2Cglobalpharmainsights.home%2Carticle%2Csectors%2Cmanufacturing_outsourcing&enc_prev_ius=%2F0%2F1%2F2%2F3%2F4&prev_iu_szs=970x90%7C970x250%7C728x90&prev_scp=pos%3D728_1_a%26combo%3Dwrap%26ptype%3DArticle%26nid%3D191%26pterm%3Dmanufacturing_outsourcing%26sterm%3Dasia%2Cmiddle_east_africa%2Cfinished_dosage%2Cnews%26author%3Dgareth_carpenter%26reg%3Danonymous&cookie=ID%3D69099b46254b0af4%3AT%3D1591983779%3AS%3DALNI_MaeRphoY9RL7Mx8Nz0L4aqW7IDznw&bc=31&abxe=1&lmt=1591981740&dt=1591983780355&dlt=1591983779394&idt=444&frm=20&biw=1600&bih=1200&oid=3&adxs=800&adys=36&adks=4260403750&ucis=7&ifi=7&u_tz=120&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&dssz=52&icsg=2265246080434172&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=0x90&msz=0x90&psts=AGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H-5udyi84zNXGn9Ndj0caYy3-56p6u6z1mOE1lM6Tn45Fa0ufKIpcOmEvMBkLhuiCqhZGTq8I69hHRK4jgXkt-4EaFmB1EVxIOd4w%2CAGkb-H9awlplzm3R5rYar7qljqzk&ga_vid=698259743.1591983780&ga_sid=1591983780&ga_hid=1403020049&fws=4&ohw=0&btvi=0

Requested by

Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060803.js?21066388

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

216.58.210.2 Mountain View, United States, ASN15169 (GOOGLE, US),

Reverse DNS

fra16s07-in-f2.1e100.net

Software

cafe /

Resource Hash

9f62b57af7ab4dd5650fbbec7e93d51e4c06ce41cf037a50ccecd5f721599667

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Fri, 12 Jun 2020 17:43:00 GMT
content-encoding: br
x-content-type-options: nosniff
google-mediationgroup-id: -2
p3p: policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status: 200
alt-svc: h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length: 162
x-xss-protection: 0
google-lineitem-id: -2
pragma: no-cache
server: cafe
google-mediationtag-id: -2
google-creative-id: -2
content-type: text/plain; charset=UTF-8
access-control-allow-origin: https://www.globalpharmainsights.com
cache-control: no-cache, must-revalidate
access-control-allow-credentials: true
timing-allow-origin: *
expires: Fri, 01 Jan 1990 00:00:00 GMT

GET
H2 200 ads Show response
securepubads.g.doubleclick.net/gampad/ 362 B
243 B 54ms
54ms XHR
text/plain 216.58.210.2
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=452895018370859&correlator=4333297944938301&output=ldjh&impl=fif&adsid=NT&eid=21066388%2C21066031%2C21065516%2C21066300&vrg=2020060803&npa=1&guci=1.2.0.0.2.1.0.0&sc=1&sfv=1-0-37&ecs=20200612&iu_parts=2441%2Cglobalpharmainsights.home%2Carticle%2Csectors%2Cmanufacturing_outsourcing&enc_prev_ius=%2F0%2F1%2F2%2F3%2F4&prev_iu_szs=320x50&fluid=height&prev_scp=pos%3Dnativekey_1_lft%26ptype%3DArticle%26nid%3D191%26pterm%3Dmanufacturing_outsourcing%26sterm%3Dasia%2Cmiddle_east_africa%2Cfinished_dosage%2Cnews%26author%3Dgareth_carpenter%26reg%3Danonymous&cookie=ID%3D69099b46254b0af4%3AT%3D1591983779%3AS%3DALNI_MaeRphoY9RL7Mx8Nz0L4aqW7IDznw&bc=31&abxe=1&lmt=1591981740&dt=1591983780362&dlt=1591983779394&idt=444&frm=20&biw=1600&bih=1200&oid=3&adxs=209&adys=490&adks=2172630196&ucis=8&ifi=8&u_tz=120&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&dssz=52&icsg=2265246080434172&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=0x0&msz=0x0&psts=AGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H-5udyi84zNXGn9Ndj0caYy3-56p6u6z1mOE1lM6Tn45Fa0ufKIpcOmEvMBkLhuiCqhZGTq8I69hHRK4jgXkt-4EaFmB1EVxIOd4w%2CAGkb-H9awlplzm3R5rYar7qljqzk&ga_vid=698259743.1591983780&ga_sid=1591983780&ga_hid=1403020049&fws=4&ohw=0&btvi=0

Requested by

Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060803.js?21066388

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

216.58.210.2 Mountain View, United States, ASN15169 (GOOGLE, US),

Reverse DNS

fra16s07-in-f2.1e100.net

Software

cafe /

Resource Hash

8ed5c3e90a42e71cc42f586f6cdfd7ce3a6147001ec655ca778165d1851ecbb4

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Fri, 12 Jun 2020 17:43:00 GMT
content-encoding: br
x-content-type-options: nosniff
google-mediationgroup-id: -2
p3p: policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status: 200
alt-svc: h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length: 168
x-xss-protection: 0
google-lineitem-id: -2
pragma: no-cache
server: cafe
google-mediationtag-id: -2
google-creative-id: -2
content-type: text/plain; charset=UTF-8
access-control-allow-origin: https://www.globalpharmainsights.com
cache-control: no-cache, must-revalidate
access-control-allow-credentials: true
timing-allow-origin: *
expires: Fri, 01 Jan 1990 00:00:00 GMT

GET
H2 200 ads Show response
securepubads.g.doubleclick.net/gampad/ 356 B
233 B 52ms
51ms XHR
text/plain 216.58.210.2
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=452895018370859&correlator=4333297944938301&output=ldjh&impl=fif&adsid=NT&eid=21066388%2C21066031%2C21065516%2C21066300&vrg=2020060803&npa=1&guci=1.2.0.0.2.1.0.0&sc=1&sfv=1-0-37&ecs=20200612&iu_parts=2441%2Cglobalpharmainsights.home%2Carticle%2Csectors%2Cmanufacturing_outsourcing&enc_prev_ius=%2F0%2F1%2F2%2F3%2F4&prev_iu_szs=320x50&fluid=height&prev_scp=pos%3Dnativekey_2_lft%26ptype%3DArticle%26nid%3D191%26pterm%3Dmanufacturing_outsourcing%26sterm%3Dasia%2Cmiddle_east_africa%2Cfinished_dosage%2Cnews%26author%3Dgareth_carpenter%26reg%3Danonymous&cookie=ID%3D69099b46254b0af4%3AT%3D1591983779%3AS%3DALNI_MaeRphoY9RL7Mx8Nz0L4aqW7IDznw&bc=31&abxe=1&lmt=1591981740&dt=1591983780367&dlt=1591983779394&idt=444&frm=20&biw=1600&bih=1200&oid=3&adxs=209&adys=936&adks=1189877961&ucis=9&ifi=9&u_tz=120&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&dssz=52&icsg=2265246080434172&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=0x0&msz=0x0&psts=AGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H-5udyi84zNXGn9Ndj0caYy3-56p6u6z1mOE1lM6Tn45Fa0ufKIpcOmEvMBkLhuiCqhZGTq8I69hHRK4jgXkt-4EaFmB1EVxIOd4w%2CAGkb-H9awlplzm3R5rYar7qljqzk&ga_vid=698259743.1591983780&ga_sid=1591983780&ga_hid=1403020049&fws=4&ohw=0&btvi=0

Requested by

Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060803.js?21066388

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

216.58.210.2 Mountain View, United States, ASN15169 (GOOGLE, US),

Reverse DNS

fra16s07-in-f2.1e100.net

Software

cafe /

Resource Hash

414d558a5d0db9e93781076d7cc8c5b50d94d0f2e5ad0db23f3df6d816bed0ef

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Fri, 12 Jun 2020 17:43:00 GMT
content-encoding: br
x-content-type-options: nosniff
google-mediationgroup-id: -2
p3p: policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status: 200
alt-svc: h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length: 162
x-xss-protection: 0
google-lineitem-id: -2
pragma: no-cache
server: cafe
google-mediationtag-id: -2
google-creative-id: -2
content-type: text/plain; charset=UTF-8
access-control-allow-origin: https://www.globalpharmainsights.com
cache-control: no-cache, must-revalidate
access-control-allow-credentials: true
timing-allow-origin: *
expires: Fri, 01 Jan 1990 00:00:00 GMT

GET
H2 200 ads Show response
securepubads.g.doubleclick.net/gampad/ 13 KB
6 KB 58ms
58ms XHR
text/plain 216.58.210.2
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=452895018370859&correlator=4333297944938301&output=ldjh&impl=fif&adsid=NT&eid=21066388%2C21066031%2C21065516%2C21066300&vrg=2020060803&npa=1&guci=1.2.0.0.2.1.0.0&sc=1&sfv=1-0-37&ecs=20200612&iu_parts=2441%2Cglobalpharmainsights.home%2Carticle%2Csectors%2Cmanufacturing_outsourcing&enc_prev_ius=%2F0%2F1%2F2%2F3%2F4&prev_iu_szs=300x250%7C300x600&prev_scp=pos%3D300_1_rht%26article_number%3D1%26ptype%3DArticle%26nid%3D191%26pterm%3Dmanufacturing_outsourcing%26sterm%3Dasia%2Cmiddle_east_africa%2Cfinished_dosage%2Cnews%26author%3Dgareth_carpenter%26reg%3Danonymous&cookie=ID%3D69099b46254b0af4%3AT%3D1591983779%3AS%3DALNI_MaeRphoY9RL7Mx8Nz0L4aqW7IDznw&bc=31&abxe=1&lmt=1591981740&dt=1591983780371&dlt=1591983779394&idt=444&frm=20&biw=1600&bih=1200&oid=3&adxs=1355&adys=1180&adks=1948744462&ucis=a&ifi=10&u_tz=120&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&dssz=52&icsg=2265246080434172&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=0x250&msz=0x250&psts=AGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H-5udyi84zNXGn9Ndj0caYy3-56p6u6z1mOE1lM6Tn45Fa0ufKIpcOmEvMBkLhuiCqhZGTq8I69hHRK4jgXkt-4EaFmB1EVxIOd4w%2CAGkb-H9awlplzm3R5rYar7qljqzk&ga_vid=698259743.1591983780&ga_sid=1591983780&ga_hid=1403020049&fws=4&ohw=0&btvi=0

Requested by

Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060803.js?21066388

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

216.58.210.2 Mountain View, United States, ASN15169 (GOOGLE, US),

Reverse DNS

fra16s07-in-f2.1e100.net

Software

cafe /

Resource Hash

13550f4391ce75162c0bb88689c09a5f76b088a5429fd57a7deb1cce1ab68b26

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Fri, 12 Jun 2020 17:43:00 GMT
content-encoding: br
x-content-type-options: nosniff
google-mediationgroup-id: -2
p3p: policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status: 200
alt-svc: h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length: 6018
x-xss-protection: 0
google-lineitem-id: 5374575282
pragma: no-cache
server: cafe
google-mediationtag-id: -2
google-creative-id: 138312304633
content-type: text/plain; charset=UTF-8
access-control-allow-origin: https://www.globalpharmainsights.com
cache-control: no-cache, must-revalidate
access-control-allow-credentials: true
timing-allow-origin: *
expires: Fri, 01 Jan 1990 00:00:00 GMT

GET
H2 200 ads Show response
securepubads.g.doubleclick.net/gampad/ 359 B
242 B 50ms
49ms XHR
text/plain 216.58.210.2
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://securepubads.g.doubleclick.net/gampad/ads?gdfp_req=1&pvsid=452895018370859&correlator=4333297944938301&output=ldjh&impl=fif&adsid=NT&eid=21066388%2C21066031%2C21065516%2C21066300&vrg=2020060803&npa=1&guci=1.2.0.0.2.1.0.0&sc=1&sfv=1-0-37&ecs=20200612&iu_parts=2441%2Cglobalpharmainsights.home%2Carticle%2Csectors%2Cmanufacturing_outsourcing&enc_prev_ius=%2F0%2F1%2F2%2F3%2F4&prev_iu_szs=1x1&prev_scp=pos%3Dinarticlevideo_1_a%26article_number%3D1%26ptype%3DArticle%26nid%3D191%26pterm%3Dmanufacturing_outsourcing%26sterm%3Dasia%2Cmiddle_east_africa%2Cfinished_dosage%2Cnews%26author%3Dgareth_carpenter%26reg%3Danonymous&cookie=ID%3D69099b46254b0af4%3AT%3D1591983779%3AS%3DALNI_MaeRphoY9RL7Mx8Nz0L4aqW7IDznw&bc=31&abxe=1&lmt=1591981740&dt=1591983780378&dlt=1591983779394&idt=444&frm=20&biw=1600&bih=1200&oid=3&adxs=-12245933&adys=-12245933&adks=4146953584&ucis=b&ifi=11&u_tz=120&u_his=2&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_sd=1&flash=0&url=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&dssz=52&icsg=2265246080434172&std=0&vis=1&dmc=8&scr_x=0&scr_y=0&psz=0x0&msz=0x0&psts=AGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H9awlplzm3R5rYar7qljqzk%2CAGkb-H-5udyi84zNXGn9Ndj0caYy3-56p6u6z1mOE1lM6Tn45Fa0ufKIpcOmEvMBkLhuiCqhZGTq8I69hHRK4jgXkt-4EaFmB1EVxIOd4w%2CAGkb-H9awlplzm3R5rYar7qljqzk&ga_vid=698259743.1591983780&ga_sid=1591983780&ga_hid=1403020049&fws=132&ohw=0

Requested by

Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060803.js?21066388

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

216.58.210.2 Mountain View, United States, ASN15169 (GOOGLE, US),

Reverse DNS

fra16s07-in-f2.1e100.net

Software

cafe /

Resource Hash

8217bcefb2b66377ec4f5cf0e4630d15cdf22d31916b3ead7fed4b652f17ea8d

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Fri, 12 Jun 2020 17:43:00 GMT
content-encoding: br
x-content-type-options: nosniff
google-mediationgroup-id: -2
p3p: policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status: 200
alt-svc: h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length: 167
x-xss-protection: 0
google-lineitem-id: -2
pragma: no-cache
server: cafe
google-mediationtag-id: -2
google-creative-id: -2
content-type: text/plain; charset=UTF-8
access-control-allow-origin: https://www.globalpharmainsights.com
cache-control: no-cache, must-revalidate
access-control-allow-credentials: true
timing-allow-origin: *
expires: Fri, 01 Jan 1990 00:00:00 GMT

GET
H2 200 p.gif
p.typekit.net/ 35 B
201 B 32ms
11ms Image
image/gif 2a02:26f0:10c:287::19fd
AKAMAI-ASN1

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://p.typekit.net/p.gif?s=1&k=ntl8rdl&ht=tk&h=www.globalpharmainsights.com&f=139.140.175.176.17391&a=4139614&js=1.19.2&app=typekit&e=js&_=1591983780388
Requested by: Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 2a02:26f0:10c:287::19fd , Ascension Island, ASN20940 (AKAMAI-ASN1, EU),
Reverse DNS
Software: nginx /
Resource Hash: 9b9265c69a5cc295d1ab0d04e0273b3677db1a6216ce2ccf4efc8c277ed84b39

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Fri, 12 Jun 2020 17:43:00 GMT
last-modified: Fri, 15 Feb 2019 23:43:47 GMT
server: nginx
etag: "5c674eb3-23"
status: 200
content-type: image/gif
access-control-allow-origin: *
cache-control: max-age=604800
accept-ranges: bytes
content-length: 35
expires: Mon, 26 Aug 2019 13:32:57 GMT

GET
H2 200 conversion_async.js Show response
www.googleadservices.com/pagead/ 29 KB
11 KB 31ms
30ms Script
text/javascript 172.217.22.98
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.googleadservices.com/pagead/conversion_async.js

Requested by

Host: www.googletagmanager.com
URL: https://www.googletagmanager.com/gtag/js?id=AW-998237655&l=dataLayer

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

172.217.22.98 , United States, ASN15169 (GOOGLE, US),

Reverse DNS

fra15s18-in-f98.1e100.net

Software

cafe /

Resource Hash

a693efa7265b630e27e537f6ba09c5558a23b9ed2f57abdbf417c237a50a5156

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Fri, 12 Jun 2020 17:43:00 GMT
content-encoding: gzip
x-content-type-options: nosniff
p3p: policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status: 200
content-disposition: attachment; filename="f.txt"
alt-svc: h3-27="googleads.g.doubleclick.net:443"; ma=2592000,h3-27=":443"; ma=2592000,h3-25="googleads.g.doubleclick.net:443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050="googleads.g.doubleclick.net:443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length: 11020
x-xss-protection: 0
server: cafe
etag: 13497728949557021888
vary: Accept-Encoding
content-type: text/javascript; charset=UTF-8
cache-control: private, max-age=3600
timing-allow-origin: *
expires: Fri, 12 Jun 2020 17:43:00 GMT

GET
H2 200 view
securepubads.g.doubleclick.net/pcs/ Frame 479B 0
54 B 31ms
31ms Image
image/gif 216.58.210.2
GOOGLE

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjssVX9bj3qP_rt4bEmIZLEAE76HgRbEfHmPmi-GRg61LVkS-JFhV7NqOmExNerzqWA_k3X7tYNX89AfaCIj3nOKq-a8RuCdSSSnKHRZXd1GH2JVprJnSWKPOZnr4mTZVp-lc8mc2TliHvI8sR4xCh8dsE04yujfv2bnuwQkKX1GyCPLOUefpFWx2XcnkY2V6IL4aVBcbYOEkvO47HY20qXMZxThgYpvwisjqv1uqpCe8owMi_Xwbxx8wUwLrNAFKAax9I-TLSOX4D8jMQ-cgu6n33GFu70HIDXoon8VuytHI5AQ9lW8Zs9vdHMnVQqji8Qg7hmwpcBYZDN8xOljNJaOekd_jpiTJ5Q&sig=Cg0ArKJSzA-JtvhShMCVEAE&adurl=

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

216.58.210.2 Mountain View, United States, ASN15169 (GOOGLE, US),

Reverse DNS

fra16s07-in-f2.1e100.net

Software

cafe /

Resource Hash

e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin: *
date: Fri, 12 Jun 2020 17:43:00 GMT
x-content-type-options: nosniff
server: cafe
status: 200
p3p: policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin: *
cache-control: private
content-type: image/gif
alt-svc: h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length: 0
x-xss-protection: 0

GET
H2 200 modules.5cd4945c79de888b7e62.js Show response
script.hotjar.com/ 369 KB
70 KB 44ms
15ms Script
application/javascript 147.75.101.5
PACKET

General

Check archive.org

Show headers Download Go to

Full URL: https://script.hotjar.com/modules.5cd4945c79de888b7e62.js
Requested by: Host: static.hotjar.com
URL: https://static.hotjar.com/c/hotjar-1097635.js?sv=6
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 147.75.101.5 Central, Hong Kong, ASN54825 (PACKET, US),
Reverse DNS: pkt-ams-k2-shared-ingress16
Software: /
Resource Hash: 998dddc13ee0857954656d34d9546ff47b99f6daea732de0dd99d17f5d5db79f

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Fri, 12 Jun 2020 17:43:00 GMT
content-encoding: br
age: 38209
status: 200
section-io-cache: Hit
content-length: 71510
last-modified: Thu, 11 Jun 2020 15:36:15 GMT
etag: "5fe7ffce3019c5c5010d946c7e87cef9"
vary: Accept-Encoding
section-io-origin-status: 200
access-control-allow-origin: *
cache-control: max-age=31536000
section-io-origin-time-seconds: 0.096
section-io-id: 7157d158371fe88bb2b96672ad270bad
accept-ranges: bytes
content-type: application/javascript
section-origin-responded: true

GET
H2 200 1026610140874609 Show response
connect.facebook.net/signals/config/ 147 KB
37 KB 39ms
39ms Script
application/x-javascript 2a03:2880:f01c:8012:face:b00c:0:3
FACEBOOK

General

Check archive.org

Show headers Download Go to

Full URL

https://connect.facebook.net/signals/config/1026610140874609?v=2.9.18&r=stable

Requested by

Host: connect.facebook.net
URL: https://connect.facebook.net/en_US/fbevents.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a03:2880:f01c:8012:face:b00c:0:3 , Ireland, ASN32934 (FACEBOOK, US),

Reverse DNS

Software

Resource Hash

2d0f94a6c3feaec5930c8a7bc2b5e5b5350f416a89a1496d7032ff2039278064

Security Headers

Name	Value
Content-Security-Policy	default-src * data: blob:;script-src .facebook.com .fbcdn.net .facebook.net .google-analytics.com .virtualearth.net .google.com 127.0.0.1:* .spotilocal.com: 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' ;connect-src .facebook.com facebook.com .fbcdn.net .facebook.net .spotilocal.com: wss://.facebook.com: https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self' chrome-extension://boadgeojelhgndaghljhdicfkmllpafd chrome-extension://dliochdbjfkdbacpmhlcpmleaejidimm;
Strict-Transport-Security	max-age=31536000; preload; includeSubDomains
X-Content-Type-Options	nosniff
X-Frame-Options	DENY
X-Xss-Protection	0

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

strict-transport-security: max-age=31536000; preload; includeSubDomains
content-encoding: gzip
x-content-type-options: nosniff
status: 200
alt-svc: h3-27=":443"; ma=3600
x-xss-protection: 0
pragma: public
x-fb-debug: oiTOfY0FBkQkFLkT+oWYnbccm+S523Nh3fKzhX8DPdkkmcwsqd+V6OEbV9OSAnmbXibNSEHsaAEr2js7xPTWCQ==
x-fb-trip-id: 664085054
x-frame-options: DENY
date: Fri, 12 Jun 2020 17:43:00 GMT, Fri, 12 Jun 2020 17:43:00 GMT
vary: Accept-Encoding
content-type: application/x-javascript; charset=utf-8
cache-control: public, max-age=1200
content-security-policy: default-src * data: blob:;script-src *.facebook.com *.fbcdn.net *.facebook.net *.google-analytics.com *.virtualearth.net *.google.com 127.0.0.1:* *.spotilocal.com:* 'unsafe-inline' 'unsafe-eval' blob: data: 'self';style-src data: blob: 'unsafe-inline' *;connect-src *.facebook.com facebook.com *.fbcdn.net *.facebook.net *.spotilocal.com:* wss://*.facebook.com:* https://fb.scanandcleanlocal.com:* attachment.fbsbx.com ws://localhost:* blob: *.cdninstagram.com 'self' chrome-extension://boadgeojelhgndaghljhdicfkmllpafd chrome-extension://dliochdbjfkdbacpmhlcpmleaejidimm;
expires: Sat, 01 Jan 2000 00:00:00 GMT

GET
DATA 200
OK truncated
/ Frame 479B 219 B
0 Image
image/png

General

Check archive.org

Show headers Download Go to Show image

Full URL: data:truncated
Protocol: DATA
Server: -, , ASN (),
Reverse DNS
Software: /
Resource Hash: 7d3a901dfd307ab7809b78efcf2d0cfa942d82fa7597caf5fada7cce66e44102

Request headers

Referer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type: image/png

GET
H2 200 view
securepubads.g.doubleclick.net/pcs/ Frame 59ED 0
0 35ms
32ms Fetch
image/gif 216.58.210.2
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjssbWL_xdBiqH6AcN-Jw5GMikq14H1F0nife-qhO9uckQWhNrDE0uygAoLOO7P5ByR8nzszYQDnq33lp2ezPwpwWqKxSPcseLzz2gOYog1otI3WJsoJK7ZQqSXTO5bZgfqZIiQv0wFovxH6mvc5hobzYgKJSLkr33Zy57XDd41rDeg5Ar5jNhIbJvX2yZ1mU1KsqvsPwouQzOg48N8ddWGiQDVPHhYZ3dxwdb4Jje-2Wst-6u2k5u83h2U3N0X55y98bpYr-Qig5sdlw33T19PuHHrfaIP6AzrWiXGfoztKA6ocGLDmO09k5VVjgZ-yFsboG0rbdOICVsmCvFZsYI-eh26meTuk&sig=Cg0ArKJSzN0lgJ-Ovf0_EAE&adurl=

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

216.58.210.2 Mountain View, United States, ASN15169 (GOOGLE, US),

Reverse DNS

fra16s07-in-f2.1e100.net

Software

cafe /

Resource Hash

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin: *
date: Fri, 12 Jun 2020 17:43:00 GMT
x-content-type-options: nosniff
server: cafe
status: 200
p3p: policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin: *
cache-control: private
content-type: image/gif
alt-svc: h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length: 0
x-xss-protection: 0

GET
H2 200 8783790369963399186
tpc.googlesyndication.com/simgad/ Frame 59ED 16 KB
16 KB 8ms
6ms Image
image/gif 2a00:1450:4001:802::2001
GOOGLE

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://tpc.googlesyndication.com/simgad/8783790369963399186

Requested by

Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060803.js?21066388

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:802::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

348ca2d79ab4ee80d72d725484651deb121af2c6ea349e6c18eef7ca833fae74

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Fri, 12 Jun 2020 09:13:15 GMT
x-content-type-options: nosniff
age: 30585
x-dns-prefetch-control: off
status: 200
alt-svc: h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length: 16265
x-xss-protection: 0
last-modified: Tue, 19 May 2020 07:50:29 GMT
server: sffe
content-type: image/gif
access-control-allow-origin: *
cache-control: public, max-age=31536000
accept-ranges: bytes
timing-allow-origin: *
expires: Sat, 12 Jun 2021 09:13:15 GMT

GET
H2 200 window_focus_fy2019.js Show response
tpc.googlesyndication.com/pagead/js/r20200609/r20110914/client/ Frame 59ED 3 KB
2 KB 9ms
7ms Script
text/javascript 2a00:1450:4001:802::2001
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://tpc.googlesyndication.com/pagead/js/r20200609/r20110914/client/window_focus_fy2019.js

Requested by

Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060803.js?21066388

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:802::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

cafe /

Resource Hash

7d2d1f9c78d8c0755bb8830fd20121d6d05c949c89b20536a89b6643f748c600

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Wed, 10 Jun 2020 00:53:40 GMT
content-encoding: gzip
x-content-type-options: nosniff
age: 233360
p3p: policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status: 200
content-disposition: attachment; filename="f.txt"
alt-svc: h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length: 1479
x-xss-protection: 0
server: cafe
etag: 9751230926324105381
vary: Accept-Encoding, Origin
content-type: text/javascript; charset=UTF-8
cache-control: public, max-age=1209600
timing-allow-origin: *
expires: Wed, 24 Jun 2020 00:53:40 GMT

GET
H2 200 osd_listener.js Show response
www.googletagservices.com/activeview/js/current/ Frame 59ED 73 KB
28 KB 39ms
37ms Script
text/javascript 2a00:1450:4001:81d::2002
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://www.googletagservices.com/activeview/js/current/osd_listener.js?cache=r20110914

Requested by

Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060803.js?21066388

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:81d::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

84058f4935f4a903f78426d22151ce5ca07e601bcf127fdc75f316b725be4c40

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Fri, 12 Jun 2020 17:43:00 GMT
content-encoding: gzip
x-content-type-options: nosniff
server: sffe
etag: "1591788966119694"
vary: Accept-Encoding
content-type: text/javascript
status: 200
cache-control: private, max-age=3000
accept-ranges: bytes
alt-svc: h3-27="googleads.g.doubleclick.net:443"; ma=2592000,h3-27=":443"; ma=2592000,h3-25="googleads.g.doubleclick.net:443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050="googleads.g.doubleclick.net:443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length: 28177
x-xss-protection: 0
expires: Fri, 12 Jun 2020 17:43:00 GMT

GET
H2 200 moatad.js Show response
z.moatads.com/pentonmedia53440730609/ Frame 59ED 290 KB
98 KB 25ms
24ms Script
application/x-javascript 72.247.226.64
AKAMAI-AS

General

Check archive.org

Show headers Download Go to

Full URL: https://z.moatads.com/pentonmedia53440730609/moatad.js
Requested by: Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060803.js?21066388
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 72.247.226.64 , United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS: a72-247-226-64.deploy.static.akamaitechnologies.com
Software: AmazonS3 /
Resource Hash: 7c86268aee3ee868908336bbb2a43d11dd200942de23762f1851e54c25233441

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Fri, 12 Jun 2020 17:43:00 GMT
content-encoding: gzip
last-modified: Tue, 09 Jun 2020 16:53:21 GMT
server: AmazonS3
x-amz-request-id: BF5F8DCB03251522
etag: "635e31427ca583c8b5d9961b3e554e44"
vary: Accept-Encoding
content-type: application/x-javascript
status: 200
cache-control: max-age=60137
accept-ranges: bytes
content-length: 100310
x-amz-id-2: bRWYBsFPZ8nI8j7IHWNM/QLpH12DxWiDHaaAUaBHiAp9vom3LyD3cMw5CJrgg9fuP9Yh6bGDsiE=

GET
H/1.1 200
OK tag.aspx Show response
ml314.com/ Frame 479B 26 KB
12 KB 126ms
32ms Script
application/javascript 34.253.133.202
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://ml314.com/tag.aspx?1252020
Requested by: Host: z.moatads.com
URL: https://z.moatads.com/pentonmedia53440730609/moatad.js
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 34.253.133.202 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS: ec2-34-253-133-202.eu-west-1.compute.amazonaws.com
Software: Microsoft-IIS/10.0 / ASP.NET
Resource Hash: 9c6af299685617864c257472040f437ef951afec994720a24781931cc3527017

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date: Fri, 12 Jun 2020 17:43:00 GMT
Content-Encoding: gzip
Last-Modified: Fri, 12 Jun 2020 05:45:06 GMT
Server: Microsoft-IIS/10.0
X-AspNet-Version: 4.0.30319
X-Powered-By: ASP.NET
Vary: Accept-Encoding
Content-Type: application/javascript; charset=utf-8
Cache-Control: public, max-age=43326
Connection: keep-alive
Content-Length: 11933
Expires: Sat, 13 Jun 2020 05:45:06 GMT

GET
H2 200 n.js Show response
geo.moatads.com/ 99 B
273 B 102ms
29ms Script
text/html 35.177.118.109
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://geo.moatads.com/n.js?e=35&ud=undefined&qn=%604%7BZEYwoqI%24%5BK%2BdLLU)%2CMm~t8!b.%5BMhS%3A15.sn_003etW6~P6Jn)s)wC%24GL3jX%7BQqDOJ%3Eoy)G3p%2FhFjrR8CL6k%24)m3*%5B%605*mF%40%23b%3DhjdbEW%3C7bNC%3ElaKc%2C%26WLRGt%269RHrOCFxBoocF)uhFAkD%3Dv%3Cy%5Dv%5BLy*hgMcpk%3FqFm%5Dm%22%2Bx%7Co%3Ee%7CwR3yC%7CQ%5Elv%3Ch%2CeI8!A2QnbjPSI.%24ki)sV~1HmDkx2KD5pf5%5BG%5BZFZ8R6tbK0pH%23bU%24(9N%2CNJJ)%2CW%2FKo7FY&th=4007238046&tf=nMzjG---CSa7H-fUfHv-j7VIQD-xFQTS-nMzjG-&vi=111111&qp=00000&is=BBBBB2IUEY4vGl2BBCBBtUTBBRmsqbKW8BsrBu0rCFE48CRBeeBS2hWTMQSQeQBBn2soYggyUig0CBlWZ0uBBCCCCCCOgRBBiOfnE6Skg7OxBb8MxOtJYHCBdm5kBhBBC9Y8oBXckXBR76iUUsJBCBBBBBBBBBWBSqj3BBBZeGV2BBBCMciUBBBjgEBBBBBB94UMgTdJMtEcpMBBBQBBBniOccypBsrB41kNBBBBBBBBBBBBBhcjG6BBJM2L4Bk8BwCBQmIoRBBCzBz1BBCTCyBBrbjBC4ehueB57NG9aJfR0BqEKiuwBBBB&iv=8&qt=0&gz=0&hh=0&hn=0&tw=&qc=0&qd=0&qf=1600&qe=1200&qh=1600&qg=1200&qm=-120&qa=1600&qb=1200&qi=1600&qj=1200&to=00&po=1-0020002000002120&vy=&ql=&qo=0&qr=0&i=PENTONMEDIA1&hp=1&wf=1&vb=11&kq=1&hq=0&hs=0&hu=0&hr=0&ht=0&dnt=0&bq=0&f=0&j=&t=1591983780493&de=333246576571&m=0&ar=c34ad4f880-clean&iw=821c7c5&q=2&cb=0&ym=0&cu=1591983780493&ll=2&lm=0&ln=1&r=0&em=0&en=0&d=4874126281%3A2696286467%3A5374575282%3A138311932788&zMoatPS=300_1_lft&zGSRC=1&gu=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&id=1&ii=4&bo=21946295198&bp=21988232143&bd=300_1_lft&zMoatOrigSlicer1=21946295198&zMoatOrigSlicer2=21988232143&zMoatDomain=globalpharmainsights.com&zMoatSubdomain=globalpharmainsights.com&dfp=0%2C1&la=21988232143&gw=pentonmedia53440730609&fd=1&ac=1&it=500&ti=0&ih=1&pe=1%3A1246%3A1246%3A0%3A1394&fs=181543&na=914050949&cs=0&callback=MoatDataJsonpRequest_74730648
Requested by: Host: z.moatads.com
URL: https://z.moatads.com/pentonmedia53440730609/moatad.js
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 35.177.118.109 London, United Kingdom, ASN16509 (AMAZON-02, US),
Reverse DNS: ec2-35-177-118-109.eu-west-2.compute.amazonaws.com
Software: TornadoServer/4.5.3 /
Resource Hash: a57972a7eebd2d820fdd2d4817f8568feec7a9c8d14f634730f0029509719f71

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Fri, 12 Jun 2020 17:43:00 GMT
server: TornadoServer/4.5.3
etag: "f9d647fcddb328fc448bd85b9025947ca7e6ca64"
content-type: text/html; charset=UTF-8
status: 200
cache-control: max-age=900
timing-allow-origin: *
content-length: 99

GET
H2 200 pixel.gif
px.moatads.com/ 43 B
260 B 26ms
25ms Image
image/gif 72.247.226.64
AKAMAI-AS

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://px.moatads.com/pixel.gif?e=17&i=PENTONMEDIA1&hp=1&wf=1&vb=11&kq=1&hq=0&hs=0&hu=0&hr=0&ht=0&dnt=0&bq=0&f=0&j=&t=1591983780493&de=333246576571&m=0&ar=c34ad4f880-clean&iw=821c7c5&q=3&cb=0&ym=0&cu=1591983780493&ll=2&lm=0&ln=1&r=0&em=0&en=0&d=4874126281%3A2696286467%3A5374575282%3A138311932788&zMoatPS=300_1_lft&zGSRC=1&gu=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&id=1&ii=4&bo=21946295198&bp=21988232143&bd=300_1_lft&zMoatOrigSlicer1=21946295198&zMoatOrigSlicer2=21988232143&zMoatDomain=globalpharmainsights.com&zMoatSubdomain=globalpharmainsights.com&dfp=0%2C1&la=21988232143&gw=pentonmedia53440730609&fd=1&ac=1&it=500&ti=0&ih=1&pe=1%3A1246%3A1246%3A0%3A1394&fs=181543&na=1039803640&cs=0
Requested by: Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 72.247.226.64 , United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS: a72-247-226-64.deploy.static.akamaitechnologies.com
Software: AkamaiNetStorage /
Resource Hash: cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma: no-cache
date: Fri, 12 Jun 2020 17:43:00 GMT
last-modified: Fri, 20 May 2016 15:16:00 GMT
server: AkamaiNetStorage
etag: "ad4b0f606e0f8465bc4c4c170b37e1a3:1463757360"
content-type: image/gif
status: 200
cache-control: max-age=0, no-cache, no-store
accept-ranges: bytes
content-length: 43
expires: Fri, 12 Jun 2020 17:43:00 GMT

GET
H2 200 editor.css
www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/skins/moono-lisa/ 46 KB
6 KB 60ms
59ms Stylesheet
text/css 143.204.237.71
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL

https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/skins/moono-lisa/editor.css?t=I3I8

Requested by

Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/ckeditor.js?qbs4lh

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

143.204.237.71 Seattle, United States, ASN16509 (AMAZON-02, US),

Reverse DNS

server-143-204-237-71.cph50.r.cloudfront.net

Software

Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /

Resource Hash

f6cd5dec07fd04b7db1a02aa063ff9550f6f595f7902a23bf466a6044bde796e

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Fri, 12 Jun 2020 17:06:10 GMT
content-encoding: gzip
x-content-type-options: nosniff
last-modified: Fri, 12 Jun 2020 14:50:39 GMT
server: Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
age: 2210
vary: Accept-Encoding
x-cache: Hit from cloudfront
content-type: text/css
status: 200
cache-control: max-age=10800
x-amz-cf-pop: CPH50-C1
x-amz-cf-id: WVvGKchsD88_UPhOMNI-8M4Q0C_ND2LZglYcthmx4TKNuTjv1_BEtQ==
via: 1.1 1624c79cd07e6098196697a6a7907e4b.cloudfront.net (CloudFront)
expires: Fri, 12 Jun 2020 20:06:10 GMT

GET
H2 200 en.js Show response
www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/lang/ 19 KB
7 KB 61ms
60ms Script
application/javascript 143.204.237.71
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL

https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/lang/en.js?t=I3I8

Requested by

Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/ckeditor.js?qbs4lh

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

143.204.237.71 Seattle, United States, ASN16509 (AMAZON-02, US),

Reverse DNS

server-143-204-237-71.cph50.r.cloudfront.net

Software

Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /

Resource Hash

69a9941f0ab4a5c4851d9286d9aaf981f7b6c8f1b716c057e77102a2759dc9e7

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Fri, 12 Jun 2020 17:06:10 GMT
content-encoding: gzip
x-content-type-options: nosniff
last-modified: Fri, 12 Jun 2020 14:48:44 GMT
server: Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
age: 2210
vary: Accept-Encoding
x-cache: Hit from cloudfront
content-type: application/javascript
status: 200
cache-control: max-age=10800
x-amz-cf-pop: CPH50-C1
x-amz-cf-id: kBkuMFs2paP01ft8JzZObunCzUjugT41Pjv3xpHR60Z0Zwk6psPD5g==
via: 1.1 1624c79cd07e6098196697a6a7907e4b.cloudfront.net (CloudFront)
expires: Fri, 12 Jun 2020 20:06:10 GMT

GET
H2 200 box-469cf41adb11dc78be68c1ae7f9457a4.html
vars.hotjar.com/ Frame EF6F 0
0 44ms
14ms Document
text/html 147.75.33.229
PACKET

General

Check archive.org

Show headers Download Go to

Full URL: https://vars.hotjar.com/box-469cf41adb11dc78be68c1ae7f9457a4.html
Requested by: Host: static.hotjar.com
URL: https://static.hotjar.com/c/hotjar-1097635.js?sv=6
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 147.75.33.229 Amsterdam, Netherlands, ASN54825 (PACKET, US),
Reverse DNS: pkt-ams-k2-shared-ingress12
Software: /
Resource Hash

Request headers

:method: GET
:authority: vars.hotjar.com
:scheme: https
:path: /box-469cf41adb11dc78be68c1ae7f9457a4.html
pragma: no-cache
cache-control: no-cache
upgrade-insecure-requests: 1
user-agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept: text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site: cross-site
sec-fetch-mode: navigate
sec-fetch-dest: iframe
referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
accept-encoding: gzip, deflate, br
accept-language: en-US
Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL

Response headers

status: 200
date: Fri, 12 Jun 2020 17:43:00 GMT
content-type: text/html
content-length: 851
last-modified: Wed, 03 Jun 2020 11:24:24 GMT
etag: "d594f1d4c3e5dbd6b556c60d34e0daea"
cache-control: max-age=31536000
content-encoding: br
section-io-origin-status: 200
section-io-origin-time-seconds: 0.120
section-origin-responded: true
age: 741745
vary: Accept-Encoding
section-io-cache: Hit
accept-ranges: bytes
section-io-id: ce1f69b09ddf0a4edf940d4062497c38

GET
DATA 200
OK truncated
/ 1 KB
0 Image
image/svg+xml

General

Check archive.org

Show headers Download Go to Show image

Full URL: data:truncated
Protocol: DATA
Server: -, , ASN (),
Reverse DNS
Software: /
Resource Hash: e6119ad52adef631ee4fb2539d02ed906dee8f8f3e64b4d8a091ea0fb864b9f4

Request headers

Referer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type: image/svg+xml

GET
H2 200 / Show response
googleads.g.doubleclick.net/pagead/viewthroughconversion/998237655/ 3 KB
1 KB 23ms
22ms Script
text/javascript 2a00:1450:4001:808::2002
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://googleads.g.doubleclick.net/pagead/viewthroughconversion/998237655/?random=1591983780598&cv=9&fst=1591983780598&num=1&bg=ffffff&guid=ON&resp=GooglemKTybQhCsO&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_his=2&u_tz=120&u_java=false&u_nplug=0&u_nmime=0&gtm=2oa640&sendb=1&ig=1&data=event%3Dgtag.config&frm=0&url=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSerie&tiba=Gilead%20signs%20agreements%20with%20generics%20firms%20to%20manufacture%20remdesivir%20%7C%20Global%20Pharma%20Insights&hn=www.googleadservices.com&async=1&rfmt=3&fmt=4

Requested by

Host: www.googleadservices.com
URL: https://www.googleadservices.com/pagead/conversion_async.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:808::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

cafe /

Resource Hash

7089a8071ad587d2190e25a6105244297badd21420f2a6ceedb90b4a64a82101

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma: no-cache
date: Fri, 12 Jun 2020 17:43:00 GMT
content-encoding: gzip
x-content-type-options: nosniff
server: cafe
timing-allow-origin: *
p3p: policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status: 200
cache-control: no-cache, must-revalidate
content-disposition: attachment; filename="f.txt"
content-type: text/javascript; charset=UTF-8
alt-svc: h3-27="googleads.g.doubleclick.net:443"; ma=2592000,h3-27=":443"; ma=2592000,h3-25="googleads.g.doubleclick.net:443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050="googleads.g.doubleclick.net:443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length: 1384
x-xss-protection: 0
expires: Fri, 01 Jan 1990 00:00:00 GMT

GET
H2 200 view
securepubads.g.doubleclick.net/pcs/ Frame 59ED 0
54 B 31ms
30ms Image
image/gif 216.58.210.2
GOOGLE

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://securepubads.g.doubleclick.net/pcs/view?xai=AKAOjsteXLEJXu9pHJHzo_nWW4yDIIYufBvrFSuABKV330cuE_wf4pySpSGEMfm8JakSgp25mssg7lRLcCVDHfKqxghx8N4wV4SWYqQgt6RisnOGb5GEimBlLvrTqMZ1NVGD0_nmjxeKNqXtyYeRu3pNGxzqVabyY7VK6bStcc3GVm9YDmWpC1oWdatLzvBXwDB9OEwGZO54ErmPhfDXTvduKFhvTGBzjl7MntNvWAGI5UxHA9glWupLMOhDEsXWVkgkvwjKsT91pKDxWFGU6pnZ1uHwE-tHP9kFHxMHXJELzlEQ6ISQVfTaCFzZVDpLsup3182WCdK3AqGg6nJCWkGlGQiyv7XX4-O-4w&sig=Cg0ArKJSzL2UTYJXqtdwEAE&adurl=

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

216.58.210.2 Mountain View, United States, ASN15169 (GOOGLE, US),

Reverse DNS

fra16s07-in-f2.1e100.net

Software

cafe /

Resource Hash

e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin: *
date: Fri, 12 Jun 2020 17:43:00 GMT
x-content-type-options: nosniff
server: cafe
status: 200
p3p: policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
access-control-allow-origin: *
cache-control: private
content-type: image/gif
alt-svc: h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length: 0
x-xss-protection: 0

GET
DATA 200
OK truncated
/ Frame 59ED 215 B
0 Image
image/png

General

Check archive.org

Show headers Download Go to Show image

Full URL: data:truncated
Protocol: DATA
Server: -, , ASN (),
Reverse DNS
Software: /
Resource Hash: 338a9bbae59629e7b677a1beb9b029d410321bac41eb88a572605af59ba8af8f

Request headers

Referer
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Content-Type: image/png

GET
H2 200 /
www.facebook.com/tr/ 44 B
260 B 6ms
6ms Image
image/gif 2a03:2880:f11c:8183:face:b00c:0:25de
FACEBOOK

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.facebook.com/tr/?id=1026610140874609&ev=PageView&dl=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&rl=&if=false&ts=1591983780642&sw=1600&sh=1200&v=2.9.18&r=stable&ec=0&o=28&fbp=fb.1.1591983780641.539611721&it=1591983780452&coo=false&rqm=GET

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a03:2880:f11c:8183:face:b00c:0:25de , Ireland, ASN32934 (FACEBOOK, US),

Reverse DNS

Software

proxygen-bolt /

Resource Hash

10d8d42d73a02ddb877101e72fbfa15a0ec820224d97cedee4cf92d571be5caa

Security Headers

Name	Value
Strict-Transport-Security	max-age=31536000; includeSubDomains

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Fri, 12 Jun 2020 17:43:00 GMT, Fri, 12 Jun 2020 17:43:00 GMT
last-modified: Fri, 21 Dec 2012 00:00:01 GMT
server: proxygen-bolt
strict-transport-security: max-age=31536000; includeSubDomains
content-type: image/gif
status: 200
cache-control: no-cache, must-revalidate, max-age=0
alt-svc: h3-27=":443"; ma=3600
content-length: 44
expires: Fri, 12 Jun 2020 17:43:00 GMT

GET
H2 200 pixel.gif
px.moatads.com/ 43 B
260 B 24ms
24ms Image
image/gif 72.247.226.64
AKAMAI-AS

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://px.moatads.com/pixel.gif?e=0&q=0&hp=1&wf=1&vb=11&kq=1&lo=0&uk=null&pk=1&wk=1&rk=1&tk=0&ak=https%3A%2F%2Ftpc.googlesyndication.com%2Fsimgad%2F8783790369963399186&i=PENTONMEDIA1&ud=undefined&qn=%604%7BZEYwoqI%24%5BK%2BdLLU)%2CMm~t8!b.%5BMhS%3A15.sn_003etW6~P6Jn)s)wC%24GL3jX%7BQqDOJ%3Eoy)G3p%2FhFjrR8CL6k%24)m3*%5B%605*mF%40%23b%3DhjdbEW%3C7bNC%3ElaKc%2C%26WLRGt%269RHrOCFxBoocF)uhFAkD%3Dv%3Cy%5Dv%5BLy*hgMcpk%3FqFm%5Dm%22%2Bx%7Co%3Ee%7CwR3yC%7CQ%5Elv%3Ch%2CeI8!A2QnbjPSI.%24ki)sV~1HmDkx2KD5pf5%5BG%5BZFZ8R6tbK0pH%23bU%24(9N%2CNJJ)%2CW%2FKo7FY&th=4007238046&tf=nMzjG---CSa7H-fUfHv-j7VIQD-xFQTS-nMzjG-&vi=111111&qp=00000&is=BBBBB2IUEY4vGl2BBCBBtUTBBRmsqbKW8BsrBu0rCFE48CRBeeBS2hWTMQSQeQBBn2soYggyUig0CBlWZ0uBBCCCCCCOgRBBiOfnE6Skg7OxBb8MxOtJYHCBdm5kBhBBC9Y8oBXckXBR76iUUsJBCBBBBBBBBBWBSqj3BBBZeGV2BBBCMciUBBBjgEBBBBBB94UMgTdJMtEcpMBBBQBBBniOccypBsrB41kNBBBBBBBBBBBBBhcjG6BBJM2L4Bk8BwCBQmIoRBBCzBz1BBCTCyBBrbjBC4ehueB57NG9aJfR0BqEKiuwBBBB&iv=8&qt=0&gz=0&hh=0&hn=0&tw=&qc=0&qd=0&qf=1600&qe=1200&qh=1600&qg=1200&qm=-120&qa=1600&qb=1200&qi=1600&qj=1200&to=00&po=1-0020002000002120&vy=&ql=&qo=0&qr=0&bq=0&g=0&hq=0&hs=0&hu=0&hr=0&ht=0&dnt=0&h=250&w=300&fy=0&gp=0&zGSRC=1&gu=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&id=1&ii=4&f=0&j=&t=1591983780493&de=333246576571&cu=1591983780493&m=64&ar=c34ad4f880-clean&iw=821c7c5&cb=0&ym=0&ll=2&lm=0&ln=1&r=0&dl=0&dn=0&gh=1&xx=undefined%3A875484570224&td=1&lk=undefined&lb=2919&le=1&gm=1&io=1&ch=0&vv=1&vw=1%3A3%3A0&vp=100&vx=100%3A-%3A-&pe=1%3A1246%3A1246%3A0%3A1394&as=0&ag=24&an=0&gf=24&gg=0&ix=24&ic=24&ez=1&aj=1&pg=100&pf=0&ib=0&cc=0&bw=24&bx=0&dj=1&aa=0&ad=0&cn=0&gk=0&gl=0&ik=0&im=0&in=0&pd=0&em=0&en=0&st=1&su=1&of=1&oz=1&oe=0%3A0%3A0%3Anull%3A-1%3Anull%3A-1%3Anull%3A-1&bu=48&cd=0&ah=48&am=0&rf=0&re=0&wb=1&cl=0&at=0&d=4874126281%3A2696286467%3A5374575282%3A138311932788&bo=21946295198&bp=21988232143&bd=300_1_lft&zMoatPS=300_1_lft&gw=pentonmedia53440730609&zMoatOrigSlicer1=21946295198&zMoatOrigSlicer2=21988232143&zMoatDomain=globalpharmainsights.com&zMoatSubdomain=globalpharmainsights.com&dfp=0%2C1&la=21988232143&hv=Standard%20Image%20Ad%20finding%20&ab=1&ac=1&fd=1&kt=strict&it=500&fz=1&oq=1&ot=ff&zMoatJS=3%3A-&ti=0&ih=1&tc=0&fs=181543&na=331218734&cs=0
Requested by: Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 72.247.226.64 , United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS: a72-247-226-64.deploy.static.akamaitechnologies.com
Software: AkamaiNetStorage /
Resource Hash: cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma: no-cache
date: Fri, 12 Jun 2020 17:43:00 GMT
last-modified: Fri, 20 May 2016 15:16:00 GMT
server: AkamaiNetStorage
etag: "ad4b0f606e0f8465bc4c4c170b37e1a3:1463757360"
content-type: image/gif
status: 200
cache-control: max-age=0, no-cache, no-store
accept-ranges: bytes
content-length: 43
expires: Fri, 12 Jun 2020 17:43:00 GMT

GET
H/1.1

200
OK

index.php Show response
a.dpmsrv.com/dpmpxl/
Redirect Chain

https://ib.adnxs.com/getuid?https://a.dpmsrv.com/dpmpxl/index.php?id=$UID&q%3DxImp%26v%3D1.x%26cl%3D55%26pixelIndex%3D0%26r%3D614811%26tzOffset%3D-120%26url%3Dhttps%253A%252F%252Fwww.globalpharmain...
https://ib.adnxs.com/bounce?%2Fgetuid%3Fhttps%3A%2F%2Fa.dpmsrv.com%2Fdpmpxl%2Findex.php%3Fid%3D%24UID%26q%253DxImp%2526v%253D1.x%2526cl%253D55%2526pixelIndex%253D0%2526r%253D614811%2526tzOffset%253...
https://a.dpmsrv.com/dpmpxl/index.php?id=2301816357575935815&q=xImp&v=1.x&cl=55&pixelIndex=0&r=614811&tzOffset=-120&url=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgile...

242 B
992 B

411ms
101ms

Script
text/javascript

34.192.142.95
AMAZON-AES

General

Check archive.org

Show headers Download Go to

Full URL: https://a.dpmsrv.com/dpmpxl/index.php?id=2301816357575935815&q=xImp&v=1.x&cl=55&pixelIndex=0&r=614811&tzOffset=-120&url=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5&_=1591983780665
Requested by: Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 34.192.142.95 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS: ec2-34-192-142-95.compute-1.amazonaws.com
Software: /
Resource Hash: 50bc2f4a959d314b9be8b3c40df30c177803fa6cc902056cfbe63f711cf84409

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Pragma: no-cache
content-encoding: gzip
Access-Control-Max-Age: 10
Access-Control-Allow-Methods: GET, POST, PUT, DELETE, OPTIONS
P3P: CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
Access-Control-Allow-Origin: *
Cache-Control: no-cache, no-store, must-revalidate
Connection: keep-alive
Content-Type: text/javascript
Access-Control-Allow-Headers: content-type, accept
Content-Length: 215
Expires: 0

Redirect headers

Pragma: no-cache
Date: Fri, 12 Jun 2020 17:43:02 GMT
X-Proxy-Origin: 185.217.171.12; 185.217.171.12; 538.bm-nginx-loadbalancer.mgmt.fra1; *.adnxs.com; 37.252.172.113:80
AN-X-Request-Uuid: e0e61411-5e75-431b-92e0-8338a625195b
Server: nginx/1.13.4
Access-Control-Allow-Origin: *
P3P: policyref="http://cdn.adnxs.com/w3c/policy/p3p.xml", CP="NOI DSP COR ADM PSAo PSDo OURo SAMo UNRo OTRo BUS COM NAV DEM STA PRE"
Location: https://a.dpmsrv.com/dpmpxl/index.php?id=2301816357575935815&q=xImp&v=1.x&cl=55&pixelIndex=0&r=614811&tzOffset=-120&url=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5&_=1591983780665
Cache-Control: no-store, no-cache, private
Access-Control-Allow-Credentials: true
Connection: keep-alive
Content-Type: text/html; charset=utf-8
Content-Length: 0
X-XSS-Protection: 0
Expires: Sat, 15 Nov 2008 16:00:00 GMT

GET
H2 200 pixel.gif
px.moatads.com/ 43 B
260 B 25ms
23ms Image
image/gif 72.247.226.64
AKAMAI-AS

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://px.moatads.com/pixel.gif?e=17&i=PENTONMEDIA1&hp=1&wf=1&vb=11&kq=1&hq=0&hs=0&hu=0&hr=0&ht=0&dnt=0&bq=0&f=0&j=&t=1591983780609&de=924173565045&m=0&ar=c34ad4f880-clean&iw=821c7c5&q=7&cb=0&ym=0&cu=1591983780609&ll=2&lm=0&ln=1&r=0&em=0&en=0&d=4874126281%3A2696286467%3A5374575282%3A138312304633&zMoatPS=300_1_rht&zGSRC=1&gu=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&id=1&ii=4&bo=21946295198&bp=21988232143&bd=300_1_rht&zMoatOrigSlicer1=21946295198&zMoatOrigSlicer2=21988232143&zMoatDomain=globalpharmainsights.com&zMoatSubdomain=globalpharmainsights.com&dfp=0%2C1&la=21988232143&gw=pentonmedia53440730609&fd=1&ac=1&it=500&ti=0&ih=1&pe=1%3A1246%3A1246%3A0%3A1394&fs=181543&na=286796680&cs=0
Requested by: Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 72.247.226.64 , United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS: a72-247-226-64.deploy.static.akamaitechnologies.com
Software: AkamaiNetStorage /
Resource Hash: cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma: no-cache
date: Fri, 12 Jun 2020 17:43:00 GMT
last-modified: Fri, 20 May 2016 15:16:00 GMT
server: AkamaiNetStorage
etag: "ad4b0f606e0f8465bc4c4c170b37e1a3:1463757360"
content-type: image/gif
status: 200
cache-control: max-age=0, no-cache, no-store
accept-ranges: bytes
content-length: 43
expires: Fri, 12 Jun 2020 17:43:00 GMT

GET
H2 200 /
www.google.com/pagead/1p-user-list/998237655/ 42 B
119 B 21ms
20ms Image
image/gif 2a00:1450:4001:819::2004
GOOGLE

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.google.com/pagead/1p-user-list/998237655/?random=1591983780598&cv=9&fst=1591981200000&num=1&bg=ffffff&guid=ON&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_his=2&u_tz=120&u_java=false&u_nplug=0&u_nmime=0&gtm=2oa640&sendb=1&data=event%3Dgtag.config&frm=0&url=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSerie&tiba=Gilead%20signs%20agreements%20with%20generics%20firms%20to%20manufacture%20remdesivir%20%7C%20Global%20Pharma%20Insights&async=1&fmt=3&is_vtc=1&random=3709137954&resp=GooglemKTybQhCsO&rmt_tld=0&ipr=y

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:819::2004 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

cafe /

Resource Hash

ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629

Security Headers

Name	Value
Content-Security-Policy	script-src 'none'; object-src 'none'
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma: no-cache
date: Fri, 12 Jun 2020 17:43:00 GMT
x-content-type-options: nosniff
server: cafe
timing-allow-origin: *
p3p: policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status: 200
cache-control: no-cache, no-store, must-revalidate
content-security-policy: script-src 'none'; object-src 'none'
content-type: image/gif
alt-svc: h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length: 42
x-xss-protection: 0
expires: Fri, 01 Jan 1990 00:00:00 GMT

GET
H2 200 /
www.google.de/pagead/1p-user-list/998237655/ 42 B
107 B 20ms
19ms Image
image/gif 2a00:1450:4001:814::2003
GOOGLE

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://www.google.de/pagead/1p-user-list/998237655/?random=1591983780598&cv=9&fst=1591981200000&num=1&bg=ffffff&guid=ON&u_h=1200&u_w=1600&u_ah=1200&u_aw=1600&u_cd=24&u_his=2&u_tz=120&u_java=false&u_nplug=0&u_nmime=0&gtm=2oa640&sendb=1&data=event%3Dgtag.config&frm=0&url=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSerie&tiba=Gilead%20signs%20agreements%20with%20generics%20firms%20to%20manufacture%20remdesivir%20%7C%20Global%20Pharma%20Insights&async=1&fmt=3&is_vtc=1&random=3709137954&resp=GooglemKTybQhCsO&rmt_tld=1&ipr=y

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:814::2003 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

cafe /

Resource Hash

ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629

Security Headers

Name	Value
Content-Security-Policy	script-src 'none'; object-src 'none'
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma: no-cache
date: Fri, 12 Jun 2020 17:43:00 GMT
x-content-type-options: nosniff
server: cafe
timing-allow-origin: *
p3p: policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status: 200
cache-control: no-cache, no-store, must-revalidate
content-security-policy: script-src 'none'; object-src 'none'
content-type: image/gif
alt-svc: h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length: 42
x-xss-protection: 0
expires: Fri, 01 Jan 1990 00:00:00 GMT

GET
H2 200 pinit.js Show response
assets.pinterest.com/js/ 361 B
301 B 22ms
21ms Script
application/javascript 2606:4700::6812:fb0
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL: https://assets.pinterest.com/js/pinit.js?_=1591983779772
Requested by: Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/cphi.com/files/js/js__PiZuK2o4XAnDCWOhogiGF01gyHzeu7QxvOyfTe-YyM.js
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700::6812:fb0 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software: cloudflare /
Resource Hash: 3faadebc89cdb21d11634a032816f152462d1cb8903eb21d0642501fcad065de

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Fri, 12 Jun 2020 17:43:00 GMT
content-encoding: br
x-cdn: cloudflare
status: 200
etag: W/"82bfd941d2c9b3b9e0650a27c9d11737"
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary: Accept-Encoding
access-control-allow-methods: GET
content-type: application/javascript; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: x-cdn
cache-control: max-age=300
cf-ray: 5a255f259fc8175a-FRA
cf-request-id: 034b39cb7b0000175a3a9e6200000001
server: cloudflare

GET
H2 200 get_poll Show response
www.globalpharmainsights.com/ 4 KB
1 KB 1193ms
1192ms XHR
application/json 143.204.237.71
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL

https://www.globalpharmainsights.com/get_poll

Requested by

Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/cphi.com/files/js/js__PiZuK2o4XAnDCWOhogiGF01gyHzeu7QxvOyfTe-YyM.js

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

143.204.237.71 Seattle, United States, ASN16509 (AMAZON-02, US),

Reverse DNS

server-143-204-237-71.cph50.r.cloudfront.net

Software

Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 / PHP/7.2.31

Resource Hash

25de2432c61885492eda0603782aee34a5d3ffce41c395ceeed6d1f0b6cc6a3b

Security Headers

Name	Value
X-Content-Type-Options	nosniff, nosniff
X-Frame-Options	SAMEORIGIN

Request headers

Accept: */*
Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
X-Requested-With: XMLHttpRequest
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Fri, 12 Jun 2020 17:43:01 GMT
content-encoding: gzip
x-content-type-options: nosniff, nosniff
x-amz-cf-pop: CPH50-C1
x-powered-by: PHP/7.2.31
x-cache: Miss from cloudfront
status: 200
x-ua-compatible: IE=edge,chrome=1
server: Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
x-frame-options: SAMEORIGIN
vary: Accept-Encoding,Cookie
content-language: en
via: 1.1 1624c79cd07e6098196697a6a7907e4b.cloudfront.net (CloudFront)
cache-control: no-cache, must-revalidate
x-drupal-cache: MISS
content-type: application/json
x-amz-cf-id: CyDcy-QkBLMXp-uRGibtEcweKdTbGVqjQ7i4jPSy3IiA8CRalt8GPg==
expires: Sun, 19 Nov 1978 05:00:00 GMT

GET
H2 200 ckeditor.styles.js Show response
www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ 4 KB
2 KB 62ms
62ms Script
application/javascript 143.204.237.71
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL

https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor.styles.js?t=I3I8

Requested by

Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/ckeditor.js?qbs4lh

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

143.204.237.71 Seattle, United States, ASN16509 (AMAZON-02, US),

Reverse DNS

server-143-204-237-71.cph50.r.cloudfront.net

Software

Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /

Resource Hash

b937394951285201e18e193006731ebafcc0336f1249c737f74a4df37c8f5f7b

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Fri, 12 Jun 2020 15:35:21 GMT
content-encoding: gzip
x-content-type-options: nosniff
last-modified: Fri, 12 Jun 2020 14:50:39 GMT
server: Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
age: 7659
vary: Accept-Encoding
x-cache: Hit from cloudfront
content-type: application/javascript
status: 200
cache-control: max-age=10800
x-amz-cf-pop: CPH50-C1
x-amz-cf-id: 0vMagTSwr91pXK8Tk5eyH8SOXe-PxTEv-bWr7s8akUvLgk8MlsL7YA==
via: 1.1 1624c79cd07e6098196697a6a7907e4b.cloudfront.net (CloudFront)
expires: Fri, 12 Jun 2020 18:35:21 GMT

GET
H2 200 rum.js Show response
securepubads.g.doubleclick.net/pagead/js/ Frame 479B 52 KB
20 KB 20ms
20ms Script
text/javascript 216.58.210.2
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://securepubads.g.doubleclick.net/pagead/js/rum.js

Requested by

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

216.58.210.2 Mountain View, United States, ASN15169 (GOOGLE, US),

Reverse DNS

fra16s07-in-f2.1e100.net

Software

cafe /

Resource Hash

c056c42ca4283c493d7b9a326610495d3f3b2c75320e4f409dedb021499415e4

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Fri, 12 Jun 2020 17:06:46 GMT
content-encoding: gzip
x-content-type-options: nosniff
age: 2174
p3p: policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
status: 200
content-disposition: attachment; filename="f.txt"
alt-svc: h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length: 20409
x-xss-protection: 0
server: cafe
etag: 14047618755752351607
vary: Accept-Encoding
content-type: text/javascript; charset=UTF-8
cache-control: public, max-age=3600
timing-allow-origin: *
expires: Fri, 12 Jun 2020 18:06:46 GMT

GET
H2 200 pixel.gif
px.moatads.com/ 43 B
260 B 25ms
24ms Image
image/gif 72.247.226.64
AKAMAI-AS

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://px.moatads.com/pixel.gif?e=0&q=0&hp=1&wf=1&vb=11&kq=1&lo=0&uk=null&pk=1&wk=1&rk=1&tk=0&ak=https%3A%2F%2Ftpc.googlesyndication.com%2Fsimgad%2F8783790369963399186&i=PENTONMEDIA1&ud=undefined&qn=%604%7BZEYwoqI%24%5BK%2BdLLU)%2CMm~t8!b.%5BMhS%3A15.sn_003etW6~P6Jn)s)wC%24GL3jX%7BQqDOJ%3Eoy)G3p%2FhFjrR8CL6k%24)m3*%5B%605*mF%40%23b%3DhjdbEW%3C7bNC%3ElaKc%2C%26WLRGt%269RHrOCFxBoocF)uhFAkD%3Dv%3Cy%5Dv%5BLy*hgMcpk%3FqFm%5Dm%22%2Bx%7Co%3Ee%7CwR3yC%7CQ%5Elv%3Ch%2CeI8!A2QnbjPSI.%24ki)sV~1HmDkx2KD5pf5%5BG%5BZFZ8R6tbK0pH%23bU%24(9N%2CNJJ)%2CW%2FKo7FY&th=4007238046&tf=nMzjG---CSa7H-fUfHv-j7VIQD-xFQTS-nMzjG-&vi=111111&qp=00000&is=BBBBB2IUEY4vGl2BBCBBtUTBBRmsqbKW8BsrBu0rCFE48CRBeeBS2hWTMQSQeQBBn2soYggyUig0CBlWZ0uBBCCCCCCOgRBBiOfnE6Skg7OxBb8MxOtJYHCBdm5kBhBBC9Y8oBXckXBR76iUUsJBCBBBBBBBBBWBSqj3BBBZeGV2BBBCMciUBBBjgEBBBBBB94UMgTdJMtEcpMBBBQBBBniOccypBsrB41kNBBBBBBBBBBBBBhcjG6BBJM2L4Bk8BwCBQmIoRBBCzBz1BBCTCyBBrbjBC4ehueB57NG9aJfR0BqEKiuwBBBB&iv=8&qt=0&gz=0&hh=0&hn=0&tw=&qc=0&qd=0&qf=1600&qe=1200&qh=1600&qg=1200&qm=-120&qa=1600&qb=1200&qi=1600&qj=1200&to=00&po=1-0020002000002120&vy=&ql=&qo=0&qr=0&bq=0&g=0&hq=0&hs=0&hu=0&hr=0&ht=0&dnt=0&h=250&w=300&fy=0&gp=0&zGSRC=1&gu=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&id=1&ii=4&f=0&j=&t=1591983780609&de=924173565045&cu=1591983780609&m=13&ar=c34ad4f880-clean&iw=821c7c5&cb=0&ym=0&ll=2&lm=0&ln=1&r=0&dl=0&dn=0&gh=1&xx=undefined%3A875484570224&td=1&lk=undefined&lb=2919&le=1&gm=1&io=1&vv=1&vw=1%3A3%3A0&vp=72&vx=72%3A-%3A-&pe=1%3A1246%3A1246%3A0%3A1394&as=0&ag=2&an=0&gf=0&gg=0&ix=0&ic=0&ez=1&aj=1&pg=72&pf=0&ib=1&cc=0&bw=2&bx=0&dj=1&aa=0&ad=0&cn=0&gk=0&gl=0&ik=0&im=0&in=0&pd=0&em=0&en=0&st=1&su=1&of=1&oz=1&oe=0%3A0%3A0%3Anull%3A-1%3Anull%3A-1%3Anull%3A-1&bu=4&cd=0&ah=4&am=0&rf=0&re=0&wb=1&cl=0&at=0&d=4874126281%3A2696286467%3A5374575282%3A138312304633&bo=21946295198&bp=21988232143&bd=300_1_rht&zMoatPS=300_1_rht&gw=pentonmedia53440730609&zMoatOrigSlicer1=21946295198&zMoatOrigSlicer2=21988232143&zMoatDomain=globalpharmainsights.com&zMoatSubdomain=globalpharmainsights.com&dfp=0%2C1&la=21988232143&hv=Standard%20Image%20Ad%20finding%20&ab=1&ac=1&fd=1&kt=strict&it=500&oq=0&ot=cc&zMoatJS=3%3A-&ti=0&ih=1&tc=0&fs=181543&na=704358764&cs=0
Requested by: Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 72.247.226.64 , United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS: a72-247-226-64.deploy.static.akamaitechnologies.com
Software: AkamaiNetStorage /
Resource Hash: cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma: no-cache
date: Fri, 12 Jun 2020 17:43:00 GMT
last-modified: Fri, 20 May 2016 15:16:00 GMT
server: AkamaiNetStorage
etag: "ad4b0f606e0f8465bc4c4c170b37e1a3:1463757360"
content-type: image/gif
status: 200
cache-control: max-age=0, no-cache, no-store
accept-ranges: bytes
content-length: 43
expires: Fri, 12 Jun 2020 17:43:00 GMT

GET
H2 200 plugin.js Show response
www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/plugins/drupalbreaks/ 6 KB
2 KB 62ms
61ms Script
application/javascript 143.204.237.71
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL

https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/plugins/drupalbreaks/plugin.js?t=I3I8

Requested by

Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/ckeditor.js?qbs4lh

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

143.204.237.71 Seattle, United States, ASN16509 (AMAZON-02, US),

Reverse DNS

server-143-204-237-71.cph50.r.cloudfront.net

Software

Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /

Resource Hash

293153343c929ef767fad32776072237665ed6286d473bfba46fcf3957e37754

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Fri, 12 Jun 2020 15:35:22 GMT
content-encoding: gzip
x-content-type-options: nosniff
last-modified: Fri, 12 Jun 2020 14:48:44 GMT
server: Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
age: 7658
vary: Accept-Encoding
x-cache: Hit from cloudfront
content-type: application/javascript
status: 200
cache-control: max-age=10800
x-amz-cf-pop: CPH50-C1
x-amz-cf-id: B5_SMOsLBkXnV0sM_ItanPfwAJBMlY_JPJFgracWNe5-vbbVYWM1SQ==
via: 1.1 1624c79cd07e6098196697a6a7907e4b.cloudfront.net (CloudFront)
expires: Fri, 12 Jun 2020 18:35:22 GMT

POST
H2 204 csi
csi.gstatic.com/ Frame 479B 0
361 B 186ms
70ms Other
image/gif 2a00:1450:4017:802::2003
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL: https://csi.gstatic.com/csi?v=2&s=pagead&action=csi_pagead&dmc=8&puid=1~kbci1exd&ctx=2&qqid=CNjO1t3p_OkCFQbKuwgdOu0MYw&met.4=fb.2~lb.3n~ol.bu~idt.9r~dt.-2l&met.3=197.3g~123.3e_9~118.6x_1~118.7c~197.7l~143.7m_1~118.7x~118.87~118.87~118.88_1~118.ab~143.b8_1~118.bq~118.bq~117.bu~118.da~113.e3_4~112.e2_5~143.e8_1&met.1=1.kbci1ejb~14.0~15.0~16.0~17.0~18.0~19.0~20.bu~21.bu~22.3j~23.3j&met.7=CBwQChgBIAMoAzAMOAloBnALePkMgAHHC4gBpxawAQG4AQM~CCoQChgBIAQoBDAyOC8~CBsQBhgBIAQoBDAYOBQ~CBsQCiAEOGs~CBcQBhgBIAQoBDANOAloBnAMeIiAAYABiX-IAYl_sAEBuAED~CCIQBhgBIIMBKIMBMKMBOCBogwFwogF4NrABAbgBAw~CBsQCiC_ATh_~CCgQChgBIN8DKN8DMPQDOBVo3wNw8wN46qABgAG5nwGIAYmeA7ABAbgBAw
Requested by: Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/pagead/js/rum.js
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2a00:1450:4017:802::2003 , Ireland, ASN15169 (GOOGLE, US),
Reverse DNS
Software: Golfe2 /
Resource Hash: e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Content-Type: text/plain;charset=UTF-8

Response headers

pragma: no-cache
date: Fri, 12 Jun 2020 17:43:00 GMT
last-modified: Wed, 21 Jan 2004 19:51:30 GMT
server: Golfe2
status: 204
content-type: image/gif
access-control-allow-origin: *
cache-control: no-cache, no-store, must-revalidate
alt-svc: h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length: 0
expires: Fri, 01 Jan 1990 00:00:00 GMT

GET
H2 200 scayt.css
www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/plugins/scayt/skins/moono-lisa/ 356 B
778 B 61ms
59ms Stylesheet
text/css 143.204.237.71
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL

https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/plugins/scayt/skins/moono-lisa/scayt.css

Requested by

Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/ckeditor.js?qbs4lh

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

143.204.237.71 Seattle, United States, ASN16509 (AMAZON-02, US),

Reverse DNS

server-143-204-237-71.cph50.r.cloudfront.net

Software

Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /

Resource Hash

94465f8a7abf4da8295e0fa93a60eba1287830dfc41e3698fb3d20091b95d58c

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Fri, 12 Jun 2020 15:35:23 GMT
via: 1.1 1624c79cd07e6098196697a6a7907e4b.cloudfront.net (CloudFront)
x-content-type-options: nosniff
age: 7657
x-cache: Hit from cloudfront
status: 200
content-length: 356
last-modified: Fri, 12 Jun 2020 14:48:44 GMT
server: Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
etag: "164-5a7e42c7be8e5"
content-type: text/css
cache-control: max-age=10800
x-amz-cf-pop: CPH50-C1
accept-ranges: bytes
x-amz-cf-id: u3VgzXrh1-kiMDW2fg99s0NVlY17Mlp3PgTAKpNHrI_LPtEwD8RJAQ==
expires: Fri, 12 Jun 2020 18:35:23 GMT

GET
H2 200 dialog.css
www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/plugins/scayt/dialogs/ 396 B
818 B 64ms
62ms Stylesheet
text/css 143.204.237.71
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL

https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/plugins/scayt/dialogs/dialog.css

Requested by

Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/ckeditor.js?qbs4lh

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

143.204.237.71 Seattle, United States, ASN16509 (AMAZON-02, US),

Reverse DNS

server-143-204-237-71.cph50.r.cloudfront.net

Software

Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /

Resource Hash

75e0679953e586ffac55af12700c15b9a4b7d49765103c16fd8943c24162bf0c

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Fri, 12 Jun 2020 15:35:23 GMT
via: 1.1 1624c79cd07e6098196697a6a7907e4b.cloudfront.net (CloudFront)
x-content-type-options: nosniff
age: 7657
x-cache: Hit from cloudfront
status: 200
content-length: 396
last-modified: Fri, 12 Jun 2020 14:50:39 GMT
server: Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
etag: "18c-5a7e4335ab44f"
content-type: text/css
cache-control: max-age=10800
x-amz-cf-pop: CPH50-C1
accept-ranges: bytes
x-amz-cf-id: h1Qb6EL27NHSzQXbVHiDR4EMQAlPa1fIgl5ALrWXDQ8-uARPnK2hDg==
expires: Fri, 12 Jun 2020 18:35:23 GMT

GET
H2 200 tableselection.css
www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/plugins/tableselection/styles/ 1 KB
851 B 97ms
96ms Stylesheet
text/css 143.204.237.71
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL

https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/plugins/tableselection/styles/tableselection.css

Requested by

Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/ckeditor.js?qbs4lh

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

143.204.237.71 Seattle, United States, ASN16509 (AMAZON-02, US),

Reverse DNS

server-143-204-237-71.cph50.r.cloudfront.net

Software

Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /

Resource Hash

654307a47b37c66a953bb6a536cd2960a05b4e52140b2fd5e9da3a85b9a8f245

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Fri, 12 Jun 2020 15:35:23 GMT
content-encoding: gzip
x-content-type-options: nosniff
last-modified: Fri, 12 Jun 2020 13:40:29 GMT
server: Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
age: 7657
vary: Accept-Encoding
x-cache: Hit from cloudfront
content-type: text/css
status: 200
cache-control: max-age=10800
x-amz-cf-pop: CPH50-C1
x-amz-cf-id: bWoMrCmSSUCjdCUjBk06Pi5WrNgEoG3WlcpZ7rxhBG0k75-1YBtL7Q==
via: 1.1 1624c79cd07e6098196697a6a7907e4b.cloudfront.net (CloudFront)
expires: Fri, 12 Jun 2020 18:35:23 GMT

GET
H2 200 wsc.css
www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/plugins/wsc/skins/moono-lisa/ 1 KB
739 B 61ms
60ms Stylesheet
text/css 143.204.237.71
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL

https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/plugins/wsc/skins/moono-lisa/wsc.css

Requested by

Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/ckeditor.js?qbs4lh

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

143.204.237.71 Seattle, United States, ASN16509 (AMAZON-02, US),

Reverse DNS

server-143-204-237-71.cph50.r.cloudfront.net

Software

Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /

Resource Hash

a0fc7fe1ba275090a93038c52950ddb538963b336f0009f4c6efd1722717404f

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Fri, 12 Jun 2020 15:35:23 GMT
content-encoding: gzip
x-content-type-options: nosniff
last-modified: Fri, 12 Jun 2020 01:48:43 GMT
server: Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
age: 7657
vary: Accept-Encoding
x-cache: Hit from cloudfront
content-type: text/css
status: 200
cache-control: max-age=10800
x-amz-cf-pop: CPH50-C1
x-amz-cf-id: A9KMlOucLksN0-Qz_aF2sZWMTqyN8g-WA6DI-Ztqnlt7MQdL2HD1hw==
via: 1.1 1624c79cd07e6098196697a6a7907e4b.cloudfront.net (CloudFront)
expires: Fri, 12 Jun 2020 18:35:23 GMT

GET
H2 200 copyformatting.css
www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/plugins/copyformatting/styles/ 1 KB
1 KB 62ms
62ms Stylesheet
text/css 143.204.237.71
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL

https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/plugins/copyformatting/styles/copyformatting.css

Requested by

Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/ckeditor.js?qbs4lh

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

143.204.237.71 Seattle, United States, ASN16509 (AMAZON-02, US),

Reverse DNS

server-143-204-237-71.cph50.r.cloudfront.net

Software

Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /

Resource Hash

7d39b20ee96b3b32389afdc846932865a236034fbabff52b230c7cb824a0f7f0

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Fri, 12 Jun 2020 15:35:23 GMT
content-encoding: gzip
x-content-type-options: nosniff
last-modified: Fri, 12 Jun 2020 12:19:52 GMT
server: Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
age: 7657
vary: Accept-Encoding
x-cache: Hit from cloudfront
content-type: text/css
status: 200
cache-control: max-age=10800
x-amz-cf-pop: CPH50-C1
x-amz-cf-id: 27zAvt3G5X9d_B-dzGrqNWJgAip6Y1y7Nvf4hGifnqFYdaPIg5dvAA==
via: 1.1 1624c79cd07e6098196697a6a7907e4b.cloudfront.net (CloudFront)
expires: Fri, 12 Jun 2020 18:35:23 GMT

GET
H2 200 ckeditor.css
www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/css/ Frame A63D 431 B
854 B 62ms
60ms Stylesheet
text/css 143.204.237.71
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL

https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/css/ckeditor.css?qbs4lh

Requested by

Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/ckeditor.js?qbs4lh

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

143.204.237.71 Seattle, United States, ASN16509 (AMAZON-02, US),

Reverse DNS

server-143-204-237-71.cph50.r.cloudfront.net

Software

Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /

Resource Hash

f2470640af17a4eb9988eed14e1110ae897fc6314340d0df1bf050d2c8d38ea6

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Fri, 12 Jun 2020 15:35:23 GMT
via: 1.1 1624c79cd07e6098196697a6a7907e4b.cloudfront.net (CloudFront)
x-content-type-options: nosniff
age: 7657
x-cache: Hit from cloudfront
status: 200
content-length: 431
last-modified: Fri, 12 Jun 2020 01:48:43 GMT
server: Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
etag: "1af-5a7d946f0c302"
content-type: text/css
cache-control: max-age=10800
x-amz-cf-pop: CPH50-C1
accept-ranges: bytes
x-amz-cf-id: twAYJGZRacdw11ZG6LUcLZEYzMjRuxjJABwftHaNuKPInaPLLmjo-A==
expires: Fri, 12 Jun 2020 18:35:23 GMT

GET
H2 200 contents.css
www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/ Frame A63D 3 KB
2 KB 62ms
61ms Stylesheet
text/css 143.204.237.71
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL

https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/contents.css?qbs4lh

Requested by

Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/ckeditor.js?qbs4lh

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

143.204.237.71 Seattle, United States, ASN16509 (AMAZON-02, US),

Reverse DNS

server-143-204-237-71.cph50.r.cloudfront.net

Software

Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /

Resource Hash

09f958e32d737ce88d6be77af3e519297dd86db7847405c3c9f1a5a1da4a1609

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Fri, 12 Jun 2020 15:35:23 GMT
content-encoding: gzip
x-content-type-options: nosniff
last-modified: Fri, 12 Jun 2020 11:06:57 GMT
server: Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
age: 7657
vary: Accept-Encoding
x-cache: Hit from cloudfront
content-type: text/css
status: 200
cache-control: max-age=10800
x-amz-cf-pop: CPH50-C1
x-amz-cf-id: HIQupJ22sGWYCZ-cIpq114DqmG7zSkKjACg17oiwNzWFZQ--uV3UWQ==
via: 1.1 1624c79cd07e6098196697a6a7907e4b.cloudfront.net (CloudFront)
expires: Fri, 12 Jun 2020 18:35:23 GMT

GET
H2 200 copyformatting.css
www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/plugins/copyformatting/styles/ Frame A63D 1 KB
1 KB 60ms
59ms Stylesheet
text/css 143.204.237.71
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL

https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/plugins/copyformatting/styles/copyformatting.css

Requested by

Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/ckeditor.js?qbs4lh

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

143.204.237.71 Seattle, United States, ASN16509 (AMAZON-02, US),

Reverse DNS

server-143-204-237-71.cph50.r.cloudfront.net

Software

Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /

Resource Hash

7d39b20ee96b3b32389afdc846932865a236034fbabff52b230c7cb824a0f7f0

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Fri, 12 Jun 2020 15:35:23 GMT
content-encoding: gzip
x-content-type-options: nosniff
last-modified: Fri, 12 Jun 2020 12:19:52 GMT
server: Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
age: 7657
vary: Accept-Encoding
x-cache: Hit from cloudfront
content-type: text/css
status: 200
cache-control: max-age=10800
x-amz-cf-pop: CPH50-C1
x-amz-cf-id: P_nzDlm8I6zESYlFOA7NXaeqItr8J1jzP_Kx-aOgSIAFyfGuwqs_ww==
via: 1.1 1624c79cd07e6098196697a6a7907e4b.cloudfront.net (CloudFront)
expires: Fri, 12 Jun 2020 18:35:23 GMT

GET
H2 200 tableselection.css
www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/plugins/tableselection/styles/ Frame A63D 1 KB
852 B 61ms
60ms Stylesheet
text/css 143.204.237.71
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL

https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/plugins/tableselection/styles/tableselection.css

Requested by

Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/all/modules/contrib/ckeditor/ckeditor/ckeditor.js?qbs4lh

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

143.204.237.71 Seattle, United States, ASN16509 (AMAZON-02, US),

Reverse DNS

server-143-204-237-71.cph50.r.cloudfront.net

Software

Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 /

Resource Hash

654307a47b37c66a953bb6a536cd2960a05b4e52140b2fd5e9da3a85b9a8f245

Security Headers

Name	Value
X-Content-Type-Options	nosniff

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Fri, 12 Jun 2020 15:35:23 GMT
content-encoding: gzip
x-content-type-options: nosniff
last-modified: Fri, 12 Jun 2020 13:40:29 GMT
server: Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
age: 7657
vary: Accept-Encoding
x-cache: Hit from cloudfront
content-type: text/css
status: 200
cache-control: max-age=10800
x-amz-cf-pop: CPH50-C1
x-amz-cf-id: KfGyA7tJOU3G46QUOdDkFH3x3RSWXKQi4b8_AQ0b6VaPqeAzvdgJIw==
via: 1.1 1624c79cd07e6098196697a6a7907e4b.cloudfront.net (CloudFront)
expires: Fri, 12 Jun 2020 18:35:23 GMT

GET
H2 200 pinit.js Show response
assets.pinterest.com/js/ 361 B
310 B 23ms
22ms Script
application/javascript 2606:4700::6812:fb0
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL: https://assets.pinterest.com/js/pinit.js?_=1591983779773
Requested by: Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/cphi.com/files/js/js__PiZuK2o4XAnDCWOhogiGF01gyHzeu7QxvOyfTe-YyM.js
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700::6812:fb0 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software: cloudflare /
Resource Hash: 3faadebc89cdb21d11634a032816f152462d1cb8903eb21d0642501fcad065de

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Fri, 12 Jun 2020 17:43:00 GMT
content-encoding: br
x-cdn: cloudflare
status: 200
etag: W/"82bfd941d2c9b3b9e0650a27c9d11737"
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary: Accept-Encoding
access-control-allow-methods: GET
content-type: application/javascript; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: x-cdn
cache-control: max-age=300
cf-ray: 5a255f26caa6175a-FRA
cf-request-id: 034b39cc3c0000175a3a9f3200000001
server: cloudflare

GET
H2 200 get_poll Show response
www.globalpharmainsights.com/ 4 KB
1 KB 809ms
809ms XHR
application/json 143.204.237.71
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL

https://www.globalpharmainsights.com/get_poll

Requested by

Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/cphi.com/files/js/js__PiZuK2o4XAnDCWOhogiGF01gyHzeu7QxvOyfTe-YyM.js

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

143.204.237.71 Seattle, United States, ASN16509 (AMAZON-02, US),

Reverse DNS

server-143-204-237-71.cph50.r.cloudfront.net

Software

Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 / PHP/7.2.31

Resource Hash

18361c8213cc449c5042b6ca7b0bfb0b3f158d810c5de824ada72d8855509b6e

Security Headers

Name	Value
X-Content-Type-Options	nosniff, nosniff
X-Frame-Options	SAMEORIGIN

Request headers

Accept: */*
Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
X-Requested-With: XMLHttpRequest
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Fri, 12 Jun 2020 17:43:01 GMT
content-encoding: gzip
x-content-type-options: nosniff, nosniff
x-amz-cf-pop: CPH50-C1
x-powered-by: PHP/7.2.31
x-cache: Miss from cloudfront
status: 200
x-ua-compatible: IE=edge,chrome=1
server: Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
x-frame-options: SAMEORIGIN
vary: Accept-Encoding,Cookie
content-language: en
via: 1.1 1624c79cd07e6098196697a6a7907e4b.cloudfront.net (CloudFront)
cache-control: no-cache, must-revalidate
x-drupal-cache: MISS
content-type: application/json
x-amz-cf-id: tl59YQn3V8i6pT09g-sjcWml2AbHsyFgLJaSVdCJH9zOG5HqmJeNPA==
expires: Sun, 19 Nov 1978 05:00:00 GMT

GET
H2 200 pinit.js Show response
assets.pinterest.com/js/ 361 B
430 B 63ms
62ms Script
application/javascript 2606:4700::6812:fb0
CLOUDFLARENET

General

Check archive.org

Show headers Download Go to

Full URL: https://assets.pinterest.com/js/pinit.js?_=1591983779774
Requested by: Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/cphi.com/files/js/js__PiZuK2o4XAnDCWOhogiGF01gyHzeu7QxvOyfTe-YyM.js
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 2606:4700::6812:fb0 , United States, ASN13335 (CLOUDFLARENET, US),
Reverse DNS
Software: cloudflare /
Resource Hash: 3faadebc89cdb21d11634a032816f152462d1cb8903eb21d0642501fcad065de

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Fri, 12 Jun 2020 17:43:01 GMT
content-encoding: br
x-cdn: cloudflare
status: 200
etag: W/"82bfd941d2c9b3b9e0650a27c9d11737"
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
vary: Accept-Encoding
access-control-allow-methods: GET
content-type: application/javascript; charset=utf-8
access-control-allow-origin: *
access-control-expose-headers: x-cdn
cache-control: max-age=300
cf-ray: 5a255f289f2c175a-FRA
cf-request-id: 034b39cd610000175a3aa06200000001
server: cloudflare

GET
H2 200 get_poll Show response
www.globalpharmainsights.com/ 4 KB
1 KB 704ms
704ms XHR
application/json 143.204.237.71
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL

https://www.globalpharmainsights.com/get_poll

Requested by

Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/sites/cphi.com/files/js/js__PiZuK2o4XAnDCWOhogiGF01gyHzeu7QxvOyfTe-YyM.js

Protocol

Security

TLS 1.2, ECDHE_RSA, AES_128_GCM

Server

143.204.237.71 Seattle, United States, ASN16509 (AMAZON-02, US),

Reverse DNS

server-143-204-237-71.cph50.r.cloudfront.net

Software

Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31 / PHP/7.2.31

Resource Hash

9fbac5db402ffc1deda2ef4777f0728d4e7b5f0650b5a52a246efea8397cabb8

Security Headers

Name	Value
X-Content-Type-Options	nosniff, nosniff
X-Frame-Options	SAMEORIGIN

Request headers

Accept: */*
Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
X-Requested-With: XMLHttpRequest
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Fri, 12 Jun 2020 17:43:01 GMT
content-encoding: gzip
x-content-type-options: nosniff, nosniff
x-amz-cf-pop: CPH50-C1
x-powered-by: PHP/7.2.31
x-cache: Miss from cloudfront
status: 200
x-ua-compatible: IE=edge,chrome=1
server: Apache/2.4.6 (CentOS) OpenSSL/1.0.2k-fips PHP/7.2.31
x-frame-options: SAMEORIGIN
vary: Accept-Encoding,Cookie
content-language: en
via: 1.1 1624c79cd07e6098196697a6a7907e4b.cloudfront.net (CloudFront)
cache-control: no-cache, must-revalidate
x-drupal-cache: MISS
content-type: application/json
x-amz-cf-id: 8XLNchupSpkDf0RcHAT3iSOqlbMllIlnVYn6EtAWgT3OylGU_LYNkA==
expires: Sun, 19 Nov 1978 05:00:00 GMT

GET
H/1.1

200
OK

index.php Show response
a.dpmsrv.com/dpmpxl/
Redirect Chain

https://cm.g.doubleclick.net/pixel?google_nid=datapoint_dmp&google_cm&ap_id=2301816357575935815&pixelIndex=0&_=1591983780666
https://a.dpmsrv.com/dpmpxl/index.php?q=dfp&ap_id=2301816357575935815&pixelIndex=0&_=1591983780666&google_gid=CAESEDoi2KiuGyoCBm8JE-ozslc&google_cver=1

0
597 B

101ms
101ms

Script
text/javascript

34.192.142.95
AMAZON-AES

General

Check archive.org

Show headers Download Go to

Full URL: https://a.dpmsrv.com/dpmpxl/index.php?q=dfp&ap_id=2301816357575935815&pixelIndex=0&_=1591983780666&google_gid=CAESEDoi2KiuGyoCBm8JE-ozslc&google_cver=1
Requested by: Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 34.192.142.95 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS: ec2-34-192-142-95.compute-1.amazonaws.com
Software: /
Resource Hash: e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Pragma: no-cache
Access-Control-Max-Age: 10
Access-Control-Allow-Methods: GET, POST, PUT, DELETE, OPTIONS
P3P: CP="IDC DSP COR ADM DEVi TAIi PSA PSD IVAi IVDi CONi HIS OUR IND CNT"
Access-Control-Allow-Origin: *
Cache-Control: no-cache, no-store, must-revalidate
Connection: keep-alive
Content-Type: text/javascript
Access-Control-Allow-Headers: content-type, accept
Content-Length: 0
Expires: 0

Redirect headers

pragma: no-cache
date: Fri, 12 Jun 2020 17:43:01 GMT
server: HTTP server (unknown)
status: 302
p3p: policyref="https://googleads.g.doubleclick.net/pagead/gcn_p3p_.xml", CP="CURa ADMa DEVa TAIo PSAo PSDo OUR IND UNI PUR INT DEM STA PRE COM NAV OTC NOI DSP COR"
location: https://a.dpmsrv.com/dpmpxl/index.php?q=dfp&ap_id=2301816357575935815&pixelIndex=0&_=1591983780666&google_gid=CAESEDoi2KiuGyoCBm8JE-ozslc&google_cver=1
cache-control: no-cache, must-revalidate
content-type: text/html; charset=UTF-8
alt-svc: h3-27="googleads.g.doubleclick.net:443"; ma=2592000,h3-27=":443"; ma=2592000,h3-25="googleads.g.doubleclick.net:443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050="googleads.g.doubleclick.net:443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length: 368
x-xss-protection: 0
expires: Fri, 01 Jan 1990 00:00:00 GMT

GET
H2 204 423396.gif
idsync.rlcdn.com/ 0
59 B 144ms
115ms Image
text/plain 35.241.8.149
GOOGLE

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://idsync.rlcdn.com/423396.gif?partner_uid=2301816357575935815
Requested by: Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol: H2
Security: TLS 1.3, , AES_128_GCM
Server: 35.241.8.149 , Ascension Island, ASN15169 (GOOGLE, US),
Reverse DNS: 149.8.241.35.bc.googleusercontent.com
Software: /
Resource Hash: e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

status: 204
date: Fri, 12 Jun 2020 17:43:01 GMT
via: 1.1 google
alt-svc: clear

GET
H2 200 sodar Show response
pagead2.googlesyndication.com/getconfig/ 7 KB
5 KB 19ms
19ms XHR
application/json 2a00:1450:4001:800::2002
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://pagead2.googlesyndication.com/getconfig/sodar?sv=200&tid=gpt&tv=2020060803&st=env

Requested by

Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060803.js?21066388

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:800::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

cafe /

Resource Hash

aa4d4ddca8e5f9caaf72df9d49cfceebe2a6cf66fe18c13428d2e1d0332ce16d

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

timing-allow-origin: *
date: Fri, 12 Jun 2020 17:43:01 GMT
content-encoding: gzip
x-content-type-options: nosniff
server: cafe
status: 200
p3p: policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
access-control-allow-origin: *
cache-control: private
content-disposition: attachment; filename="f.txt"
content-type: application/json; charset=UTF-8
alt-svc: h3-27="googleads.g.doubleclick.net:443"; ma=2592000,h3-27=":443"; ma=2592000,h3-25="googleads.g.doubleclick.net:443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050="googleads.g.doubleclick.net:443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length: 5541
x-xss-protection: 0

GET
H2

200

rt=ifr
bcp.crwdcntrl.net/5/ct=y/c=7499/rand=349806432/pv=y/int=%23OpR%2366886%23globalpharmainsights%20%3A%20Site%20Section%20%3A%20manufacturing-outsourcing/int=%23OpR%2366887%23globalpharmainsights%20%3... Frame D275
Redirect Chain

https://bcp.crwdcntrl.net/5/c=7499/rand=349806432/pv=y/int=%23OpR%2366886%23globalpharmainsights%20%3A%20Site%20Section%20%3A%20manufacturing-outsourcing/int=%23OpR%2366887%23globalpharmainsights%2...
https://bcp.crwdcntrl.net/5/ct=y/c=7499/rand=349806432/pv=y/int=%23OpR%2366886%23globalpharmainsights%20%3A%20Site%20Section%20%3A%20manufacturing-outsourcing/int=%23OpR%2366887%23globalpharmainsig...

0
0

45ms
45ms

Document
text/html

99.80.128.92
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://bcp.crwdcntrl.net/5/ct=y/c=7499/rand=349806432/pv=y/int=%23OpR%2366886%23globalpharmainsights%20%3A%20Site%20Section%20%3A%20manufacturing-outsourcing/int=%23OpR%2366887%23globalpharmainsights%20%3A%20Site%20Section%20%3A%20manufacturing-outsourcing%20%3A%20gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir/int=%23OpR%2366985%23globalpharmainsights%20%3A%20Total%20Site%20Traffic/rb=%7B%22article_category%22%3A%5B%22Home%22%2C%22Sectors%22%2C%22Manufacturing%20%26%20Outsourcing%22%5D%7D/rt=ifr
Requested by: Host: tags.crwdcntrl.net
URL: https://tags.crwdcntrl.net/c/7499/cc_af.js
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 99.80.128.92 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS: ec2-99-80-128-92.eu-west-1.compute.amazonaws.com
Software: /
Resource Hash

Request headers

:method: GET
:authority: bcp.crwdcntrl.net
:scheme: https
:path: /5/ct=y/c=7499/rand=349806432/pv=y/int=%23OpR%2366886%23globalpharmainsights%20%3A%20Site%20Section%20%3A%20manufacturing-outsourcing/int=%23OpR%2366887%23globalpharmainsights%20%3A%20Site%20Section%20%3A%20manufacturing-outsourcing%20%3A%20gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir/int=%23OpR%2366985%23globalpharmainsights%20%3A%20Total%20Site%20Traffic/rb=%7B%22article_category%22%3A%5B%22Home%22%2C%22Sectors%22%2C%22Manufacturing%20%26%20Outsourcing%22%5D%7D/rt=ifr
pragma: no-cache
cache-control: no-cache
upgrade-insecure-requests: 1
user-agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept: text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site: cross-site
sec-fetch-mode: navigate
sec-fetch-dest: iframe
referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
accept-encoding: gzip, deflate, br
accept-language: en-US
cookie: _cc_cc=ctst
Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL

Response headers

status: 200
date: Fri, 12 Jun 2020 17:43:01 GMT
content-type: text/html;charset=UTF-8
content-length: 163
p3p: CP=NOI DSP COR NID PSAa PSDa OUR UNI COM NAV
cache-control: no-cache
pragma: no-cache
expires: 0
x-server: 10.45.28.135
set-cookie: _cc_dc=1;Path=/;Domain=crwdcntrl.net;Expires=Tue, 09-Mar-2021 17:03:00 GMT;SameSite=None;Secure _cc_id=f0cc0aa62485e07238fcc529311904d1;Path=/;Domain=crwdcntrl.net;Expires=Tue, 09-Mar-2021 17:03:00 GMT;SameSite=None;Secure _cc_cc="ACZ4nGNQSDNITjZITDQzMrEwTTUwNzK2SEtONjWyNDY0tDQwSTFkAIK4x%2FuWMiAAAFjaCxg%3D";Version=1;Path=/;Domain=crwdcntrl.net;Expires=Tue, 09-Mar-2021 17:03:00 GMT;Max-Age=23328000;SameSite=None;Secure _cc_aud="ABR4nGNgYGCIe7xvKQMcAAAgvAKl";Version=1;Path=/;Domain=crwdcntrl.net;Expires=Tue, 09-Mar-2021 17:03:00 GMT;Max-Age=23328000;SameSite=None;Secure
access-control-allow-origin: *

Redirect headers

status: 302
date: Fri, 12 Jun 2020 17:43:01 GMT
content-length: 0
location: https://bcp.crwdcntrl.net/5/ct=y/c=7499/rand=349806432/pv=y/int=%23OpR%2366886%23globalpharmainsights%20%3A%20Site%20Section%20%3A%20manufacturing-outsourcing/int=%23OpR%2366887%23globalpharmainsights%20%3A%20Site%20Section%20%3A%20manufacturing-outsourcing%20%3A%20gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir/int=%23OpR%2366985%23globalpharmainsights%20%3A%20Total%20Site%20Traffic/rb=%7B%22article_category%22%3A%5B%22Home%22%2C%22Sectors%22%2C%22Manufacturing%20%26%20Outsourcing%22%5D%7D/rt=ifr
p3p: CP=NOI DSP COR NID PSAa PSDa OUR UNI COM NAV
cache-control: no-cache
pragma: no-cache
expires: 0
x-server: 10.45.23.245
set-cookie: _cc_cc=ctst;Path=/;Domain=crwdcntrl.net;SameSite=None;Secure

GET
H2 200 sodar2.js Show response
tpc.googlesyndication.com/sodar/ 14 KB
6 KB 39ms
39ms Script
text/javascript 2a00:1450:4001:802::2001
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://tpc.googlesyndication.com/sodar/sodar2.js

Requested by

Host: securepubads.g.doubleclick.net
URL: https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020060803.js?21066388

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:802::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

08f50e9e70388c99977ca13b6af3a49f8f48c83e79230d51ea72a56c0735bd0c

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Fri, 12 Jun 2020 17:43:01 GMT
content-encoding: gzip
x-content-type-options: nosniff
server: sffe
etag: "1591403518460474"
vary: Accept-Encoding
content-type: text/javascript
status: 200
cache-control: private, max-age=3000
accept-ranges: bytes
alt-svc: h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"
content-length: 5540
x-xss-protection: 0
expires: Fri, 12 Jun 2020 17:43:01 GMT

GET
H/1.1 200
OK roundtrip.js Show response
s.adroll.com/j/ 35 KB
12 KB 81ms
26ms Script
text/javascript 72.247.224.172
AKAMAI-AS

General

Check archive.org

Show headers Download Go to

Full URL: https://s.adroll.com/j/roundtrip.js
Requested by: Host: www.globalpharmainsights.com
URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_256_GCM
Server: 72.247.224.172 , United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS: a72-247-224-172.deploy.static.akamaitechnologies.com
Software: AmazonS3 /
Resource Hash: 0b5b4a374d6dfb06f111c288ba9042d5c4e1305b3da110bea8116f3090bce2e5

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id: ehJgGpzGzAbK8GzMvrCmhGB9QIvRjX3O
Content-Encoding: gzip
ETag: "493863a9069eb4663881ed7b590bc370"
x-amz-request-id: 8393F29BD54D87DE
x-amz-server-side-encryption: AES256
Connection: keep-alive
Vary: Accept-Encoding
Content-Length: 11133
x-amz-id-2: miMLhnoXTzMbkpI/Ji2w3CyUXZw4pZXEFmJZKsS61LZ0pZLqpMoZS7tKKnTP2qGfg1jGmaqQFew=
Last-Modified: Tue, 02 Jun 2020 21:58:20 GMT
Server: AmazonS3
Date: Fri, 12 Jun 2020 17:43:01 GMT
Access-Control-Max-Age: 600
Access-Control-Allow-Methods: GET
Content-Type: text/javascript
Access-Control-Allow-Origin: *
Cache-Control: max-age=3600, must-revalidate
Access-Control-Allow-Credentials: false
Accept-Ranges: bytes
Access-Control-Allow-Headers: *

GET
H2 200 runner.html
tpc.googlesyndication.com/sodar/sodar2/210/ Frame 333A 0
0 6ms
6ms Document
text/html 2a00:1450:4001:802::2001
GOOGLE

General

Check archive.org

Show headers Download Go to

Full URL

https://tpc.googlesyndication.com/sodar/sodar2/210/runner.html

Requested by

Host: tpc.googlesyndication.com
URL: https://tpc.googlesyndication.com/sodar/sodar2.js

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:802::2001 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

sffe /

Resource Hash

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

:method: GET
:authority: tpc.googlesyndication.com
:scheme: https
:path: /sodar/sodar2/210/runner.html
pragma: no-cache
cache-control: no-cache
upgrade-insecure-requests: 1
user-agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
accept: text/html,application/xhtml+xml,application/xml;q=0.9,image/webp,image/apng,*/*;q=0.8,application/signed-exchange;v=b3;q=0.9
sec-fetch-site: cross-site
sec-fetch-mode: navigate
sec-fetch-dest: iframe
referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
accept-encoding: gzip, deflate, br
accept-language: en-US
Upgrade-Insecure-Requests: 1
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36
Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL

Response headers

status: 200
accept-ranges: bytes
vary: Accept-Encoding
content-encoding: gzip
content-type: text/html
content-length: 4590
date: Fri, 12 Jun 2020 17:22:18 GMT
expires: Sat, 12 Jun 2021 17:22:18 GMT
last-modified: Wed, 26 Feb 2020 19:47:50 GMT
x-content-type-options: nosniff
server: sffe
x-xss-protection: 0
cache-control: public, max-age=31536000
age: 1243
alt-svc: h3-27=":443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"

GET
H2 200 /
log.pinterest.com/ 0
437 B 173ms
126ms Image
text/plain 151.101.12.84
FASTLY

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://log.pinterest.com/?type=pidget&guid=3s1garcREvRL&tv=2020060301&event=init&sub=www&button_count=1&follow_count=0&pin_count=0&profile_count=0&board_count=0&section_count=0&lang=en&nvl=en-US&via=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 151.101.12.84 Frankfurt am Main, Germany, ASN54113 (FASTLY, US),
Reverse DNS
Software: envoy /
Resource Hash: e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

date: Fri, 12 Jun 2020 17:43:01 GMT
via: 1.1 varnish
server: envoy
x-timer: S1591983782.627662,VS0,VE104
x-served-by: cache-fra19156-FRA
x-cache: MISS
status: 200
x-envoy-upstream-service-time: 13
x-pinterest-rid: 1734916158129257
accept-ranges: bytes
content-length: 0
x-cache-hits: 0

GET
H2 200 pixel.gif
px.moatads.com/ 43 B
260 B 47ms
46ms Image
image/gif 72.247.226.64
AKAMAI-AS

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://px.moatads.com/pixel.gif?e=37&q=0&hp=1&wf=1&vb=11&kq=1&lo=0&uk=null&pk=1&wk=1&rk=1&tk=0&ak=-&i=PENTONMEDIA1&ud=undefined&qn=%604%7BZEYwoqI%24%5BK%2BdLLU)%2CMm~t8!b.%5BMhS%3A15.sn_003etW6~P6Jn)s)wC%24GL3jX%7BQqDOJ%3Eoy)G3p%2FhFjrR8CL6k%24)m3*%5B%605*mF%40%23b%3DhjdbEW%3C7bNC%3ElaKc%2C%26WLRGt%269RHrOCFxBoocF)uhFAkD%3Dv%3Cy%5Dv%5BLy*hgMcpk%3FqFm%5Dm%22%2Bx%7Co%3Ee%7CwR3yC%7CQ%5Elv%3Ch%2CeI8!A2QnbjPSI.%24ki)sV~1HmDkx2KD5pf5%5BG%5BZFZ8R6tbK0pH%23bU%24(9N%2CNJJ)%2CW%2FKo7FY&th=4007238046&tf=nMzjG---CSa7H-fUfHv-j7VIQD-xFQTS-nMzjG-&vi=111111&qp=00000&is=BBBBB2IUEY4vGl2BBCBBtUTBBRmsqbKW8BsrBu0rCFE48CRBeeBS2hWTMQSQeQBBn2soYggyUig0CBlWZ0uBBCCCCCCOgRBBiOfnE6Skg7OxBb8MxOtJYHCBdm5kBhBBC9Y8oBXckXBR76iUUsJBCBBBBBBBBBWBSqj3BBBZeGV2BBBCMciUBBBjgEBBBBBB94UMgTdJMtEcpMBBBQBBBniOccypBsrB41kNBBBBBBBBBBBBBhcjG6BBJM2L4Bk8BwCBQmIoRBBCzBz1BBCTCyBBrbjBC4ehueB57NG9aJfR0BqEKiuwBBBB&iv=8&qt=0&gz=0&hh=0&hn=0&tw=&qc=0&qd=0&qf=1600&qe=1200&qh=1600&qg=1200&qm=-120&qa=1600&qb=1200&qi=1600&qj=1200&to=00&po=1-0020002000002120&vy=&ql=&qo=0&qr=0&vf=1&vg=100&bq=0&g=1&hq=0&hs=0&hu=0&hr=0&ht=0&dnt=0&h=250&w=300&fy=0&gp=0&zGSRC=1&gu=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&id=1&ii=4&f=0&j=&t=1591983780493&de=333246576571&cu=1591983780493&m=1091&ar=c34ad4f880-clean&iw=821c7c5&cb=0&ym=0&rd=1&ll=2&lm=0&ln=1&r=0&dl=0&dn=0&gh=1&xx=undefined%3A875484570224&td=1&lk=undefined&lb=3004&le=1&gm=1&io=1&ch=0&vv=1&vw=1%3A3%3A0&vp=100&vx=100%3A100%3A-&pe=1%3A1246%3A1246%3A0%3A1394&as=1&ag=1056&an=24&gi=1&gf=1056&gg=24&ix=1056&ic=1056&ez=1&ck=1056&kw=878&aj=1&pg=100&pf=100&ib=0&cc=1&bw=1056&bx=24&ci=1056&jz=878&dj=1&aa=0&ad=949&cn=0&gk=949&gl=0&ik=949&cq=1&im=1&in=1&pd=1&nb=1&em=0&en=0&st=1&su=1&of=1&oz=1&oe=1%3A1%3A0%3Anull%3A-1%3Anull%3A-1%3Anull%3A-1&bu=878&cd=48&ah=878&am=48&rf=0&re=1&ft=949&fv=0&fw=949&wb=1&cl=0&at=0&d=4874126281%3A2696286467%3A5374575282%3A138311932788&bo=21946295198&bp=21988232143&bd=300_1_lft&zMoatPS=300_1_lft&gw=pentonmedia53440730609&zMoatOrigSlicer1=21946295198&zMoatOrigSlicer2=21988232143&zMoatDomain=globalpharmainsights.com&zMoatSubdomain=globalpharmainsights.com&dfp=0%2C1&la=21988232143&hv=Standard%20Image%20Ad%20finding%20&ab=1&ac=1&fd=1&kt=strict&it=500&fz=1&oq=1&ot=ff&zMoatJS=3%3A-&ti=0&ih=1&tc=0&fs=181543&na=1415223732&cs=0
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 72.247.226.64 , United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS: a72-247-226-64.deploy.static.akamaitechnologies.com
Software: AkamaiNetStorage /
Resource Hash: cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma: no-cache
date: Fri, 12 Jun 2020 17:43:01 GMT
last-modified: Fri, 20 May 2016 15:16:00 GMT
server: AkamaiNetStorage
etag: "ad4b0f606e0f8465bc4c4c170b37e1a3:1463757360"
content-type: image/gif
status: 200
cache-control: max-age=0, no-cache, no-store
accept-ranges: bytes
content-length: 43
expires: Fri, 12 Jun 2020 17:43:01 GMT

GET
H2 200 activeview
pagead2.googlesyndication.com/pcs/ Frame 479B 42 B
107 B 15ms
14ms Image
image/gif 2a00:1450:4001:800::2002
GOOGLE

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://pagead2.googlesyndication.com/pcs/activeview?xai=AKAOjsvvSfcUjO27PwHvnu0Mefgz28bWuF_Uxpu4qeijJFsG1rjHSoGvifqSPkEy3NKg8dFW4FyVaKzPs487J41sfKq1bSxz8CWEZ4UdAzWZsk8&sig=Cg0ArKJSzC_puHuosPONEAE&adk=913738584&tt=-1&bs=1600%2C1200&mtos=1052,1052,1052,1052,1052&tos=1052,0,0,0,0&p=428,219,678,519&mcvt=1052&rs=0&ht=0&tfs=7&tls=1158&mc=1&lte=1&bas=0&bac=0&met=mue&avms=nio&exg=1&md=2&btr=0&lm=2&rst=1591983780316&dlt&rpt=280&isd=0&msd=0&ext&xdi=0&ps=1600%2C3004&ss=1600%2C1200&pt=-1&bin=4&deb=1-0-0-11-5-10-10-0-0-0&tvt=1154&is=300%2C250&iframe_loc=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSerie&r=v&id=osdim&vs=4&uc=11&upc=1&tgt=DIV&cl=1&cec=1&wf=0&cac=1&cd=300x250&itpl=3&v=20200610

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:800::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

cafe /

Resource Hash

ef1955ae757c8b966c83248350331bd3a30f658ced11f387f8ebf05ab3368629

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma: no-cache
date: Fri, 12 Jun 2020 17:43:01 GMT
x-content-type-options: nosniff
server: cafe
timing-allow-origin: *
status: 200
p3p: policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
access-control-allow-origin: *
cache-control: no-cache, must-revalidate
content-type: image/gif
alt-svc: h3-27="googleads.g.doubleclick.net:443"; ma=2592000,h3-27=":443"; ma=2592000,h3-25="googleads.g.doubleclick.net:443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050="googleads.g.doubleclick.net:443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length: 42
x-xss-protection: 0
expires: Fri, 01 Jan 1990 00:00:00 GMT

GET
H/1.1

200
OK

index.js Show response
s.adroll.com/j/exp/
Redirect Chain

https://s.adroll.com/j/exp/IXZC4QKE6BDSVNBBOX54JQ/index.js
https://s.adroll.com/j/exp/index.js

28 B
747 B

38ms
37ms

Script
application/javascript

72.247.224.172
AKAMAI-AS

General

Check archive.org

Show headers Download Go to

Full URL: https://s.adroll.com/j/exp/index.js
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_256_GCM
Server: 72.247.224.172 , United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS: a72-247-224-172.deploy.static.akamaitechnologies.com
Software: AmazonS3 /
Resource Hash: f59e5f34a941183aacaed25322ac0856628493c2cfd936ded3fddc0a49510e52

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id: MvaZYW7xXR9M9hUcWDgUVAWVyUlL21ST
Content-Encoding: gzip
ETag: "5816cced8568d223aa09d889f300692b"
x-amz-request-id: 3F87A35F219B4CEA
x-amz-server-side-encryption: AES256
Connection: keep-alive
Vary: Accept-Encoding
Content-Length: 48
x-amz-id-2: j0gRIfdWAmMono3re8RAgQhTHKTcGReQALszGck6lZDA6y+qanswCu7Zc4mE9aslf8juJNaOUyU=
Last-Modified: Fri, 05 Jun 2020 15:32:25 GMT
Server: AmazonS3
Date: Fri, 12 Jun 2020 17:43:01 GMT
Access-Control-Max-Age: 600
Access-Control-Allow-Methods: GET
Content-Type: application/javascript
Access-Control-Allow-Origin: *
Access-Control-Allow-Credentials: false
Accept-Ranges: bytes
Access-Control-Allow-Headers: *

Redirect headers

Date: Fri, 12 Jun 2020 17:43:01 GMT
Server: AkamaiGHost
Location: https://s.adroll.com/j/exp/index.js
Access-Control-Max-Age: 600
Access-Control-Allow-Methods: GET
Access-Control-Allow-Origin: *
Access-Control-Allow-Credentials: false
Connection: keep-alive
Access-Control-Allow-Headers: *
Content-Length: 0

GET
H/1.1 200
OK index.js Show response
s.adroll.com/j/pre/IXZC4QKE6BDSVNBBOX54JQ/3BQ2N447KNEODAIZTDTY2B/ 0
773 B 72ms
26ms Script
text/javascript 72.247.224.172
AKAMAI-AS

General

Check archive.org

Show headers Download Go to

Full URL: https://s.adroll.com/j/pre/IXZC4QKE6BDSVNBBOX54JQ/3BQ2N447KNEODAIZTDTY2B/index.js
Requested by: Host: s.adroll.com
URL: https://s.adroll.com/j/roundtrip.js
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_256_GCM
Server: 72.247.224.172 , United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS: a72-247-224-172.deploy.static.akamaitechnologies.com
Software: AmazonS3 /
Resource Hash: e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

x-amz-version-id: TFDLRSmk.5uUkVOXm8IDqIof4oJzquU5
Content-Encoding: gzip
ETag: "d41d8cd98f00b204e9800998ecf8427e"
x-amz-request-id: 78AB0DB26BD24A94
x-amz-server-side-encryption: AES256
Connection: keep-alive
Vary: Accept-Encoding
Content-Length: 20
x-amz-id-2: 3Hmfe85xKph4wbt2ZtYW/SW+HWeUGNjHGDzXJS1waDDfHrZu22OxQCDKDGl+bq3Ytb3s4A8RCGI=
Last-Modified: Thu, 11 Jun 2020 19:57:43 GMT
Server: AmazonS3
Date: Fri, 12 Jun 2020 17:43:01 GMT
Access-Control-Max-Age: 600
Access-Control-Allow-Methods: GET
Content-Type: text/javascript; charset=utf-8
Access-Control-Allow-Origin: *
Cache-Control: max-age=3600, must-revalidate
Access-Control-Allow-Credentials: false
Accept-Ranges: bytes
Access-Control-Allow-Headers: *

GET
H2

200

/ Show response
d.adroll.com/consent/check/IXZC4QKE6BDSVNBBOX54JQ/
Redirect Chain

https://d.adroll.mgr.consensu.org/consent/iabcheck/IXZC4QKE6BDSVNBBOX54JQ?_s=8ee5f25dbb67299de2a6efc265a5b475&_b=2
https://d.adroll.com/consent/check/IXZC4QKE6BDSVNBBOX54JQ/?_s=8ee5f25dbb67299de2a6efc265a5b475&_b=2

132 B
224 B

91ms
31ms

Script
application/javascript

54.171.23.184
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://d.adroll.com/consent/check/IXZC4QKE6BDSVNBBOX54JQ/?_s=8ee5f25dbb67299de2a6efc265a5b475&_b=2
Protocol: H2
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 54.171.23.184 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS: ec2-54-171-23-184.eu-west-1.compute.amazonaws.com
Software: nginx/1.16.1 /
Resource Hash: 9d87422caa700b6e060c7d91101c111843c773534fd464d8bad2eb5511fd8bc6

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

status: 200
date: Fri, 12 Jun 2020 17:43:01 GMT
server: nginx/1.16.1
content-length: 132
content-type: application/javascript

Redirect headers

status: 302
date: Fri, 12 Jun 2020 17:43:01 GMT
server: nginx/1.16.1
content-length: 105
location: https://d.adroll.com/consent/check/IXZC4QKE6BDSVNBBOX54JQ/?_s=8ee5f25dbb67299de2a6efc265a5b475&_b=2

GET
H2 204 gen_204
pagead2.googlesyndication.com/pagead/ 0
55 B 15ms
14ms Image
image/gif 2a00:1450:4001:800::2002
GOOGLE

General

Check archive.org

Show headers Download Go to Show image

Full URL

https://pagead2.googlesyndication.com/pagead/gen_204?id=sodar2&v=210&t=2&li=gpt_2020060803&jk=452895018370859&bg=!z8ylzNRYTVOMSXOQ32kCAAAAM1IAAAAKmQGE9QD0xHO340Ksy7UxOZrKGeLY_0qLrjehgLdz9qoH9mV-Ws1qzo4t4GnS2hIkgt_eTukH-ZRhnuRTN3aQtqL-uvjCHsTFfe2AbZhljYpeg-QsgZu1grKk4ME3JBJnLKW_97iLB00_MXQS-IIoLCr4W_ZegvOOePNxpawsF69yZihP5IIltzCzqcIJtq2d4lB3MmQZSSFHJmC7TVTr_doXTMlF0e1sBVx8F6FZ091hrlNPDAL9BPoE7PvqZLqGvK2DkGl5UOtFaup7wvTnJ6NLKELOKUbW0CxRy4OXRMAXi2KJwCC9M_qvho0Jnt9M-728XJr0u3ghP0D9KVzmrjM06EUFeE0Ygs-xocO1SQokHkKLCFdthPnXT8IXBVYI-pjh-IYQ5DTvw5lXGY1wK_l4B4vpxyZp6kbyCjRO6N5EDqn8TWFrWFgqpZYbfsp4hEim4b9LJeoOsQjFGJk4bG2qLCNtRk42szvHgsi7W5sDH26tiv9GMzvC5PizOG35wNgEkwFkLA

Protocol

Security

TLS 1.3, , AES_128_GCM

Server

2a00:1450:4001:800::2002 Frankfurt am Main, Germany, ASN15169 (GOOGLE, US),

Reverse DNS

Software

cafe /

Resource Hash

e3b0c44298fc1c149afbf4c8996fb92427ae41e4649b934ca495991b7852b855

Security Headers

Name	Value
X-Content-Type-Options	nosniff
X-Xss-Protection	0

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma: no-cache
date: Fri, 12 Jun 2020 17:43:01 GMT
x-content-type-options: nosniff
server: cafe
timing-allow-origin: *
p3p: policyref="https://www.googleadservices.com/pagead/p3p.xml", CP="NOI DEV PSA PSD IVA IVD OTP OUR OTR IND OTC"
status: 204
cache-control: no-cache, must-revalidate
content-type: image/gif
alt-svc: h3-27="googleads.g.doubleclick.net:443"; ma=2592000,h3-27=":443"; ma=2592000,h3-25="googleads.g.doubleclick.net:443"; ma=2592000,h3-25=":443"; ma=2592000,h3-T050="googleads.g.doubleclick.net:443"; ma=2592000,h3-T050=":443"; ma=2592000,h3-Q050="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q049="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q049=":443"; ma=2592000,h3-Q048="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q048=":443"; ma=2592000,h3-Q046="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043="googleads.g.doubleclick.net:443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic="googleads.g.doubleclick.net:443"; ma=2592000; v="46,43",quic=":443"; ma=2592000; v="46,43"
content-length: 0
x-xss-protection: 0
expires: Fri, 01 Jan 1990 00:00:00 GMT

GET
H2 200 pixel.gif
px.moatads.com/ 43 B
260 B 29ms
29ms Image
image/gif 72.247.226.64
AKAMAI-AS

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://px.moatads.com/pixel.gif?e=5&q=0&hp=1&wf=1&vb=11&kq=1&lo=0&uk=null&pk=1&wk=1&rk=1&tk=0&ak=-&i=PENTONMEDIA1&ud=undefined&qn=%604%7BZEYwoqI%24%5BK%2BdLLU)%2CMm~t8!b.%5BMhS%3A15.sn_003etW6~P6Jn)s)wC%24GL3jX%7BQqDOJ%3Eoy)G3p%2FhFjrR8CL6k%24)m3*%5B%605*mF%40%23b%3DhjdbEW%3C7bNC%3ElaKc%2C%26WLRGt%269RHrOCFxBoocF)uhFAkD%3Dv%3Cy%5Dv%5BLy*hgMcpk%3FqFm%5Dm%22%2Bx%7Co%3Ee%7CwR3yC%7CQ%5Elv%3Ch%2CeI8!A2QnbjPSI.%24ki)sV~1HmDkx2KD5pf5%5BG%5BZFZ8R6tbK0pH%23bU%24(9N%2CNJJ)%2CW%2FKo7FY&th=4007238046&tf=nMzjG---CSa7H-fUfHv-j7VIQD-xFQTS-nMzjG-&vi=111111&qp=00000&is=BBBBB2IUEY4vGl2BBCBBtUTBBRmsqbKW8BsrBu0rCFE48CRBeeBS2hWTMQSQeQBBn2soYggyUig0CBlWZ0uBBCCCCCCOgRBBiOfnE6Skg7OxBb8MxOtJYHCBdm5kBhBBC9Y8oBXckXBR76iUUsJBCBBBBBBBBBWBSqj3BBBZeGV2BBBCMciUBBBjgEBBBBBB94UMgTdJMtEcpMBBBQBBBniOccypBsrB41kNBBBBBBBBBBBBBhcjG6BBJM2L4Bk8BwCBQmIoRBBCzBz1BBCTCyBBrbjBC4ehueB57NG9aJfR0BqEKiuwBBBB&iv=8&qt=0&gz=0&hh=0&hn=0&tw=&qc=0&qd=0&qf=1600&qe=1200&qh=1600&qg=1200&qm=-120&qa=1600&qb=1200&qi=1600&qj=1200&to=00&po=1-0020002000002120&vy=&ql=&qo=0&qr=0&vf=1&vg=100&bq=0&g=2&hq=0&hs=0&hu=0&hr=0&ht=0&dnt=0&h=250&w=300&fy=0&gp=0&zGSRC=1&gu=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&id=1&ii=4&f=0&j=&t=1591983780493&de=333246576571&cu=1591983780493&m=1092&ar=c34ad4f880-clean&iw=821c7c5&cb=0&ym=0&rd=1&ll=2&lm=0&ln=1&r=0&dl=0&dn=0&gh=1&xx=undefined%3A875484570224&td=1&lk=undefined&lb=3004&le=1&gm=1&io=1&ch=0&vv=1&vw=1%3A3%3A0&vp=100&vx=100%3A100%3A-&pe=1%3A1246%3A1246%3A0%3A1394&as=1&ag=1056&an=1056&gi=1&gf=1056&gg=1056&ix=1056&ic=1056&ez=1&ck=1056&kw=878&aj=1&pg=100&pf=100&ib=0&cc=1&bw=1056&bx=1056&ci=1056&jz=878&dj=1&aa=0&ad=949&cn=949&gk=949&gl=949&ik=949&cq=1&im=1&in=1&pd=1&nb=1&em=0&en=0&st=1&su=1&of=1&oz=1&oe=1%3A1%3A0%3Anull%3A-1%3Anull%3A-1%3Anull%3A-1&bu=878&cd=878&ah=878&am=878&rf=0&re=1&ft=949&fv=949&fw=949&wb=1&cl=0&at=0&d=4874126281%3A2696286467%3A5374575282%3A138311932788&bo=21946295198&bp=21988232143&bd=300_1_lft&zMoatPS=300_1_lft&gw=pentonmedia53440730609&zMoatOrigSlicer1=21946295198&zMoatOrigSlicer2=21988232143&zMoatDomain=globalpharmainsights.com&zMoatSubdomain=globalpharmainsights.com&dfp=0%2C1&la=21988232143&hv=Standard%20Image%20Ad%20finding%20&ab=1&ac=1&fd=1&kt=strict&it=500&fz=1&oq=1&ot=ff&zMoatJS=3%3A-&ti=0&ih=1&tc=0&fs=181543&na=1621626627&cs=0
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 72.247.226.64 , United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS: a72-247-226-64.deploy.static.akamaitechnologies.com
Software: AkamaiNetStorage /
Resource Hash: cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma: no-cache
date: Fri, 12 Jun 2020 17:43:01 GMT
last-modified: Fri, 20 May 2016 15:16:00 GMT
server: AkamaiNetStorage
etag: "ad4b0f606e0f8465bc4c4c170b37e1a3:1463757360"
content-type: image/gif
status: 200
cache-control: max-age=0, no-cache, no-store
accept-ranges: bytes
content-length: 43
expires: Fri, 12 Jun 2020 17:43:01 GMT

GET
H2 200 pixel.gif
px.moatads.com/ 43 B
260 B 25ms
25ms Image
image/gif 72.247.226.64
AKAMAI-AS

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://px.moatads.com/pixel.gif?e=37&q=1&hp=1&wf=1&vb=11&kq=1&lo=0&uk=null&pk=1&wk=1&rk=1&tk=0&ak=-&i=PENTONMEDIA1&ud=undefined&qn=%604%7BZEYwoqI%24%5BK%2BdLLU)%2CMm~t8!b.%5BMhS%3A15.sn_003etW6~P6Jn)s)wC%24GL3jX%7BQqDOJ%3Eoy)G3p%2FhFjrR8CL6k%24)m3*%5B%605*mF%40%23b%3DhjdbEW%3C7bNC%3ElaKc%2C%26WLRGt%269RHrOCFxBoocF)uhFAkD%3Dv%3Cy%5Dv%5BLy*hgMcpk%3FqFm%5Dm%22%2Bx%7Co%3Ee%7CwR3yC%7CQ%5Elv%3Ch%2CeI8!A2QnbjPSI.%24ki)sV~1HmDkx2KD5pf5%5BG%5BZFZ8R6tbK0pH%23bU%24(9N%2CNJJ)%2CW%2FKo7FY&th=4007238046&tf=nMzjG---CSa7H-fUfHv-j7VIQD-xFQTS-nMzjG-&vi=111111&qp=00000&is=BBBBB2IUEY4vGl2BBCBBtUTBBRmsqbKW8BsrBu0rCFE48CRBeeBS2hWTMQSQeQBBn2soYggyUig0CBlWZ0uBBCCCCCCOgRBBiOfnE6Skg7OxBb8MxOtJYHCBdm5kBhBBC9Y8oBXckXBR76iUUsJBCBBBBBBBBBWBSqj3BBBZeGV2BBBCMciUBBBjgEBBBBBB94UMgTdJMtEcpMBBBQBBBniOccypBsrB41kNBBBBBBBBBBBBBhcjG6BBJM2L4Bk8BwCBQmIoRBBCzBz1BBCTCyBBrbjBC4ehueB57NG9aJfR0BqEKiuwBBBB&iv=8&qt=0&gz=0&hh=0&hn=0&tw=&qc=0&qd=0&qf=1600&qe=1200&qh=1600&qg=1200&qm=-120&qa=1600&qb=1200&qi=1600&qj=1200&to=00&po=1-0020002000002120&vy=&ql=&qo=0&qr=0&vf=1&vg=100&bq=0&g=3&hq=0&hs=0&hu=0&hr=0&ht=0&dnt=0&h=250&w=300&fy=0&gp=0&zGSRC=1&gu=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&id=1&ii=4&f=0&j=&t=1591983780493&de=333246576571&cu=1591983780493&m=1093&ar=c34ad4f880-clean&iw=821c7c5&cb=0&ym=0&rd=1&ll=2&lm=0&ln=1&r=0&dl=0&dn=0&gh=1&xx=undefined%3A875484570224&td=1&lk=undefined&lb=3004&le=1&gm=1&io=1&ch=0&vv=1&vw=1%3A3%3A0&vp=100&vx=100%3A100%3A-&pe=1%3A1246%3A1246%3A0%3A1394&as=1&ag=1056&an=1056&gi=1&gf=1056&gg=1056&ix=1056&ic=1056&ez=1&ck=1056&kw=878&aj=1&pg=100&pf=100&ib=0&cc=1&bw=1056&bx=1056&ci=1056&jz=878&dj=1&aa=0&ad=949&cn=949&gk=949&gl=949&ik=949&cq=1&im=1&in=1&pd=1&nb=1&em=0&en=0&st=1&su=1&of=1&oz=1&oe=1%3A1%3A0%3Anull%3A-1%3Anull%3A-1%3Anull%3A-1&bu=878&cd=878&ah=878&am=878&rf=0&re=1&ft=949&fv=949&fw=949&wb=1&cl=0&at=0&d=4874126281%3A2696286467%3A5374575282%3A138311932788&bo=21946295198&bp=21988232143&bd=300_1_lft&zMoatPS=300_1_lft&gw=pentonmedia53440730609&zMoatOrigSlicer1=21946295198&zMoatOrigSlicer2=21988232143&zMoatDomain=globalpharmainsights.com&zMoatSubdomain=globalpharmainsights.com&dfp=0%2C1&la=21988232143&hv=Standard%20Image%20Ad%20finding%20&ab=1&ac=1&fd=1&kt=strict&it=500&fz=1&oq=1&ot=ff&zMoatJS=3%3A-&ti=0&ih=1&tc=0&fs=181543&na=1130154719&cs=0
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 72.247.226.64 , United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS: a72-247-226-64.deploy.static.akamaitechnologies.com
Software: AkamaiNetStorage /
Resource Hash: cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma: no-cache
date: Fri, 12 Jun 2020 17:43:01 GMT
last-modified: Fri, 20 May 2016 15:16:00 GMT
server: AkamaiNetStorage
etag: "ad4b0f606e0f8465bc4c4c170b37e1a3:1463757360"
content-type: image/gif
status: 200
cache-control: max-age=0, no-cache, no-store
accept-ranges: bytes
content-length: 43
expires: Fri, 12 Jun 2020 17:43:01 GMT

GET
H2 200 pixel.gif
px.moatads.com/ 43 B
260 B 24ms
24ms Image
image/gif 72.247.226.64
AKAMAI-AS

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://px.moatads.com/pixel.gif?e=5&q=1&hp=1&wf=1&vb=11&kq=1&lo=0&uk=null&pk=1&wk=1&rk=1&tk=0&ak=-&i=PENTONMEDIA1&ud=undefined&qn=%604%7BZEYwoqI%24%5BK%2BdLLU)%2CMm~t8!b.%5BMhS%3A15.sn_003etW6~P6Jn)s)wC%24GL3jX%7BQqDOJ%3Eoy)G3p%2FhFjrR8CL6k%24)m3*%5B%605*mF%40%23b%3DhjdbEW%3C7bNC%3ElaKc%2C%26WLRGt%269RHrOCFxBoocF)uhFAkD%3Dv%3Cy%5Dv%5BLy*hgMcpk%3FqFm%5Dm%22%2Bx%7Co%3Ee%7CwR3yC%7CQ%5Elv%3Ch%2CeI8!A2QnbjPSI.%24ki)sV~1HmDkx2KD5pf5%5BG%5BZFZ8R6tbK0pH%23bU%24(9N%2CNJJ)%2CW%2FKo7FY&th=4007238046&tf=nMzjG---CSa7H-fUfHv-j7VIQD-xFQTS-nMzjG-&vi=111111&qp=00000&is=BBBBB2IUEY4vGl2BBCBBtUTBBRmsqbKW8BsrBu0rCFE48CRBeeBS2hWTMQSQeQBBn2soYggyUig0CBlWZ0uBBCCCCCCOgRBBiOfnE6Skg7OxBb8MxOtJYHCBdm5kBhBBC9Y8oBXckXBR76iUUsJBCBBBBBBBBBWBSqj3BBBZeGV2BBBCMciUBBBjgEBBBBBB94UMgTdJMtEcpMBBBQBBBniOccypBsrB41kNBBBBBBBBBBBBBhcjG6BBJM2L4Bk8BwCBQmIoRBBCzBz1BBCTCyBBrbjBC4ehueB57NG9aJfR0BqEKiuwBBBB&iv=8&qt=0&gz=0&hh=0&hn=0&tw=&qc=0&qd=0&qf=1600&qe=1200&qh=1600&qg=1200&qm=-120&qa=1600&qb=1200&qi=1600&qj=1200&to=00&po=1-0020002000002120&vy=&ql=&qo=0&qr=0&vf=1&vg=100&bq=0&g=4&hq=0&hs=0&hu=0&hr=0&ht=0&dnt=0&h=250&w=300&fy=0&gp=0&zGSRC=1&gu=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&id=1&ii=4&f=0&j=&t=1591983780493&de=333246576571&cu=1591983780493&m=1295&ar=c34ad4f880-clean&iw=821c7c5&cb=0&ym=0&rd=1&ll=2&lm=0&ln=1&r=0&dl=0&dn=0&gh=1&xx=undefined%3A875484570224&td=1&lk=undefined&lb=3004&le=1&gm=1&io=1&ch=0&vv=1&vw=1%3A3%3A0&vp=100&vx=100%3A100%3A-&pe=1%3A1246%3A1246%3A0%3A1394&as=1&ag=1260&an=1056&gi=1&gf=1260&gg=1056&ix=1260&ic=1260&ez=1&ck=1056&kw=878&aj=1&pg=100&pf=100&ib=0&cc=1&bw=1260&bx=1056&ci=1056&jz=878&dj=1&aa=1&ad=1153&cn=949&gn=1&gk=1153&gl=949&ik=1153&co=1153&cp=1080&cq=1&im=1&in=1&pd=1&nb=1&em=0&en=0&st=1&su=1&of=1&oz=1&oe=1%3A1%3A0%3Anull%3A-1%3Anull%3A-1%3Anull%3A-1&bu=1080&cd=878&ah=1080&am=878&rf=0&re=1&ft=1153&fv=949&fw=949&wb=1&cl=0&at=0&d=4874126281%3A2696286467%3A5374575282%3A138311932788&bo=21946295198&bp=21988232143&bd=300_1_lft&zMoatPS=300_1_lft&gw=pentonmedia53440730609&zMoatOrigSlicer1=21946295198&zMoatOrigSlicer2=21988232143&zMoatDomain=globalpharmainsights.com&zMoatSubdomain=globalpharmainsights.com&dfp=0%2C1&la=21988232143&hv=Standard%20Image%20Ad%20finding%20&ab=1&ac=1&fd=1&kt=strict&it=500&fz=1&oq=1&ot=ff&zMoatJS=3%3A-&ti=0&ih=1&tc=0&fs=181543&na=740376576&cs=0
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 72.247.226.64 , United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS: a72-247-226-64.deploy.static.akamaitechnologies.com
Software: AkamaiNetStorage /
Resource Hash: cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma: no-cache
date: Fri, 12 Jun 2020 17:43:01 GMT
last-modified: Fri, 20 May 2016 15:16:00 GMT
server: AkamaiNetStorage
etag: "ad4b0f606e0f8465bc4c4c170b37e1a3:1463757360"
content-type: image/gif
status: 200
cache-control: max-age=0, no-cache, no-store
accept-ranges: bytes
content-length: 43
expires: Fri, 12 Jun 2020 17:43:01 GMT

GET
H/1.1 200
OK utsync.ashx Show response
ml314.com/ Frame 479B 36 B
2 KB 33ms
32ms Script
application/javascript 34.253.133.202
AMAZON-02

General

Check archive.org

Show headers Download Go to

Full URL: https://ml314.com/utsync.ashx?pub=&adv=&et=0&eid=62439&ct=js&pi=&fp=&clid=&if=1&ps=&cl=&mlt=&data=&&cp=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&pv=1591983780723_gg6dewhfl&bl=en-us&cb=3157439&return=&ht=&d=&dc=&si=1591983780723_gg6dewhfl&cid=&s=1600x1200&rp=
Requested by: Host: ml314.com
URL: https://ml314.com/tag.aspx?1252020
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 34.253.133.202 Dublin, Ireland, ASN16509 (AMAZON-02, US),
Reverse DNS: ec2-34-253-133-202.eu-west-1.compute.amazonaws.com
Software: Microsoft-IIS/10.0 / ASP.NET
Resource Hash: 92280389ae3e8444e0985f8e79e2d5081d0e8895b86dfeab86c288dde2f983aa

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Pragma: no-cache
Date: Fri, 12 Jun 2020 17:43:02 GMT
Content-Encoding: gzip
Server: Microsoft-IIS/10.0
X-AspNet-Version: 4.0.30319
X-Powered-By: ASP.NET
Vary: Accept-Encoding
p3P: CP="NON DSP COR ADMo PSAo DEVo BUS COM UNI NAV DEM STA"
Cache-Control: private
Connection: keep-alive
Content-Type: application/javascript; charset=utf-8
Content-Length: 157
Expires: 0

GET
H/1.1 200
OK ud.ashx Show response
in.ml314.com/ Frame 479B 20 B
481 B 498ms
182ms Script
application/javascript 54.84.119.213
AMAZON-AES

General

Check archive.org

Show headers Download Go to

Full URL: https://in.ml314.com/ud.ashx?topiclimit=&cb=1252020
Requested by: Host: ml314.com
URL: https://ml314.com/tag.aspx?1252020
Protocol: HTTP/1.1
Security: TLS 1.2, ECDHE_RSA, AES_128_GCM
Server: 54.84.119.213 Ashburn, United States, ASN14618 (AMAZON-AES, US),
Reverse DNS: ec2-54-84-119-213.compute-1.amazonaws.com
Software: Microsoft-IIS/8.5 / ASP.NET
Resource Hash: d0e4a6372d6fb5ffe9505dbe9e94aee8f1b9b96ec8e5e20684cce8b4c5a88fa7

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

Date: Fri, 12 Jun 2020 17:43:03 GMT
Content-Encoding: gzip
Server: Microsoft-IIS/8.5
X-AspNet-Version: 4.0.30319
X-Powered-By: ASP.NET
Vary: Accept-Encoding
Content-Type: application/javascript; charset=utf-8
Cache-Control: public
Connection: keep-alive
Content-Length: 138
Expires: Sat, 13 Jun 2020 17:43:04 GMT

GET
H2 200 pixel.gif
px.moatads.com/ 43 B
260 B 24ms
24ms Image
image/gif 72.247.226.64
AKAMAI-AS

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://px.moatads.com/pixel.gif?e=9&q=0&hp=1&wf=1&vb=11&kq=1&lo=0&uk=null&pk=1&wk=1&rk=1&tk=0&ak=-&i=PENTONMEDIA1&ud=undefined&qn=%604%7BZEYwoqI%24%5BK%2BdLLU)%2CMm~t8!b.%5BMhS%3A15.sn_003etW6~P6Jn)s)wC%24GL3jX%7BQqDOJ%3Eoy)G3p%2FhFjrR8CL6k%24)m3*%5B%605*mF%40%23b%3DhjdbEW%3C7bNC%3ElaKc%2C%26WLRGt%269RHrOCFxBoocF)uhFAkD%3Dv%3Cy%5Dv%5BLy*hgMcpk%3FqFm%5Dm%22%2Bx%7Co%3Ee%7CwR3yC%7CQ%5Elv%3Ch%2CeI8!A2QnbjPSI.%24ki)sV~1HmDkx2KD5pf5%5BG%5BZFZ8R6tbK0pH%23bU%24(9N%2CNJJ)%2CW%2FKo7FY&th=4007238046&tf=nMzjG---CSa7H-fUfHv-j7VIQD-xFQTS-nMzjG-&vi=111111&qp=00000&is=BBBBB2IUEY4vGl2BBCBBtUTBBRmsqbKW8BsrBu0rCFE48CRBeeBS2hWTMQSQeQBBn2soYggyUig0CBlWZ0uBBCCCCCCOgRBBiOfnE6Skg7OxBb8MxOtJYHCBdm5kBhBBC9Y8oBXckXBR76iUUsJBCBBBBBBBBBWBSqj3BBBZeGV2BBBCMciUBBBjgEBBBBBB94UMgTdJMtEcpMBBBQBBBniOccypBsrB41kNBBBBBBBBBBBBBhcjG6BBJM2L4Bk8BwCBQmIoRBBCzBz1BBCTCyBBrbjBC4ehueB57NG9aJfR0BqEKiuwBBBB&iv=8&qt=0&gz=0&hh=0&hn=0&tw=&qc=0&qd=0&qf=1600&qe=1200&qh=1600&qg=1200&qm=-120&qa=1600&qb=1200&qi=1600&qj=1200&to=00&po=1-0020002000002120&vy=&ql=&qo=0&qr=0&vf=1&vg=100&bq=0&g=5&hq=0&hs=0&hu=0&hr=0&ht=0&dnt=0&h=250&w=300&fy=0&gp=0&zGSRC=1&gu=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&id=1&ii=4&f=0&j=&t=1591983780493&de=333246576571&cu=1591983780493&m=5114&ar=c34ad4f880-clean&iw=821c7c5&cb=0&ym=0&rd=1&ll=2&lm=0&ln=1&r=0&dl=0&dn=0&gh=1&xx=undefined%3A875484570224&td=1&lk=undefined&lb=3004&le=1&gm=1&io=1&ch=0&vv=1&vw=1%3A3%3A0&vp=100&vx=100%3A100%3A-&pe=1%3A1246%3A1246%3A0%3A1394&as=1&ag=5079&an=1260&gi=1&gf=5079&gg=1260&ix=5079&ic=5079&ez=1&ck=1056&kw=878&aj=1&pg=100&pf=100&ib=0&cc=1&bw=5079&bx=1260&ci=1056&jz=878&dj=1&aa=1&ad=4972&cn=1153&gn=1&gk=4972&gl=1153&ik=4972&co=1153&cp=1080&cq=1&im=1&in=1&pd=1&nb=1&em=0&en=0&st=1&su=1&of=1&oz=1&oe=1%3A1%3A0%3Anull%3A-1%3Anull%3A-1%3Anull%3A-1&bu=4903&cd=1080&ah=4903&am=1080&rf=0&re=1&ft=4972&fv=1153&fw=949&wb=2&cl=0&at=0&d=4874126281%3A2696286467%3A5374575282%3A138311932788&bo=21946295198&bp=21988232143&bd=300_1_lft&zMoatPS=300_1_lft&gw=pentonmedia53440730609&zMoatOrigSlicer1=21946295198&zMoatOrigSlicer2=21988232143&zMoatDomain=globalpharmainsights.com&zMoatSubdomain=globalpharmainsights.com&dfp=0%2C1&la=21988232143&hv=Standard%20Image%20Ad%20finding%20&ab=1&ac=1&fd=1&kt=strict&it=500&fz=1&oq=1&ot=ff&zMoatJS=3%3A-&ti=0&ih=1&tc=0&fs=181543&na=386126556&cs=0
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 72.247.226.64 , United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS: a72-247-226-64.deploy.static.akamaitechnologies.com
Software: AkamaiNetStorage /
Resource Hash: cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma: no-cache
date: Fri, 12 Jun 2020 17:43:05 GMT
last-modified: Fri, 20 May 2016 15:16:00 GMT
server: AkamaiNetStorage
etag: "ad4b0f606e0f8465bc4c4c170b37e1a3:1463757360"
content-type: image/gif
status: 200
cache-control: max-age=0, no-cache, no-store
accept-ranges: bytes
content-length: 43
expires: Fri, 12 Jun 2020 17:43:05 GMT

GET
H2 200 pixel.gif
px.moatads.com/ 43 B
260 B 26ms
26ms Image
image/gif 72.247.226.64
AKAMAI-AS

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://px.moatads.com/pixel.gif?e=9&q=0&hp=1&wf=1&vb=11&kq=1&lo=0&uk=null&pk=1&wk=1&rk=1&tk=0&ak=-&i=PENTONMEDIA1&ud=undefined&qn=%604%7BZEYwoqI%24%5BK%2BdLLU)%2CMm~t8!b.%5BMhS%3A15.sn_003etW6~P6Jn)s)wC%24GL3jX%7BQqDOJ%3Eoy)G3p%2FhFjrR8CL6k%24)m3*%5B%605*mF%40%23b%3DhjdbEW%3C7bNC%3ElaKc%2C%26WLRGt%269RHrOCFxBoocF)uhFAkD%3Dv%3Cy%5Dv%5BLy*hgMcpk%3FqFm%5Dm%22%2Bx%7Co%3Ee%7CwR3yC%7CQ%5Elv%3Ch%2CeI8!A2QnbjPSI.%24ki)sV~1HmDkx2KD5pf5%5BG%5BZFZ8R6tbK0pH%23bU%24(9N%2CNJJ)%2CW%2FKo7FY&th=4007238046&tf=nMzjG---CSa7H-fUfHv-j7VIQD-xFQTS-nMzjG-&vi=111111&qp=00000&is=BBBBB2IUEY4vGl2BBCBBtUTBBRmsqbKW8BsrBu0rCFE48CRBeeBS2hWTMQSQeQBBn2soYggyUig0CBlWZ0uBBCCCCCCOgRBBiOfnE6Skg7OxBb8MxOtJYHCBdm5kBhBBC9Y8oBXckXBR76iUUsJBCBBBBBBBBBWBSqj3BBBZeGV2BBBCMciUBBBjgEBBBBBB94UMgTdJMtEcpMBBBQBBBniOccypBsrB41kNBBBBBBBBBBBBBhcjG6BBJM2L4Bk8BwCBQmIoRBBCzBz1BBCTCyBBrbjBC4ehueB57NG9aJfR0BqEKiuwBBBB&iv=8&qt=0&gz=0&hh=0&hn=0&tw=&qc=0&qd=0&qf=1600&qe=1200&qh=1600&qg=1200&qm=-120&qa=1600&qb=1200&qi=1600&qj=1200&to=00&po=1-0020002000002120&vy=&ql=&qo=0&qr=0&vf=1&vg=100&bq=0&g=1&hq=0&hs=0&hu=0&hr=0&ht=0&dnt=0&h=250&w=300&fy=0&gp=0&zGSRC=1&gu=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&id=1&ii=4&f=0&j=&t=1591983780609&de=924173565045&cu=1591983780609&m=5306&ar=c34ad4f880-clean&iw=821c7c5&cb=0&ym=0&rd=1&ll=2&lm=0&ln=1&r=0&dl=0&dn=0&gh=1&xx=undefined%3A875484570224&td=1&lk=undefined&lb=3004&le=1&gm=1&io=1&vv=1&vw=1%3A3%3A0&vp=38&vx=38%3A38%3A-&pe=1%3A1246%3A1246%3A0%3A1394&as=0&ag=533&an=2&gf=0&gg=0&ix=0&ic=0&ez=1&aj=1&pg=72&pf=72&ib=1&cc=0&bw=533&bx=2&dj=1&aa=0&ad=672&cn=0&gk=0&gl=0&ik=0&cq=1&im=0&in=0&pd=0&em=0&en=0&st=1&su=1&of=1&oz=1&oe=1%3A1%3A0%3Anull%3A-1%3Anull%3A-1%3Anull%3A-1&bu=5100&cd=4&ah=5100&am=4&rf=0&re=0&wb=1&cl=0&at=0&d=4874126281%3A2696286467%3A5374575282%3A138312304633&bo=21946295198&bp=21988232143&bd=300_1_rht&zMoatPS=300_1_rht&gw=pentonmedia53440730609&zMoatOrigSlicer1=21946295198&zMoatOrigSlicer2=21988232143&zMoatDomain=globalpharmainsights.com&zMoatSubdomain=globalpharmainsights.com&dfp=0%2C1&la=21988232143&hv=Standard%20Image%20Ad%20finding%20&ab=1&ac=1&fd=1&kt=strict&it=500&oq=0&ot=cc&zMoatJS=3%3A-&ti=0&ih=1&tc=0&fs=181543&na=390885579&cs=0
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 72.247.226.64 , United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS: a72-247-226-64.deploy.static.akamaitechnologies.com
Software: AkamaiNetStorage /
Resource Hash: cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma: no-cache
date: Fri, 12 Jun 2020 17:43:05 GMT
last-modified: Fri, 20 May 2016 15:16:00 GMT
server: AkamaiNetStorage
etag: "ad4b0f606e0f8465bc4c4c170b37e1a3:1463757360"
content-type: image/gif
status: 200
cache-control: max-age=0, no-cache, no-store
accept-ranges: bytes
content-length: 43
expires: Fri, 12 Jun 2020 17:43:05 GMT

GET
H2 200 pixel.gif
px.moatads.com/ 43 B
260 B 24ms
23ms Image
image/gif 72.247.226.64
AKAMAI-AS

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://px.moatads.com/pixel.gif?e=9&q=1&hp=1&wf=1&vb=11&kq=1&lo=0&uk=null&pk=1&wk=1&rk=1&tk=0&ak=-&i=PENTONMEDIA1&ud=undefined&qn=%604%7BZEYwoqI%24%5BK%2BdLLU)%2CMm~t8!b.%5BMhS%3A15.sn_003etW6~P6Jn)s)wC%24GL3jX%7BQqDOJ%3Eoy)G3p%2FhFjrR8CL6k%24)m3*%5B%605*mF%40%23b%3DhjdbEW%3C7bNC%3ElaKc%2C%26WLRGt%269RHrOCFxBoocF)uhFAkD%3Dv%3Cy%5Dv%5BLy*hgMcpk%3FqFm%5Dm%22%2Bx%7Co%3Ee%7CwR3yC%7CQ%5Elv%3Ch%2CeI8!A2QnbjPSI.%24ki)sV~1HmDkx2KD5pf5%5BG%5BZFZ8R6tbK0pH%23bU%24(9N%2CNJJ)%2CW%2FKo7FY&th=4007238046&tf=nMzjG---CSa7H-fUfHv-j7VIQD-xFQTS-nMzjG-&vi=111111&qp=00000&is=BBBBB2IUEY4vGl2BBCBBtUTBBRmsqbKW8BsrBu0rCFE48CRBeeBS2hWTMQSQeQBBn2soYggyUig0CBlWZ0uBBCCCCCCOgRBBiOfnE6Skg7OxBb8MxOtJYHCBdm5kBhBBC9Y8oBXckXBR76iUUsJBCBBBBBBBBBWBSqj3BBBZeGV2BBBCMciUBBBjgEBBBBBB94UMgTdJMtEcpMBBBQBBBniOccypBsrB41kNBBBBBBBBBBBBBhcjG6BBJM2L4Bk8BwCBQmIoRBBCzBz1BBCTCyBBrbjBC4ehueB57NG9aJfR0BqEKiuwBBBB&iv=8&qt=0&gz=0&hh=0&hn=0&tw=&qc=0&qd=0&qf=1600&qe=1200&qh=1600&qg=1200&qm=-120&qa=1600&qb=1200&qi=1600&qj=1200&to=00&po=1-0020002000002120&vy=&ql=&qo=0&qr=0&vf=1&vg=100&bq=0&g=6&hq=0&hs=0&hu=0&hr=0&ht=0&dnt=0&h=250&w=300&fy=0&gp=0&zGSRC=1&gu=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&id=1&ii=4&f=0&j=&t=1591983780493&de=333246576571&cu=1591983780493&m=10144&ar=c34ad4f880-clean&iw=821c7c5&cb=0&ym=0&rd=1&ll=2&lm=0&ln=1&r=0&dl=0&dn=0&gh=1&xx=undefined%3A875484570224&td=1&lk=undefined&lb=3004&le=1&gm=1&io=1&ch=0&vv=1&vw=1%3A3%3A0&vp=100&vx=100%3A100%3A-&pe=1%3A1246%3A1246%3A0%3A1394&as=1&ag=10110&an=5079&gi=1&gf=10110&gg=5079&ix=10110&ic=10110&ez=1&ck=1056&kw=878&aj=1&pg=100&pf=100&ib=0&cc=1&bw=10110&bx=5079&ci=1056&jz=878&dj=1&aa=1&ad=10003&cn=4972&gn=1&gk=10003&gl=4972&ik=10003&co=1153&cp=1080&cq=1&im=1&in=1&pd=1&nb=1&em=0&en=0&st=1&su=1&of=1&oz=1&oe=1%3A1%3A0%3Anull%3A-1%3Anull%3A-1%3Anull%3A-1&bu=9933&cd=4903&ah=9933&am=4903&rf=0&re=1&ft=5073&fv=4972&fw=949&wb=2&cl=0&at=0&d=4874126281%3A2696286467%3A5374575282%3A138311932788&bo=21946295198&bp=21988232143&bd=300_1_lft&zMoatPS=300_1_lft&gw=pentonmedia53440730609&zMoatOrigSlicer1=21946295198&zMoatOrigSlicer2=21988232143&zMoatDomain=globalpharmainsights.com&zMoatSubdomain=globalpharmainsights.com&dfp=0%2C1&la=21988232143&hv=Standard%20Image%20Ad%20finding%20&ab=1&ac=1&fd=1&kt=strict&it=500&fz=1&oq=1&ot=ff&zMoatJS=3%3A-&ti=0&ih=1&tc=0&fs=181543&na=1889127478&cs=0
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 72.247.226.64 , United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS: a72-247-226-64.deploy.static.akamaitechnologies.com
Software: AkamaiNetStorage /
Resource Hash: cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma: no-cache
date: Fri, 12 Jun 2020 17:43:10 GMT
last-modified: Fri, 20 May 2016 15:16:00 GMT
server: AkamaiNetStorage
etag: "ad4b0f606e0f8465bc4c4c170b37e1a3:1463757360"
content-type: image/gif
status: 200
cache-control: max-age=0, no-cache, no-store
accept-ranges: bytes
content-length: 43
expires: Fri, 12 Jun 2020 17:43:10 GMT

GET
H2 200 pixel.gif
px.moatads.com/ 43 B
260 B 24ms
23ms Image
image/gif 72.247.226.64
AKAMAI-AS

General

Check archive.org

Show headers Download Go to Show image

Full URL: https://px.moatads.com/pixel.gif?e=9&q=1&hp=1&wf=1&vb=11&kq=1&lo=0&uk=null&pk=1&wk=1&rk=1&tk=0&ak=-&i=PENTONMEDIA1&ud=undefined&qn=%604%7BZEYwoqI%24%5BK%2BdLLU)%2CMm~t8!b.%5BMhS%3A15.sn_003etW6~P6Jn)s)wC%24GL3jX%7BQqDOJ%3Eoy)G3p%2FhFjrR8CL6k%24)m3*%5B%605*mF%40%23b%3DhjdbEW%3C7bNC%3ElaKc%2C%26WLRGt%269RHrOCFxBoocF)uhFAkD%3Dv%3Cy%5Dv%5BLy*hgMcpk%3FqFm%5Dm%22%2Bx%7Co%3Ee%7CwR3yC%7CQ%5Elv%3Ch%2CeI8!A2QnbjPSI.%24ki)sV~1HmDkx2KD5pf5%5BG%5BZFZ8R6tbK0pH%23bU%24(9N%2CNJJ)%2CW%2FKo7FY&th=4007238046&tf=nMzjG---CSa7H-fUfHv-j7VIQD-xFQTS-nMzjG-&vi=111111&qp=00000&is=BBBBB2IUEY4vGl2BBCBBtUTBBRmsqbKW8BsrBu0rCFE48CRBeeBS2hWTMQSQeQBBn2soYggyUig0CBlWZ0uBBCCCCCCOgRBBiOfnE6Skg7OxBb8MxOtJYHCBdm5kBhBBC9Y8oBXckXBR76iUUsJBCBBBBBBBBBWBSqj3BBBZeGV2BBBCMciUBBBjgEBBBBBB94UMgTdJMtEcpMBBBQBBBniOccypBsrB41kNBBBBBBBBBBBBBhcjG6BBJM2L4Bk8BwCBQmIoRBBCzBz1BBCTCyBBrbjBC4ehueB57NG9aJfR0BqEKiuwBBBB&iv=8&qt=0&gz=0&hh=0&hn=0&tw=&qc=0&qd=0&qf=1600&qe=1200&qh=1600&qg=1200&qm=-120&qa=1600&qb=1200&qi=1600&qj=1200&to=00&po=1-0020002000002120&vy=&ql=&qo=0&qr=0&vf=1&vg=100&bq=0&g=2&hq=0&hs=0&hu=0&hr=0&ht=0&dnt=0&h=250&w=300&fy=0&gp=0&zGSRC=1&gu=https%3A%2F%2Fwww.globalpharmainsights.com%2Fmanufacturing-outsourcing%2Fgilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir%3Futm_campaign%3DHLN00GPI-ES-AWARENESS-GENERAL1%26utm_emailname%3DHLN00GPI-ES-AWARENESS-EM1%252F1-FEATURES%26utm_medium%3Demail%26utm_source%3DEloqua%26utm_MDMContactID%3Df3bea1f6-c791-47dc-8d2d-b71160403f3f%26utm_campaigntype%3DOthers%26utm_sub%3DIntroducing%2520your%2520new%2520knowledge%2520platform%253A%2520Global%2520Pharma%2520Insights%26eM%3D99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b%26eventSeriesCode%3DES_GLBPHARINS%26eventEditionCode%3DHLN00GPI%26SessionCode%3DNULL&id=1&ii=4&f=0&j=&t=1591983780609&de=924173565045&cu=1591983780609&m=10334&ar=c34ad4f880-clean&iw=821c7c5&cb=0&ym=0&rd=1&ll=2&lm=0&ln=1&r=0&dl=0&dn=0&gh=1&xx=undefined%3A875484570224&td=1&lk=undefined&lb=3004&le=1&gm=1&io=1&vv=1&vw=1%3A3%3A0&vp=38&vx=38%3A38%3A-&pe=1%3A1246%3A1246%3A0%3A1394&as=0&ag=533&an=533&gf=0&gg=0&ix=0&ic=0&ez=1&aj=1&pg=72&pf=72&ib=1&cc=0&bw=533&bx=533&dj=1&aa=0&ad=672&cn=672&gk=0&gl=0&ik=0&cq=1&im=0&in=0&pd=0&em=0&en=0&st=1&su=1&of=1&oz=1&oe=1%3A1%3A0%3Anull%3A-1%3Anull%3A-1%3Anull%3A-1&bu=10128&cd=5100&ah=10128&am=5100&rf=0&re=0&wb=1&cl=0&at=0&d=4874126281%3A2696286467%3A5374575282%3A138312304633&bo=21946295198&bp=21988232143&bd=300_1_rht&zMoatPS=300_1_rht&gw=pentonmedia53440730609&zMoatOrigSlicer1=21946295198&zMoatOrigSlicer2=21988232143&zMoatDomain=globalpharmainsights.com&zMoatSubdomain=globalpharmainsights.com&dfp=0%2C1&la=21988232143&hv=Standard%20Image%20Ad%20finding%20&ab=1&ac=1&fd=1&kt=strict&it=500&oq=0&ot=cc&zMoatJS=3%3A-&ti=0&ih=1&tc=0&fs=181543&na=1545282529&cs=0
Protocol: H2
Security: TLS 1.3, , AES_256_GCM
Server: 72.247.226.64 , United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS: a72-247-226-64.deploy.static.akamaitechnologies.com
Software: AkamaiNetStorage /
Resource Hash: cf4724b2f736ed1a0ae6bc28f1ead963d9cd2c1fd87b6ef32e7799fc1c5c8bda

Request headers

Referer: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL
User-Agent: Mozilla/5.0 (Macintosh; Intel Mac OS X 10_14_5) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/83.0.4103.61 Safari/537.36

Response headers

pragma: no-cache
date: Fri, 12 Jun 2020 17:43:10 GMT
last-modified: Fri, 20 May 2016 15:16:00 GMT
server: AkamaiNetStorage
etag: "ad4b0f606e0f8465bc4c4c170b37e1a3:1463757360"
content-type: image/gif
status: 200
cache-control: max-age=0, no-cache, no-store
accept-ranges: bytes
content-length: 43
expires: Fri, 12 Jun 2020 17:43:10 GMT

Verdicts & Comments Add Verdict or Comment

157 JavaScript Global Variables

These are the non-standard "global" variables defined on the window object. These can be helpful in identifying possible client-side frameworks and code.

24 Cookies

Cookies are little pieces of information stored in the browser of a user. Whenever a user visits the site again, he will also send his cookie values, thus allowing the website to re-identify him even if he changed locations. This is how permanent logins work.

Domain/Path	Expires	Name / Value
.demdex.net/	1970-01-19 14:32:15	Name: demdex Value: 70003426728527337834171526736603995012
.globalpharmainsights.com/	1969-12-31 23:59:59	Name: s_ppv Value: Gilead%2520signs%2520agreements%2520with%2520generics%2520firms%2520to%2520manufacture%2520and%2520market%2520remdesivir%2C40%2C40%2C1200
.globalpharmainsights.com/	1969-12-31 23:59:59	Name: AMCVS_DD4C6A00570E3C0F7F000101%40AdobeOrg Value: 1
www.globalpharmainsights.com/	1970-01-19 18:58:39	Name: Drupal.legal[119][confirm] Value: 0
.globalpharmainsights.com/	1969-12-31 23:59:59	Name: _hjid Value: b9906e63-cfaa-4b25-b139-464b273e0792
www.globalpharmainsights.com/	1970-01-19 18:58:39	Name: Drupal.legal[119][for_review] Value: 0
.globalpharmainsights.com/	1969-12-31 23:59:59	Name: s_tp Value: 3004
.globalpharmainsights.com/	1970-01-19 10:46:23	Name: aucp13n Value: w9v6dh
www.globalpharmainsights.com/	1969-12-31 23:59:59	Name: dpm_url_count Value: 1
.globalpharmainsights.com/	1970-01-20 03:44:15	Name: __gads Value: ID=69099b46254b0af4:T=1591983779:S=ALNI_MaeRphoY9RL7Mx8Nz0L4aqW7IDznw
.globalpharmainsights.com/	1970-01-19 10:56:15	Name: s_campaign Value: email%3AEloqua%3A%3A%3A%3AHLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES%3Af3bea1f6-c791-47dc-8d2d-b71160403f3f%3AOthers%3AIntroducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights
.globalpharmainsights.com/	1970-01-20 03:44:15	Name: AMCV_DD4C6A00570E3C0F7F000101%40AdobeOrg Value: -432600572%7CMCIDTS%7C18426%7CMCMID%7C70257649895089538484126005266317095467%7CMCAAMLH-1592588579%7C6%7CMCAAMB-1592588579%7C6G1ynYcLPuiQxYZrsz_pkqfLG9yMXBpb2zX5dvJdYQJzPXImdj0y%7CMCOPTOUT-1591990979s%7CNONE%7CMCSYNCSOP%7C411-18433%7CvVersion%7C4.5.2
.globalpharmainsights.com/	1970-01-19 10:13:05	Name: s_lv_s Value: First%20Visit
.globalpharmainsights.com/	1970-01-20 12:29:51	Name: s_lv Value: 1591983780247
www.globalpharmainsights.com/manufacturing-outsourcing	1969-12-31 23:59:59	Name: hasLiveRampMatch Value: true
www.globalpharmainsights.com/	1969-12-31 23:59:59	Name: has_js Value: 1
.globalpharmainsights.com/	1970-01-19 10:46:23	Name: SSESSabb96de343dde80a1e2e8a1591776328 Value: Lj1SRVdogv1PpwQOISdyTZMg7XDTk12gTJnqOadYw3g
.globalpharmainsights.com/	1969-12-31 23:59:59	Name: s_cc Value: true
www.globalpharmainsights.com/	1970-01-19 18:58:39	Name: Drupal.legal[119][nid] Value: 119
www.globalpharmainsights.com/manufacturing-outsourcing	1970-01-21 06:01:03	Name: penton_gdpr_cookie Value: 1
.globalpharmainsights.com/	1970-01-19 10:13:05	Name: gpv_pn Value: Gilead%20signs%20agreements%20with%20generics%20firms%20to%20manufacture%20and%20market%20remdesivir
.globalpharmainsights.com/	1970-01-19 12:22:39	Name: _fbp Value: fb.1.1591983780641.539611721
www.globalpharmainsights.com/	1970-01-19 10:14:30	Name: utm_parameters Value: utm_source:Eloqua,utm_medium:email,utm_campaign:HLN00GPI-ES-AWARENESS-GENERAL1,utmMDMContactID:f3bea1f6-c791-47dc-8d2d-b71160403f3f,utm_content:undefined,utm_term:undefined,utm_refCode:undefined
www.globalpharmainsights.com/	1970-01-19 18:58:39	Name: Drupal.legal[119][count] Value: 1

8 Console Messages

A page may trigger messages to the console to be logged. These are often error messages about being unable to load a resource or execute a piece of JavaScript. Sometimes they also provide insight into the technology behind a website.

Source	Level	URL Text
console-api	log	URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL(Line 68) Message: gdpr cookie not set
console-api	log	URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL(Line 73) Message: gdprCookie==>on
console-api	log	URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL(Line 77) Message: lpage==>notblocked
console-api	log	URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL(Line 126) Message: emptyInterstitial
console-api	log	URL: https://assets.adobedtm.com/100e8b570010/c89496dc0f21/launch-560312491757.min.js(Line 6) Message: Account - ,informaglobalprod
console-api	log	URL: https://assets.adobedtm.com/100e8b570010/c89496dc0f21/launch-560312491757.min.js(Line 6) Message: MC Rule: email:Eloqua::::HLN00GPI-ES-AWARENESS-EM1/1-FEATURES:f3bea1f6-c791-47dc-8d2d-b71160403f3f:Others:Introducing your new knowledge platform: Global Pharma Insights
console-api	log	URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL(Line 110) Message: adblockval
console-api	log	URL: https://www.globalpharmainsights.com/manufacturing-outsourcing/gilead-signs-agreements-generics-firms-manufacture-and-market-remdesivir?utm_campaign=HLN00GPI-ES-AWARENESS-GENERAL1&utm_emailname=HLN00GPI-ES-AWARENESS-EM1%2F1-FEATURES&utm_medium=email&utm_source=Eloqua&utm_MDMContactID=f3bea1f6-c791-47dc-8d2d-b71160403f3f&utm_campaigntype=Others&utm_sub=Introducing%20your%20new%20knowledge%20platform%3A%20Global%20Pharma%20Insights&eM=99989a0aed9527a7a0bd4da6f4980e5c7277acca90b3f52fd903eff4d1f05f5b&eventSeriesCode=ES_GLBPHARINS&eventEditionCode=HLN00GPI&SessionCode=NULL(Line 110) Message: 0

Security Headers

This page lists any security headers set by the main page. If you want to understand what these mean and how to use them, head on over to this page

Header	Value
X-Content-Type-Options	nosniff
X-Frame-Options	SAMEORIGIN

Indicators

This is a term in the security industry to describe indicators such as IPs, Domains, Hashes, etc. This does not imply that any of these indicate malicious activity.

a.dpmsrv.com
adservice.google.de
app.go02.informamarkets.com
assets.adobedtm.com
assets.pinterest.com
bcp.crwdcntrl.net
cm.everesttech.net
cm.g.doubleclick.net
connect.facebook.net
csi.gstatic.com
d.adroll.com
d.adroll.mgr.consensu.org
dpm.demdex.net
ed730ada98a1d488854a0d81e1ecf867.safeframe.googlesyndication.com
geo.moatads.com
googleads.g.doubleclick.net
ib.adnxs.com
idsync.rlcdn.com
in.ml314.com
informaglobalexhibitions.d3.sc.omtrdc.net
informaglobalexhibitions.demdex.net
log.pinterest.com
ml314.com
p.typekit.net
pagead2.googlesyndication.com
px.moatads.com
s.adroll.com
s.delvenetworks.com
s.dpmsrv.com
s734445500.t.eloqua.com
script.hotjar.com
securepubads.g.doubleclick.net
static.hotjar.com
tags.crwdcntrl.net
tpc.googlesyndication.com
use.typekit.net
vars.hotjar.com
video.limelight.com
www.facebook.com
www.globalpharmainsights.com
www.google.com
www.google.de
www.googleadservices.com
www.googletagmanager.com
www.googletagservices.com
z.moatads.com
141.145.8.13
141.145.8.14
143.204.237.68
143.204.237.71
143.204.89.116
147.75.101.5
147.75.33.229
147.75.33.233
15.188.154.177
151.101.12.84
172.217.22.98
172.217.23.130
178.79.227.128
178.79.245.69
216.58.210.2
2606:4700::6812:fb0
2a00:1450:4001:800::2002
2a00:1450:4001:802::2001
2a00:1450:4001:808::2002
2a00:1450:4001:809::2001
2a00:1450:4001:814::2003
2a00:1450:4001:819::2004
2a00:1450:4001:81d::2002
2a00:1450:4001:821::2002
2a00:1450:4001:825::2008
2a00:1450:4017:802::2003
2a01:4a0:1338:28::c38a:ff0a
2a02:26f0:10c:287::19fd
2a02:26f0:10c:382::1e80
2a03:2880:f01c:8012:face:b00c:0:3
2a03:2880:f11c:8183:face:b00c:0:25de
3.248.3.168
34.192.142.95
34.241.125.133
34.253.133.202
35.177.118.109
35.241.8.149
37.252.172.250
54.171.23.184
54.229.146.68
54.84.119.213
66.117.28.86
72.247.224.172
72.247.226.64
99.80.128.92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www.globalpharmainsights.com Open in urlscan Pro 143.204.237.71 Public Scan

Summary

urlscan.io Verdict: No classification

Domain & IP information

Screenshot Live screenshot Full Image

Page URL History Show full URLs

Detected technologies

Page Statistics

152 Requests

100 %HTTPS

36 %IPv6

30 Domains

46 Subdomains

39 IPs

9 Countries

1945 kBTransfer

6138 kBSize

24 Cookies

28 Outgoing links

Page URL History

Redirected requests

152 HTTP transactions Everything HTML Script AJAX CSS Image Expand all 3 data transactions

Request headers

Response headers

Redirect headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Redirect headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

Request headers

Response headers

www.globalpharmainsights.com Open in urlscan Pro
143.204.237.71 Public Scan

Screenshot
Live screenshot

Full Image

152
Requests

100 %
HTTPS

36 %
IPv6

30
Domains

46
Subdomains

39
IPs

9
Countries

1945 kB
Transfer

6138 kB
Size

24
Cookies

152 HTTP transactions
3 data transactions